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Abstract
Prodiginines are a large family of red-pigmented tripyrrole-based antibiotics.
Their biosynthesis in Streptomyces coelicolor A3(2), by enzymes encoded in the
red gene cluster, involves the condensation of 4-methoxy-2,2′-bipyrrole-5-
carboxaldehyde (MBC) and 2-undecylpyrrole, catalysed by the RedH enzyme to
give undecylprodiginine. This is followed by the mechanistically interesting
oxidative carbocyclisation, catalysed by RedG to give streptorubin B.
In this thesis prodiginine analogues have been generated by a mutasynthetic
approach, in which chemically synthesised analogues of intermediates MBC and
2-undecylpyrrole were fed to mutant strains of S. coelicolor in which one of the
genes required to biosynthesise MBC or 2-undecylpyrrole (redM or redL
respectively) have been deleted. RedH and RedG have been shown to display
relatively broad substrate tolerances and several analogues of both
undecylprodiginine and streptorubin B have been generated by this approach. A
variety of factors which are potentially limiting to substrate tolerances have been
probed, including the steric size, alkyl chain hydrophobicity and introduction of
π-electrons.  
The absolute stereochemistry of streptorubin B has been investigated by a
mutasynthetic approach in which 2-undecylpyrrole, stereospecifically labelled
with deuterium, is fed to a mutant strain of S. coelicolor unable to biosynthesise
2-undecylpyrrole. During the course of the investigation streptorubin B was
analysed on a homochiral stationary phase HPLC and evidence of both ent- and
dia-streptorubin B was discovered in the natural product isolated from S.
coelicolor. When the position of the deuterium label from the mutasynthesis
experiment was investigated by 1H-NMR and 2H-NMR the partial epimerization
of the synthetic material became apparent. This made the definitive
determination of the absolute stereochemistry of streptorubin B impossible.
However, a tentative assignment of the absolute stereochemistry was possible.
This was supported by comparison with the related natural products
metacycloprodigiosin, the stereochemistry of which was established here by CD
spectroscopy and chiral HPLC analyses, and roseophilin.
11.0 Introduction
1.1 Introduction to the prodiginine antibiotics
Prodiginines are a large family of red-pigmented antibiotics produced by
actinomycetes and other eubacteria. Their structure is based around the
tripyrrole nucleus observed in prodigiosin 1 (Figure 1), which is the major
pigment observed in Serratia marcescens. Prodigiosin was first isolated in 1902
but not structurally resolved until 1960.1 Since its discovery, several prodigiosin-
like pigments have been isolated. Gerber proposed prodiginine as a trivial name
for the group of compounds which contain the common tripyrrole aromatic
moiety, in which three pyrrole rings are linked in a highly conjugated system 2
(Figure 1).2
Figure 1: Prodigiosin 1 and the prodiginines general structure 2
Among the known prodiginines most are produced by actinomycetes including
the linear undecylprodiginine 3 (Figure 2), originally isolated from Streptomyces
sp. Y-42, and several isomeric cyclic derivatives like butyl-meta-
cycloheptylprodiginine (Streptorubin B) 4, meta-cyclo-prodigiosin (ethyl-meta-
cyclononylprodigiosin, streptorubin A) 5,3 nonylprodigiosin 6, isolated from
Actinomadura madurae,4 and roseophilin 8, isolated from Streptomyces
griseoviridis which can be considered of related structure (Figure 2).5
Roseophilin actually contains a methoxyfuran in place of the methoxypyrrole ring
but shares the conjugated core structure of the prodiginine antibiotics. These
natural products all possess high levels of biological activity, and although they
2have found no current clinical use due to their high non-specific cytotoxicity,
(thought to result from their ability to facilitate double strand DNA cleavage in the
presence of Cu2+ ions and molecular oxygen)6 their pharmacological activity
makes their study of interest. These structurally intriguing metabolites have
already been shown to possess immunosuppressant properties at non-toxic
doses, 7, 8, 9, 10, 11 and the cyclic prodiginines, most notably metacycloprodigiosin
5 (streptorubin A), have been shown to display strong anti-malarial activity.12
Furthermore a synthetic prodiginine analogue, obatoclax 7 (Figure 2), is
currently in phase 1/2 clinical trials for a variety of solid tumours and multiple
myeloma.13 The activity of obatoclax appears to derive from its interaction with
the Bcl-2 family of proteins, which are involved in mediating apoptotic processes
within the cell. Anti-apoptotic Bcl-2 proteins (Bcl-xL, Mcl-1, and Bcl-2 itself) have
been shown to be overproduced in numerous cancer cell lines,14, 15making them
promising targets for oncology treatments. 16, 17 The Bcl-2 family of proteins are
known to bind to pro-apoptotic proteins within the cell (including Bad, Bid and
Bim), which are involved in initiating the signalling cascade that triggers
cytochrome c release that in turn activates caspases responsible for dismantling
the cell during apoptosis. 18, 19 Obatoclax 7 has been shown to disrupt the
binding of the anti-apoptotic Bcl-2 proteins with pro-apoptotic proteins and hence
restore normal cell death processes within immortal cell lines overproducing Bcl-
2.20, 21
3Figure 2: Related prodiginine and prodiginine-like antibiotics including synthetic
analogue obatoclax 7
1.2 Streptomyces coelicolor
Streptomyces coelicolor A3(2) is a known producer of prodiginine antibiotics and
is the subject of this research project. In 2002, the complete genome sequence
was reported,22 making it an ideal strain to study prodiginine biosynthesis via the
construction of designed mutants lacking one or more genes required for the
biosynthesis of prodiginine antibiotics.23 S. coelicolor A3(2) is known to produce
several structurally distinct antibiotics, including the calcium-dependent
antibiotics (CDAs), actinorhodin, methylenomycins and the spore germination
inhibitors, germicidins (Figure 3), all in addition to the compounds of interest for
this study undecylprodiginine 3,24 and streptorubin B 4.25
4Figure 3: Some other known antibiotics produced by S. coelicolor A3(2)
1.3 Early studies of prodiginine biosynthesis
The first work on prodiginine biosynthesis focused on prodigiosin 1 production in
Serratia marcescens, in which Fourier transform NMR (FT-NMR) spectroscopy
studies were used to determine the incorporation of stable isotope labelled
precursors. These studies first identified methionine as the source of the
methoxy carbon and the incorporation of serine and proline into the
2-2′-bipyrrole ring system on the left hand side of prodigiosin, which, at this time 
was already suggested to be a common intermediate in both the prodigiosin and
undecylprodiginine pathways due to their structural similiarities.26 Later work in
5Streptomyces longispororuber, a known producer of undecylprodiginine and
streptorubin A, confirmed, again by FT-NMR studies, that the biosynthetic origin
of the left hand side of undecylprodiginine is the same as observed for the left
hand side of prodigiosin in S. marcescens. This investigation also established
the biosynthetic origin of the right hand side monopyrrole fragment, which was
determined to be derived from one unit of glycine and seven units of acetate. In
addition this study was the first to confirm the common biosynthetic origin of
undecylprodiginine and its cyclic derivatives, in this case streptorubin A, which
was observed to display the same incorporation pattern of these stable isotope
labels as undecylprodiginine (Figure 4).27
Based on these stable isotope feeding experiments carried out in S.
longispororuber, prodiginine biosynthesis in this organism was proposed to
occur via a convergent method. The condensation of two late stage key
intermediates, 4-methoxy-2,2′-bipyrrole-5-carboxaldehyde 9 (MBC), and 2-
undecylpyrrole 10 would yield undecylprodiginine and subsequently streptorubin
A, in a matter consistent with the observed labelling pattern (Figure 4).27 Later
studies confirmed the biosynthetic origin of streptorubin B as matching that
previously established for streptorubin A and undecylprodiginine.28
Some pioneering genetics studies identified several of the prodiginine
biosynthetic genes in S. coelicolor by way of classic UV irradiation mutagenesis.
Rudd and Hopwood identified mutants deficient in prodiginine biosynthesis and
classified several genomic regions involved in directing prodiginine biosynthesis
in S. coelicolor into five groups (A to E). The groups were classified on the basis
of their co-synthesis behaviour of the red pigment, the structure of which was
not known at this time.29 Subsequently, a mutant strain from class E was used
as a host for screening DNA fragments from chromosomal digests of M145
(wild-type S. coelicolor known to produce the red pigment). This allowed the
identification of a DNA fragment that efficiently complemented the class E
6mutant.30 Feitelson et al. then identified a series of overlapping clones, which
together complemented classes A, B and E, and introduced the new
classification F as a result of a sub-division of the class E mutants.31 Later work
by Hopwood et al. identified a final clone which complemented classes C and D.
Together with the clones from the previous work this allowed the creation of a
single clone capable of complementing all mutant classes and to result in
production of the red pigment (now identified as a mixture of undecylprodiginine
and streptorubin B) in a heterologous host Streptomyces parvulus.32
Figure 4: Proposed biosynthetic pathway to metacycloprodigiosin in
S. longispororuber based on feeding of labelled precursors27
71.4 The red cluster
In 2002, the completion of the genome sequence of S. coelicolor A3(2), made
the sequence of the red cluster available. It comprises twenty three genes
arranged in four transcription units (Figure 5). The putative functions of the
products of most of the genes were suggested on the basis of sequence
comparisons.3 These putative functions led to a proposed biosynthetic pathway,3
which has been subsequently revised in light of subsequent experimental
evidence.25, 33, 34, 35
Figure 5: The red cluster
By analogy with the proposed prodiginine biosynthetic pathway in S.
longispororuber (Figure 4) and in light of the available genetic data, the
biosynthetic origin of undecylprodiginine and streptorubin B in S. coelicolor was
suggested to be analogous. Their biosynthesis was proposed to proceed via the
condensation of two putative key late stage intermediates 4-methoxy-2, 2′-
bipyrrole-5-carboxaldehyde 9 (MBC) and 2-undecylpyrrole 10 (2-UP). The
presence and origin of MBC 935 and 2-undecylpyrrole 1025 in the prodiginine
biosynthetic pathway has subsequently been proven by a variety of
experimental data.
Seven genes are known to be required for the biosynthesis of the key
intermediate 4-methoxy-2,2′-bipyrrole-5-carboxyaldehyde 9 (MBC),35, 33 and five
genes are required for the biosynthesis of a second key intermediate 2-
8undecylpyrrole 10 (2-UP).25, 36 Two genes (redD and redZ) are known to encode
pathway specific transcriptional regulators (Figure 5).37, 38, 39
One gene (redH) has been shown to encode the enzyme involved in the
condensation of MBC 9 and 2-undecylpyrrole 10 to form undecylprodiginine 3.34
The protein encoded by redG shows similarity to Rieske non-heme, iron-
dependent oxygenase enzymes and has been shown to be involved in the
oxidative cyclisation of undecylprodiginine to form the carbocyclic derivative
streptorubin B.3, 40, 41, 42 The role of redJ and redT, is unclear however they
appear to play a role in prodiginine biosynthesis because mutants in which they
are knocked out show reduced prodiginine titres.42 Three genes (redE, redF and
redY) do not appear to be required for prodiginine biosynthesis (Figure 5). 23, 41
Finally, redV is yet to be fully investigated and redS appears to encode for a
truncated, non functional protein.3, 43
1.5 4-methoxy-2, 2′-bipyrrole-5-carboxaldehyde (MBC) 
biosynthesis
4-methoxy-2, 2′-bipyrrole-5-carboxaldehyde 9 (MBC) is a known intermediate
common to both the prodiginine biosynthetic pathway in S. coelicolor and the
related prodigiosin 1 biosynthetic pathway in Serratia species. The mechanism
of biosynthesis proposed by Cerdeño et al.3 and Walsh et al.44 and then later
revised by Williamson et al.33 and Stanley et al.35 appears to be common to both
species with homologous enzymes in each pathway (Figure 6).
The MBC-derived portion of undecylprodiginine is generated from one unit each
of acetate, L-proline and L-serine as shown by labelling experiments (Figure
4).27 L-proline is activated for loading onto the phosphopantetheine arm of the
peptidyl carrier protein (PCP) RedO by adenylation catalysed by RedM (Figure
6). L-prolyl-RedO is then dehydrogenated by the FAD-dependent oxidase RedW
to give pyrrole-2-carboxyl-RedO.44,35 The pyrrole-2-carboxyl group attached to
9RedO is transferred to the C-terminal ketosynthase (KS) domain of RedX where
concomitant decarboxylation and condensation with a malonyl group attached to
one of the two tandem acyl carrier protein (ACP) domains in RedN gives a β-
keto-ACP-thioester. Subsequently, the action of the C-terminal α-oxoamine 
synthase (OAS) domain of RedN cleaves the ACP-thioester by catalysing a
decarboxylative condensation with L-serine. 4-hydroxy-2-2´-bipyrrole-4-
methanol (HBM) results from subsequent, probably spontaneous, cyclisation
and dehydration. Finally, oxidation of the hydroxymethyl group to the
corresponding aldehyde by a currently undefined enzyme and SAM-dependent
methylation of the pyrrole hydroxyl group catalysed by RedI gives 4-methoxy-
2,2′-bipyrrole-5-carboxaldehyde (MBC).42
Figure 6: Proposed biosynthetic pathway to MBC in S. coelicolor
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1.6 2-undecylpyrrole biosynthesis
The 2-undecylpyrrole derived portion of undecylprodiginine has been shown by
labelling studies to be biosynthesised from seven units of acetate and one unit
of glycine (Figure 4).27 RedP is thought to generate an acetoacyl thioester on the
acyl carrier protein (ACP) RedQ, by decarboxylative condensation of an acetyl-
CoA starter unit with a malonyl-CoA extender unit attached to RedQ (Figure 7).
Subsequent keto-reduction, dehydration and enoyl-reduction of the resulting
thioester intermediate gives butyryl-ACP, by the action of ketoreductase,
dehydratase and enoylreductase enzymes from the type II fatty acid synthase
family (FAS) in S. coelicolor. Iterative chain extension by the action of RedR and
continued rounds of reduction and dehydration by the corresponding FAS
enzymes after each elongation would give dodecanoyl-RedQ.36, 25 This would
then undergo one further chain extension after transfer to the N-terminal ACP
domain of RedL via one of two mechanisms: direct transfer from RedQ, or via
hydrolysis to the free acid which could subsequently be loaded onto the ACP
domain after activation by the NRPS-like adenylation domain of RedL. The RedL
ketosynthase (KS) domain then catalyses the reaction of the resulting
dodecanoyl thioester with a malonyl thioester attached to the C-terminal ACP
domain of RedL to form β-ketomyristoyl-ACP. The subsequent pyridoxal-5′-
phosphate (PLP)-dependent decarboxylative condensation with glycine,
catalysed by the C-terminal OAS domain of RedL, would result in chain release.
Spontaneous cyclisation and elimination of water would lead to 4-keto-2-
undecylpyrroline. Reduction of the keto group, catalysed by the NAD(P)H-
dependent RedK, and elimination of water, yields 2-undecylpyrrole (Figure 7).25
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Figure 7: Proposed biosynthetic pathway to 2-undecylpyrrole in S. coelicolor
1.7 Condensation of MBC and 2-undecylpyrrole and
subsequent carbocyclisation
As mentioned previously, after the formation of MBC and 2-undecylpyrrole, it
was proposed that condensation of these two late stage intermediates is
catalysed by RedH to give undecylprodiginine.33 RedH is predicted to encode for
a protein with three functional domains; two of which show sequence similarity
to the ATP-binding domains and the phosphotransfer domains respectively, of
phosphoenol pyruvate synthase (PEPS) and pyruvate-phosphate dikinase
(PPDK).3 However, the third proposed functional domain of RedH does not
12
show sequence similarity to any proteins or protein domains of known function.3
Using this knowledge it is hypothesised, by analogy with the known catalytic
mechanism of PEPS and PPDK, that RedH activates the aldehyde carbonyl of
MBC towards nucleophilic attack by phosphorylation of the aldehyde oxygen
atom. Subsequent nucleophilic attack by C-5 of 2-undecylpyrrole at this
activated position followed by elimination of phosphate would yield
undecylprodiginine (Figure 8).
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Figure 8: Action of RedH, catalysing the formation of undecylprodiginine
The redG gene encodes a protein that is predicted to contain two domains and
has been shown to catalyze the oxidative carbocyclisation of undecylprodiginine
3 to streptorubin B 4.42 CXH and CX2H sequences found in the N-terminal
domain of RedG match those known to bind iron within the Fe2S2 cluster
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characteristically found in N-terminal domains of the α-subunits of Rieske 
dioxygenases such as naphthalene dioxygenase (NDO) (Figure 9). The C-
terminal domain of RedG contains an EX2HX4H sequence motif. This bears
strong similarity to the known conserved sequence in the C-terminal domain of
the α-subunit of NDO and related Rieske dioxygenases, DX2HX4H (Figure 9).
This motif contains two His residues that bind the non-heme iron centre and an
Asp residue, which is proposed to be involved in mediating electron transfer
from the Rieske cluster to the non-heme iron centre via a hydrogen bond
network.45 In RedG the mutation of the Asp residue of this motif to Glu is
predicted to have no functional significance.
RedG ARCPHKGANLGDGRMKGNT-IECPYHGF-X85-L-EFYHVTYVHRD
McpG ARCPHKGANLADGRLVGNS-VACPYHGF-X83-L-EFYHVTFVHRD
NDO NVCRHRGKTLVSVEAGNAKGFVCSYHGW-X96-VGDAYHVGWTHAS
* *:* .* . . . . . *.***: : : *** :.* .
Figure 9: Sequence comparison of RedG (S. coelicolor), homologue McpG (S.
longispororuber) and archetypal Rieske dioxygenase, NDO (naphthalene
dioxygenase)
Prior to recent work in the Challis group on the red cluster, no previous
examples of Rieske dioxygenases have been observed to carry out the
chemically challenging C-H bond activation required for the proposed oxidative
carbocyclisation of undecylprodiginine to streptorubin B. It has been shown that
RedG catalyses the formation of the 10-membered carbocycle in streptorubin B,
and that a RedG homologue (McpG) from Streptomyces longispororuber
catalyses the analogous formation of the 12-membered carbocyclisation in
metacycloprodigiosin (streptorubin A) (Figure 10).42
Oxidative cyclisations catalysed by non-heme iron dependent dioxygenase-like
enzymes are generally assumed to proceed via a Fe(IV)=O intermediate, which
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is formed by the reductive cleavage of the O=O bond of an iron-bound molecular
oxygen. This Fe(IV)=O intermediate is proposed to carry out a variety of stereo-
and regio-specific cleavages of C-H bonds to generate carbon-centred radicals
as the key intermediates in oxidative cyclisations.
Figure 10: Different sites of cyclisation to form streptorubin B and
metacycloprodigiosin (streptorubin A) from a common precursor.
By analogy with this proposal, the oxidative carbocyclisation of
undecylprodiginine to streptorubin B, in the case of RedG, or
metacycloprodigiosin (streptorubin A), in the case of McpG, is predicted to occur
via carbon-centred radicals at appropriate positions on the alkyl chain of
undecylprodiginine. Transformation of a radical intermediate into streptorubin B
can be envisaged by one of several pathways: either by (1) conversion to a
hydroxylated intermediate, in which nucleophilic displacement of the hydroxyl
group by C4 of the pyrrole followed by deprotonation and re-aromatization would
yield streptorubin B (Figure 11, pathway A); or by (2) direct attack of the radical
on C-4 of the pyrrole ring, to give a stabilised, conjugated radical intermediate
15
from which abstraction of a second pyrrole-derived hydrogen atom by RedG
would give streptorubin B (Figure 11, pathway B).
Figure 11: Outline of possible intermediates in the conversion of
undecylprodiginine to streptorubin B, as catalysed by RedG.
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1.8 Relative and absolute stereochemistry of
streptorubin B
Examination of a molecular model of streptorubin B showed that free rotation
about the bond linking the stereocentre of the alkyl chain to the pyrrole C-ring
(C-4 of the pyrrole C-ring and C-7′) is restricted, so that rotation of the alkyl 
chain across the plane of the tripyrrole ring system cannot occur freely. This
forces the tripyrrole system and the hydrocarbon portion of the carbocycle to
adopt a defined relative configuration. No signal broadening is observed in the
1H-NMR spectrum of the hydrochloride salt of streptorubin B at temperatures up
to 120 °C,46 indicating that it is configurationally stable up to temperatures
considerably above room temperature. NOESY experiments were used to define
the relative stereochemistry in the hydrochloride salt of streptorubin B.46 Key
long-range correlations in the NOESY spectrum allowed the relative
configuration of the alkyl side chain of the carbocycle and the endocyclic alkyl
carbons to be defined (Figure 12).
Figure 12: Key long-range correlations observed in the NOESY spectrum of
streptorubin B hydrochloride, and the deduced relative stereochemical
relationship of C8′-C11′ to C2′-C6′ in streptorubin B 
This intriguing structural feature of streptorubin B is reflected in the highly
diastereotopic nature of the alkyl protons of the carbocycle, especially the C-4′ 
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pair of hydrogen atoms, one of which is heavily shielded by the ring current of
the pyrrole π-electrons, resulting in a characteristic upfield-shift of its resonance 
to -1.54 ppm in the 1H-NMR spectrum. In comparison, the other C-4′ proton 
resonates at 1.16 ppm (Figure 13).
Figure 13: Comparison of shielding effects on C-4′ protons of streptorubin B (left) 
and metacycloprodigiosin (streptorubin A, right)
It is interesting to note that the -1.54 ppm signal in the 1H-NMR spectrum of
streptorubin B is characteristic for the 10-membered carbocyclic ring system.
The related compound metacycloprodigiosin (streptorubin A), isolated from
Streptomyces longispororuber, has a twelve-membered carbocyclic ring instead
of the 10-membered ring of streptorubin B. The comparable C-4′ proton in 
streptorubin A no longer resonates at -1.54 ppm, but at 0.28 ppm, seemingly
because the larger ring allows the proton on C-4′ to be positioned further away 
from the pyrrole π-electrons. Thus the shielding effect is weaker, though still 
clearly significant, because it shifts the proton resonance substantially from the
typical value of ~1.5 ppm for a CH2 group (Figure 13).
Also of note is that the circular dichroism spectra of methanol solutions of
metacycloprodigiosin (streptorubin A) and streptorubin B are essentially
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mirror-images (Figure 14).46 This may imply that metacycloprodigiosin
(streptorubin A) and streptorubin B are pseudoenantiomeric (i.e. display
opposite stereochemical configurations at their respective chiral centres).
Comparison of CD spectra of streptorubin A and streptorubin B
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Figure 14: Circular dichroism spectra of metacycloprodigiosin (streptorubin A)
and streptorubin B
1.9 Synthetic approaches to undecylprodiginine,
metacycloprodigiosin and streptorubin B
Since the discovery of prodigiosin the total synthesis of prodiginine alkaloids has
been of significant interest. In particular, the cyclic undecylic prodiginine
derivatives and roseophilin have attracted considerable attention due to the
synthetic challenge posed by the carbocyclic rings in their structures.
Syntheses of streptorubin B and other carbocyclic prodiginines have been
limited, primarily due to the strained ansa-bridged medium rings in these
structures. Syntheses in which the stereochemistry of the carbocyclic ring
systems has been controlled are particularly scarce. The first synthesis of
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(racemic) metacycloprodigiosin (streptorubin A) involved elaboration of the
ansa-bridged medium ring from cyclododecanone 11 via functionalisation and
subsequent pyrrole formation.47 This reaction sequence consisted of twelve
linear steps and proceeded with an overall yield of 0.02% from the
cyclododecanone. Subsequent acid promoted coupling of the carbocyclic pyrrole
12 with MBC afforded the natural product (Scheme 1).
Scheme 1: Outline of Wasserman’s total synthesis of (±)-metacycloprodigiosin
Fürstner et al.48 completed a formal total synthesis of the carbocyclic pyrrole
fragment of both metacycloprodigiosin (streptorubin A) and streptorubin B with a
much improved yield compared to Wasserman’s metacycloprodigiosin
synthesis. A critical skeletal reorganisation catalysed by platinum (II) chloride is
a key step in both cases. Overall yields of ≈ 16 % of 15 from cyclooctene 13 and
≈ 5 % of 18 from cyclodecene 16 over nine linear steps were reported (Scheme
2). However, the stereochemistry of the medium ring in the product was not
controlled in either case, nor was the condensation of the bipyrrole aldehyde
(MBC) with 13 or 20 carried out to complete the total syntheses.48
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Scheme 2: Fürstner formal total syntheses of metacycloprodigiosin (streptorubin
A) and streptorubin B via platinum catalysed rearrangement
The same N-tosyl dihydropyrrole 14 intermediate in Fürstner’s synthesis of 15
has also been synthesised by ring-closing metathesis using Grubbs’ second
generation catalyst (Scheme 3). This pathway marginally increases the overall
yield of 15 (to 19 %) but consists of fifteen linear steps from trans-4-
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hydroxyproline 19 and again the stereochemistry of the product was not
controlled and the condensation with MBC to complete the total synthesis was
not attempted.49
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Scheme 3: Synthesis of tosyl dihydropyrrole intermediate 14 via Grubbs catalysis
Confusion regarding the structure of streptorubin B has resulted in several
syntheses of the ortho-annelated isomer butylcycloheptylprodigiosin 22,50, 25 in
the belief that this is a natural product. Initially, it was synthesised by Fürstner et
al. in eighteen linear steps from 20 (Scheme 4).51 Subsequently a synthesis via
oxazole 24 using a combination of one-pot reactions was reported by Reeves
(Scheme 5).52 Key steps in this synthesis were a one-pot conjugate
addition/aldol reaction and a one-pot dehydration/oxazole hydrolysis/pyrrole
22
formation reaction to afford the same formyl pyrrole 21 to that seen in Fürstner’s
earlier synthesis, in only two steps from cyclononenone 23. The total synthesis
was completed by the same method used by Fürstner to converted formyl
pyrrole 21 to butylcycloheptylprodigiosin 22. In both these syntheses no control
over the absolute stereochemistry of the product was attempted.
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(i) DIBAL-H, DCM, 0 °C (ii) Ac2O, Et3N, DMAP, DCM (iii) Methylacetoacetate, NaH, [Pd(PPh3)4] (5 mol %)
(iv) DMSO (aq), 180 °C (v) H2NOH.HCl. NaOAc, EtOH (aq), 100 °C (vi) Pentafluorobenzyl chloride, Et3N,
Et2O, -78 °C to RT (vii) Pd(OAc)2 (12 mol %), [P(o-tolyl)3] (12 mol %), Et3N, DMF, 110 °C (viii) KH,
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Scheme 4: Fürstner’s synthesis of butylcycloheptylprodigiosin
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Scheme 5: Reeves’ synthesis of butylcycloheptylprodigiosin
The first stereoselective synthesis of metacycloprodigiosin (streptorubin A) was
recently reported by Thomson and coworkers,53 in which the absolute
stereochemistry is installed by the enantioselective conjugate addition of an
ethyl cuprate to enone 25. The stereochemistry of the reaction is controlled by
using 6 % (R,S)-JosiPhos to give a 93:7 mixture of enantiomers. The enolate
product of this reaction is trapped using chlorosilyl enol ether 26, after which
oxidative C-C bond formation yields the desired dialkenyl diketone 27 in an
enantioselective manner. Ring closing metathesis with Grubbs second
generation catalyst followed by pyrrole formation upon exposure to NH4OAc
completed the formation of the key carbocyclic monopyrrole moiety 28 (Scheme
6).
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Scheme 6: Thomson’s enantioselective synthesis of streptorubin A
It is interesting to note that the synthesis of streptorubin B via a similar route has
yet to be achieved, seemingly because of the increased strain in the 10-
membered ring of streptorubin B compared to the 12-membered ring in
metacycloprodigiosin (streptorubin A).54
Finally, the total synthesis of the related natural product nonylprodigiosin 6
together with some synthetic analogues 29-32 has been reported by ring closing
metathesis of various dialkene tripyrrole intermediates, formed by Suzuki
coupling of dipyrrole intermediate with various heterocyclic boronic acids
(Scheme 7).55 It should be noted that the tertiary carbon centres within the
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carbocycles of metacycloprodigiosin (streptorubin A) and streptorubin B make
them inaccessible by a similar synthetic strategy.
Scheme 7: Fürstner’s synthesis of nonylprodigiosin and synthetic analogues
1.10 Synthetic approaches to roseophilin
The total synthesis of the prodiginine-related natural product roseophilin has
been reported by several groups as discussed below. In all the syntheses
developed, the generation of the monopyrrole fragment 34 bearing the
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carbocycle has proved to be a vital step. In all cases this fragment has been
elaborated to N-protected roseophilin by base mediated condensation with
furano-pyrrole 35 (Scheme 8).
Scheme 8: Key late stage intermediates in roseophilin total syntheses
The key carbocycle formation step en route to 34 has been performed by a
variety of strategies. Fürstner et al. employed a palladium-catalysed carbanion
addition to allylic epoxide 36 to furnish the racemic carbocycle 37 (Scheme 9,
route 1).56 They later re-designed the early stages of their synthesis, to allow for
easier adaptation to analogue synthesis, by replacing the palladium catalysed
carbocyclisation with ring closing metathesis followed by hydrogenation to form
the carbocycle 37 (Scheme 9, route 2).57 Compound 37 was then elaborated to
34 by the same method in both cases: Desilylation and oxidation provided the
required precursor for palladium-catalysed pyrrole formation. Conversion of the
resulting carboxylic acid to the corresponding acid chloride and treatment with
tin chloride resulted in the formation of the required tricyclic ketone 38. The
missing isopropyl substituent was then installed by base-mediated elimination of
the adjacent sulfone followed by a 1,4-nucleophilic addition to give 34 (R = Bn).
Debenzylation of this compound proved troublesome and required a reductive
cleavage with calcium in liquid ammonia followed by re-oxidation of the adjacent
carbonyl with pyridinium dichromate. The desired, base mediated coupling of the
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potassium salt of 34b with 35 did not proceed; instead N-SEM 34c was required
to observe the desired coupling in good yield.
Scheme 9: Fürstner’s total syntheses of the roseophilin carbocyclic pyrrole
fragment
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Robertson et al. later completed the formal total synthesis of roseophilin by
developing a radical-mediated cyclisation of iodoalkene 39 using Bu3SnH and
AIBN as the key step in their synthesis of the roseophilin carbocyclic pyrrole
fragment 34 (R = Bn, Scheme 10).58
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Scheme 10: Robertson’s free radical cyclisation approach to roseophilin
Tius and co-workers described the first enantioselective total synthesis of
roseophilin and thus determined its absolute stereochemistry (Scheme 11).59
The key step in their synthesis is an asymmetric cyclopentannelation reaction
initiated by the addition of a lithioallene 41 bearing a chiral auxiliary to the
required amide 40. Subsequent acid treatment results in the generation of the
pentadienyl cation, the formation of which is followed by cyclisation via a 4π 
conrotation to yield the desired product 42 in 86 % ee. 42 is further elaborated to
the desired precursor 34c through the Stetter reaction with 6-heptenal followed
29
by installation of the carbocyclic moiety via a Grubbs catalysed ring closing
metathesis.
Scheme 11: Tius’ enantioselective total synthesis of roseophilin monopyrrole
fragment
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In all of the roseophilin syntheses and synthetic approaches the 13-membered
carbocycle is constructed before strain in the molecule is introduced by the
formation of the fused five-membered rings.
In summary, the formation of the ansa-bridged medium ring has made the
synthesis of carbocyclic prodiginines and related compounds difficult. The total
syntheses of such compounds are typically long and challenging, making the
preparation of analogues a daunting task.
1.11 Mutasynthesis as a strategy for preparation of
natural product analogues
Natural products are often of such significant structural complexity that synthetic
access to these compounds for their further investigation, including the
structure-activity relationships necessary for drug lead development, is a
common stumbling-block in their study. However, a variety of semi-synthetic or
biotechnology approaches have been developed to ease their preparation.
Figure 15: Schematic representation illustrating the differences between
precursor-directed biosynthesis (A) and mutasynthesis (B)
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One of the most widely used and successful strategies is mutasynthesis (or
mutational biosynthesis) and the closely related technique, precursor-directed
biosynthesis. Both of these systems are based upon the process of cellular
uptake of relatively simple biosynthetic building blocks and their subsequent
incorporation into complex antibiotics. These pathways differ by one crucial
factor, in precursor-directed biosynthesis growth media of ‘wild-type’ producers
of the metabolite of interest are supplemented with analogues of intermediates
in the pathway. These analogues then compete with the natural building blocks
for incorporation into the natural products. This can result in a range of natural
product analogues being produced from a single incubation which require
isolation or considerable optimisation of the incorporation of the desired
precursor (Figure 15A).60 This is in contrast to mutasynthesis, which was first
termed by Rinehart61 and proposed as an alternative method of obtaining a new
diversity of compounds compared to those accessible through the existing
precursor-directed biosynthesis. Mutasynthesis involves the feeding of
analogues of crucial intermediates in antibiotic biosynthesis to mutants of the
wild-type strain inactivated in an important step of the intermediate assembly
(Figure 15B).
This process has been used elegantly to avoid lengthy total synthetic strategies
by exploiting the biosynthetic machinery of a given microorganism to perform the
required chemical transformation.
The first reported examples of mutasynthetic approaches relied on random
mutagenesis. Cultures of the neomycin 43 producer Streptomyces fradiae were
treated with the mutagen nitrosoguanidine, which killed nearly all of the cells.
The survivors were then grown and screened for a mutation which had resulted
in the desired deoxystreptamine deficient phenotype. Colonies were grown with
and without deoxystreptamine, an important subunit of neomycin, and checked
for a zone of inhibition when grown with Bacillus subtilus. Colonies that showed
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a zone of inhibition with deoxystreptamine and no zone of inhibition without
deoxystreptamine were identified as mutants deficient in deoxystreptamine
moiety biosynthesis. The selected mutant was then grown in the presence of
other aminocyclitols closely related to deoxystreptamine. This study identified
several mutasynthetic analogues of neomycin 44a-44c using streptamine,
epistreptamine and 2,6-dideoxystreptamine (Scheme 12). In addition this
technique was applied to other aminocyclitol containing antibiotics with some
success including Kanamycin and Ribostamycin.62, 61
Scheme 12: Feeding of aminocyclitol analogues to give neomycin and neomycin
analogues
Recent advances in sequencing technologies have resulted in a dramatic
increase in the number of biosynthetic gene clusters being identified. This
combined with the advent of new molecular biology techniques which have
allowed for faster characterisation of the enzymes involved in antibiotic
biosynthesis, has resulted in a deeper understanding of secondary metabolite
biosynthesis at a genetic level. This has led to the generation of large numbers
of designed biosynthetic mutants in which discrete steps in a biosynthetic
pathway have been targeted and disrupted, and has resulted in a revitalisation
in mutasynthetic techniques.
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The aminocoumarin antibiotic, chlorobiocin (Scheme 13A), provides a good
example of targeted genetic disruption and subsequent analogue generation by
mutasynthesis. Chlorobiocin consists of three major components; an
aminocoumarin moiety, a noviose sugar, and a 3-dimethylallyl-4-hydroxybenzoic
acid (DMAHB) moiety. CloQ catalyses a key step in the biosynthesis of DMAHB,
and when it was deleted from the producing strain Streptomyces
roseochromogenes, the resulting CloQ- strain was unable to make chlorobiocin
unless fed with synthetic DMAHB. This strain was then demonstrated to
incorporate synthetic analogues of DMAHB (Scheme 13B) into new and
biologically active chlorobiocin analogues. 63, 64, 65
Scheme 13: (A) Chlorobiocin biosynthesis from DMAHB (B) a selection of DMAHB
analogues successfully incorporated into chlorobiocin analogues
Polyketide antibiotics have been particularly well exploited by mutasynthesis,
notably the starter unit of polyketides seem particularly amenable to substitution
during mutasynthesis.66 Rapamycin (Scheme 14A), the immunosuppressant
polyketide, incorporates a 4,5-dihydroxycyclohex-1-enecarboxylic acid (DHCHC)
starter unit derived from shikimic acid. Researchers at Biotica generated a
mutant strain of Streptomyces hygroscopicus (rapK-) which was unable to
biosynthesise the DHCHC starter unit, and was subsequently unable to produce
rapamycin unless supplemented with synthetic DHCHC. The rapK- mutant was
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fed with a variety of analogues of DHCHC (Scheme 14B), resulting in the
production of rapamycin analogues containing structural, regio- and stereo-
chemical alterations in the starter unit derived portion (Scheme 14).67 Several of
these “rapalogues” are currently being developed as potential drugs in
collaboration with Wyeth.68
Scheme 14: (A) Rapamycin biosynthesis from DHCHC (B) a selection of DMAHB
analogues successfully incorporated into chlorobiocin analogues
Finally, the commercial viability of mutasynthesis strategies has been
demonstrated in the manipulation of the biosynthetic pathway of avermectin
(Figure 16A) in Streptomyces avermitilis. Generation of a mutant unable to
biosynthesise the necessary branched chain fatty acid starter unit was achieved
by inactivating the required branched-chain 2-oxo acid dehydrogenase. This
strategy was used to generate 36 novel avermectin derivatives and
demonstrated the remarkably broad substrate tolerances of this pathway,
including analogues containing unsaturated elements and heterocyclic rings in
place of the alkyl branched chain observed in avermectin.69 This work then led
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the way for the mutasynthetic commercial synthesis of the antiparasitic
veterinary drug, Doramectin (Figure 16B).70, 71
Figure 16: (A) Structure of avermectin A1 (B) Examples of avermectin analogues
from mutasynthesis including Doramectin
The design of a successful mutasynthetic strategy for streptorubin B analogues,
which due to their unusual carbocyclic structure have proved synthetically
challenging, would be particularly appealing. This would allow the demanding
formation of this carbocyclic moiety to be carried out enzymatically. The
extensive existing knowledge of the prodiginine biosynthetic pathway makes
streptorubin B an ideal candidate for a mutasynthetic strategy. Concise
syntheses towards intermediates proven to be key in prodiginine biosynthesis,
for example 2-undecylprodiginine 10 and MBC 9, would make natural product
analogue generation an achievable goal.
1.12 Total synthesis of undecylprodiginine
Undecylprodiginine, unlike its carbocyclic derivatives, has proved very amenable
to total synthetic strategies. It has been synthesised by a convergent route
involving acid-catalysed condensation of the two key intermediates 2-
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undecylpyrrole 10 with 4-methoxy-2,2′-bipyrrole-5-carboxaldehyde 9 (MBC),
which have been synthesised by a variety of methods (Scheme 15).72 This
convergent route mirrors Wasserman’s proposed biosynthetic pathway,26 which
has since been substantiated in the Challis group.25, 35, 34
Scheme 15: Biomimetic total synthesis of undecylprodiginine
1.13 Previous synthetic approaches to MBC
There are several reported syntheses of the bipyrrole aldehyde intermediate in
prodigiosin biosynthesis. MBC was first synthesised by Rapoport and co-
workers via the reaction of ethyl 3-methoxypyrrole-2-carboxylate 45 with
pyrroline (Scheme 16).73 This gave the 2,2′-pyrrolidinyl-pyrrole 46, which was
subsequently dehydrogenated in refluxing xylene to give the desired
2,2′-bipyrrole ester 47. However, at this stage the desired reduction of the ester
proved troublesome. Lithium aluminium hydride failed to reduce the ester.
However, reduction of the ester was achieved by MacFadyen-Stevens reduction
via the corresponding hydrazide to give MBC 9. This chemistry provides a
synthetic route to MBC. However, analogue generation by this approach is not
feasible because of the protracted synthesis of the substituted pyrrole starting
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material 45 and because of the troublesome and low-yielding MacFadyen-
Stevens reduction and pyrrole-pyrroline coupling steps.
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Scheme 16: First reported synthesis of MBC via pyrroline-pyrrole condensation
A later synthesis reported by Wasserman et al.,74 uses a reactive intermediate
generated by the reaction of singlet oxygen with 3-methoxy-2-pyrrole carboxylic
acid tert-butyl ester 48 (Scheme 17). The transient imino hydroperoxide
intermediate 49 has been shown to react with a number of nucleophiles, such as
pyrrole, to give MBC 9 or 2-ethylpyrrole to give the corresponding A-ring
substituted MBC analogue 50 (after subsequent MacFadyen-Stevens reduction
of the resulting esters). Although this chemistry gives access to substituted MBC
analogues, it is, like the related chemistry reported by Holden et al.,73 limited by
the low yields of both the singlet oxygen reaction and the subsequent
MacFadyen-Stevens reduction.
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Scheme 17: Singlet oxygen reaction to bipyrrole fragment
A more concise and higher yielding route to MBC was recently reported by
Tripathy and Lavallée,75 in follow up to a 2004 patent.76 This route is currently in
use for the preparation of obatoclax (GX15-070), the first streptorubin B
analogue to reach clinical trials in oncology.77 Treatment of commercially-
available 4-methoxy-3-pyrrolin-2-one 51 (Scheme 18) with the Vilsmeier-Haack
reagent, generated from diethylformamide and phosphorus oxybromide, yields
52 in one step. This reaction introduces in a single step both the bromide
required for subsequent cross-coupling and the aldehyde ‘protected’ as an
enamine. Importantly, this route has the potential to generate a large number of
A-ring MBC analogues because of the broad substrate tolerance of the
subsequent Suzuki cross-coupling reaction. This reaction, originally designed to
couple the bromo pyrrole enamine 52 with BOC-pyrrole boronic acid 53 to give
MBC (after enamine hydrolysis), can be envisaged to be applied with a variety of
other boronic acids to give MBC analogues.
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Scheme 18: Synthesis of MBC via Suzuki cross-coupling
1.14 Previous synthetic approaches to 2-undecylpyrrole
Previous synthetic approaches to 2-undecylpyrrole have been limited in their
scope. They are primarily based upon the addition of n-undecyl bromide to a
solution of pyrrole magnesium bromide prepared in situ from ethyl magnesium
bromide and freshly distilled pyrrole (Scheme 19). These reactions are typically
low yielding, resulting in <30 % of monoalkylated pyrroles 10 and 54,
contaminated with multiple insoluble polyalkylated pyrrole species 55. The
mixture of 2-undecypyrrole 10 and 3-undecylpyrrole 54 obtained by filtration of
an acetone solution of the crude reaction mixture has to be separated by
crystallisation (Scheme 19).72
Scheme 19: Literature synthesis of 2-undecylpyrrole
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1.15 Aims and objectives
 To synthesise and isolate streptorubin B analogues via a
mutasynthetic approach.
By making use of the existing knowledge of the prodiginine biosynthetic
pathway in S. coelicolor, mutasynthesis of streptorubin B analogues can
be envisaged by a combination of relatively straightforward synthetic
methodologies and enzymatic processes that install the synthetically
challenging carbocyclic moiety.
Initially, synthesis of key intermediates MBC and 2-undecylpyrrole, via
routes amenable to analogue generation, would be used in order to
optimise the incorporation of synthetic supplements into the biosynthetic
process.
Finally, the mutasynthesis of streptorubin B analogues is foreseen by
feeding of MBC and 2-undecylpyrrole analogues to S. coelicolor mutants
deficient in intermediate biosynthesis (Figure 17).
Figure 17: Schematic representation of envisaged mutasynthesis approach
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 To elucidate the currently unknown absolute stereochemistry of
streptorubin B
The relative stereochemistry of streptorubin B has been previously
determined. However, the absolute stereochemistry of streptorubin B
determined by the configuration at C-7′ is currently unknown (Figure 18).  
Figure 18: Curly arrows indicate key correlations observed in the NOESY
spectrum of streptorubin B hydrochloride, and the defined relative
stereochemistry of streptorubin
Feeding of 2-undecylpyrrole containing a stereospecific deuterium label
at C-4′, in a manner analogous to the 2-undecylpyrrole mutasynthesis 
strategy should allow the absolute stereochemistry of C-7′ to be defined. 
The protons at C-4′ which are diastereotopic and well-defined are an 
ideal choice for this mutasynthetic approach.
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2.0 Results and discussion: Synthesis of
4-methoxy-2,2′-bipyrrole-5-carboxaldehyde, 
2-undecylpyrrole and analogues
Before the envisaged mutasynthetic approach towards prodiginine analogues
could be undertaken a robust synthesis of the prodiginine precursors 4-methoxy-
2,2′-bipyrrole-5-carboxaldehyde 9 (MBC) and 2-undecylpyrrole 10 that is
amenable to analogue generation had to be developed.
2.1 Synthesis of 4-methoxy-2,2′-bipyrrole-5-
carboxaldehyde (MBC, 9)
At the outset of this work a Pd catalysed coupling approach to MBC was initially
envisaged, and when researching the literature regarding possible procedures, a
very similar approach to the envisaged route had recently been reported. This
procedure was first described in a patent relating to a prodiginine analogue,
obatoclax 6.76 This was subsequently published as a formal total synthesis of
prodigiosin in which the preparation of MBC is described.75 Therefore the initial
aim was to reproduce this literature method for MBC synthesis in good yield.
The N-BOC-pyrrole-2-boronic acid required for this synthesis was prepared by
directed C-2 lithiation of N-BOC-pyrrole 56 using lithium tetramethylpiperazide
(Scheme 20). Under these conditions, lithiation is known to be directed by the
interaction of the BOC carbonyl oxygen with the lithiating species 57.78, 79 This
allowed the regiospecific synthesis of N-BOC-pyrrole-2-boronic acid 56 in good
yield.
43
Scheme 20: Synthesis of N-BOC-pyrrole-2-boronic acid via directed lithiation
4-methoxy-3-pyrrolin-2-one 51 was reported to be converted in good yield to
bromo-enamine 52 in one step via the action of the Vilsmeier-Haack reagent
obtained from reacting diethylformamide with phosphorus oxybromide (Scheme
21). This allowed C-acylation and bromination to be carried out in one step,
without the need to protect the pyrrolidinone nitrogen. A subsequent Suzuki
cross-coupling between the bromo-enamine 52 and N-BOC-pyrrole-2-boronic
acid 53 furnished MBC in good yield after basic aqueous work-up. Both the BOC
protecting group and the enamine were hydrolysed in the work-up to yield the
doubly deprotected product as a crude solid. Washing of this largely insoluble
solid with acetone removed residual triphenylphosphine and palladium-based
impurities to give MBC 9 as a fine yellow solid.
Scheme 21: Synthesis of MBC via palladium-catalysed cross coupling
44
2.2 Synthesis of MBC analogues with A-ring variation
We recognised that the synthesis of MBC described above could be readily
adapted to prepare several A-ring analogues of MBC by simply varying the
boronic acid used in the Suzuki-coupling. Phenyl 58, 2-thiophenyl 60 and 2-
furanyl 61 boronic acid are all commercially available. However, N-BOC-indolyl-
2-boronic acid 59, of particular interest because it could be used to prepare
prodiginine analogues similar in structure to the clinical candidate, obatoclax 7,
is not commercially available. Thus, N-BOC-indolyl-2-boronic acid 59 was
synthesised via the same C-2-directed lithiation strategy used to synthesise N-
BOC-pyrrole-2-boronic acid 53 (Scheme 20). The aromatic boronic acids 58-61
were used in Suzuki coupling reactions analogous to that used to synthesise
MBC to synthesise the corresponding MBC analogues 62-65 (Scheme 22) in
average to good yields.
Scheme 22: Synthesis of MBC analogues by palladium-catalysed cross coupling
of bromo enamine 52 with a variety of aromatic boronic acids
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The MBC analogues resulting from these reactions were sufficiently soluble in
acetone to preclude their purification by washing with this solvent (as had been
used to purify MBC). However, the indolyl analogue could be washed with a
mixture of diethyl ether and chloroform to yield the desired product in high purity
as a yellow solid. The remaining crude MBC analogues were purified on basic
alumina.
2.3 Synthesis of MBC analogues with B-ring variation
In addition to MBC analogues that vary at the A-ring, analogues that differ at the
B-ring would also be useful as probes of the substrate specificities of RedH and
RedG. It was thought that the analogue with a furan B-ring 71 might prove
particularly interesting. By analogy with the known intermediates in the
prodiginine biosynthetic pathway it was thought this compound could be an
intermediate in the biosynthesis of the structurally-related natural product
roseophilin 8. Therefore, it was reasoned that use of this compound in our
mutasynthesis experiments in S. coelicolor might result in a
roseophilin/prodiginine hybrid.
The initial proposed route to furanyl-pyrrole 71 was from
4-methoxy-2(5H)-furanone 66 (Scheme 23). Reduction of this compound with
DIBAL-H or LiAlH4 would produce 3-methoxyfuran 68, via the hemi-acetal
intermediate 67. Subsequent reaction with the Vilsmeier-Haack reagent derived
from DMF would furnish aldehyde 69. Finally, bromination of aldehyde 69 with
N-bromosuccinimide (NBS) followed by Suzuki coupling with N-BOC-pyrrole-2-
boronic acid 53 would yield the desired furanyl-pyrrole 71 (Scheme 23).
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Scheme 23: Initial proposed route for production of B-ring analogues
Unfortunately, the reduction of compound 66 could not be achieved under a
variety of conditions, probably because of the deactivation of the furanone
carbonyl carbon towards nucleophilic attack by electron donation from the
adjacent vinyl enol ether.
Commonly, Suzuki couplings are carried out with triflates in place of bromides.80,
81 With this in mind, it was proposed that compound 66 could be deprotonated
and triflated to afford the corresponding furan 72 in one step (Scheme 24).
However, none of the desired product 72 could be obtained using a variety of
bases such as LDA and Hünig’s base and triflating reagents such as triflic
anhydride and N-(5-chloro-2-pyridyl) triflimide in different solvents e.g. DCM and
THF.
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Scheme 24: Proposed synthetic route to the furan B-ring analogue of MBC via a
furanyl triflate
Finally, synthesis of the desired bromo-aldehyde 70 was achieved via the
furanone enamine 74 (Scheme 25). 4-methoxy-2(5H)-furanone 66 was reacted
with excess dimethyl formamide dimethyl acetal. Continuous distillation of
methanol from the reaction mixture drove the reaction to completion to give the
furanone enamine 74 in high yield.82 Bromination of 74 was carried out with
phosphorus oxybromide in chloroform to yield the desired bromo aldehyde 70 as
an unstable solid, which decomposed rapidly to an intractable mixture of
(presumably polymerisation) products. Suzuki coupling between the freshly
prepared bromo aldehyde 70 and N-BOC-pyrrole-2-boronic acid 52 afforded the
N-BOC-protected derivative 75 of the desired MBC analogue, which was
deprotected with LiOH in MeOH to give the MBC analogue 71 in good yield.79
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Scheme 25: Synthetic route to furanyl B-ring analogue of MBC
2.4 Synthesis of 2-undecylpyrrole
With the synthesis of MBC and several analogues completed we shifted our
focus to the other prodiginine biosynthetic intermediate, 2-undecylpyrrole. The
synthesis of 2-undecylpyrrole was attempted by a number of methods. Initially,
due to the success of the lithiation of N-BOC pyrrole with lithium
tetramethylpiperazide during the preparation of N-BOC-pyrrole-2-boronic acid 53
(Scheme 20), the same base was used to deprotonate N-BOC-pyrrole and
reaction of the resulting anion with undecyl bromide and undecanal was
examined (Scheme 26). Unfortunately, when the proposed reaction was
attempted using undecyl bromide, only starting material was recovered from the
reaction. Presumably this was due to insufficient SN2 transition state stabilisation
by the reaction solvent, THF. In retrospect, perhaps the use of a more polar co-
solvent, such as DMPU, would have favoured the efficiency of this reaction. 83
2-acyl pyrroles are known to be reduced directly to the corresponding 2-alkyl
pyrroles by treatment with sodium borohydride in alcohol solvents.84 Therefore, it
was envisaged that reaction of 2-lithiated N-BOC-pyrrole with undecanal 77
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could provide a convenient method for the synthesis of 2-undecylpyrrole via the
resulting alcohol 78.
Scheme 26: Proposed synthesis of 2-undecylpyrrole via lithiation of N-BOC
pyrrole
The reaction of N-BOC-pyrrole with undecanal 77 afforded the expected alcohol
78, in low yield. However, the subsequent deprotection of the BOC group, which
was required for hydroxyalkyl pyrrole reduction, did not yield the desired product
79 under the previously described nucleophilic deprotection conditions using
LiOH/MeOH.79 Instead the removal of the BOC protecting group was
accompanied by methylation of the free hydroxyl group to give the methyl ether
80, reduction of which gave none of the desired alkyl pyrrole 10. In fact, in the
presence of sodium borohydride the methyl ether 80 afforded pyrrole and
undecyl alcohol methyl ether, presumably via an initial retro-aldol reaction to
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give pyrrole and O-methylated undecyl aldehyde, which is then reduced by
sodium borohydride to give undecyl alcohol methyl ether.
BOC deprotection of 78 under acidic conditions, both with aqueous acid and
trifluoroacetic acid, gave none of the desired product.85 Thermal decomposition
of the BOC-protecting group resulted in the production of a complex mixture of
compounds.86
Consequently, an alternative synthesis of 2-undecylpyrrole was devised
(Scheme 27), based upon the literature precedent of carboxylic acid activation
via the corresponding pyridyl thioester.87, 88 Undecanoic acid 81 is activated as
the corresponding 2-pyridylthioester 82 using 2,2′-dipyridyl-disulfide and 
triphenylphosphine. Reaction of the resulting thioester with pyrrylmagnesium
chloride, generated in situ, resulted in regiospecific production of the 2-acyl
pyrrole 83. Subsequent reduction with excess sodium borohydride in
isopropanol proceeded cleanly to give 2-undecylpyrrole 10.
Scheme 27: Synthesis of 2-undecylpyrrole via pyridyl thioester
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The reduction of acyl pyrrole 83 to the corresponding alkyl pyrrole appears to be
sensitive to the reaction conditions. A competing reduction-protonation-retro-
aldol cleavage sequence, resulting in the formation of pyrrole and undecanal
(which subsequently undergoes sodium borohydride mediated reduction to
undecanol), appears to take place under certain conditions in addition to the
desired reduction. The retro-aldol mediated process becomes the predominant
pathway under anhydrous conditions and when sodium borohydride is added to
a solution of 2-acylpyrrole in anhydrous isopropanol under argon. In contrast,
when sodium borohydride is refluxed under atmospheric conditions in reagent
grade isopropanol for a short period before addition of the 2-acylpyrrole,
reduction to the alkyl pyrrole appears to be the only reaction that occurs. It is
notable that, when refluxing sodium borohydride in reagent grade isopropanol,
the basicity of the solution is markedly increased, presumably as a result of the
reaction of sodium borohydride with a small amount of water present in the
isopropanol. This observation suggests that activation of pyrrole as a leaving
group by protonation at C-2 controls the rate of the undesired retro-aldol
cleavage (Scheme 28). The retro-aldol side reaction appears to be completely
shut down by increasing the basicity of the reaction mixture before addition of
the acyl pyrrole.
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Scheme 28: Proposed mechanisms for reactions observed in reduction of
2-acylpyrrole with sodium borohydride under different conditions
2.5 Synthesis of 2-undecylpyrrole analogues
After the successful development of a synthetic route to 2-undecylpyrrole our
attention turned to the synthesis of analogues of 2-undecylpyrrole, which could
be used to probe the substrate specificity of RedH and RedG.
The robust synthetic route used to generate 2-undecylpyrrole is compatible with
a variety of different functional groups, allowing for the rapid generation of
several 2-undecylpyrrole analogues by the same route. Commercially available
carboxylic acids were converted to their corresponding 2-alkyl pyrroles as
described above, to afford 2-undecylpyrrole analogues which have C8 85, C10
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86, C12 87 or C18 88 alkyl chains. A 2-undecylpyrrole analogue with a
C-10′-C-11′ double bond in the alkyl chain (Δ-10′-11′) 89 was also prepared by
this route (Scheme 29).
Scheme 29: 2-undecylpyrrole analogues synthesised from commercially available
carboxylic acids using the methodology described in section 2.4
In addition to the 2-undecylpyrrole analogues prepared from commercially
available carboxylic acids, it was decided to further probe the substrate
specificity of RedH and RedG by synthesising some additional analogues from
carboxylic acids that are not available commercially.
First, in order to establish the importance of steric effects on the reactions
catalysed by RedH and RedG, carboxylic acids containing methyl-branches at
C-9 or C-10 of the undecyl chain were synthesised (Scheme 30).
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Scheme 30: Synthetic route to methyl-branched 2-undecylpyrrole analogues
Ethyl 7-bromoheptanoate 90 was converted to the corresponding phosphonium
salt by reaction with excess triphenylphosphine in toluene. Subsequent
treatment with n-butyl lithium generated the desired ylid 91. It should be noted
that a side reaction resulting from the addition of the butyl anion to the carbonyl
group lowered the yield of this reaction. To the ylid 91 was added either
isovaleraldehyde 93 or 2-methyl butyraldehyde 92 and the resulting expected
alkene products from each reaction 94 or 95 were isolated as inseparable
mixtures of E and Z isomers. Hydrogenation of the double bonds in these
compounds with hydrogen gas over Pd/C, followed by base promoted ester
hydrolysis, in each case gave the desired methyl branched carboxylic acid 96 or
97. These two acids were converted to the corresponding 2-alkyl pyrroles 98
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and 99 via their pyridyl thioesters by the route described above for synthesis of
2-undecylpyrrole 10 (Scheme 27).
It was also decided to probe the specificity of RedH and RedG with substrates
containing a polar ether linkage, either close to, or far from, the site of
carbocyclisation to form streptorubin B. Therefore, carboxylic acids containing
either a C2-C4 ether linkage, or a C5-C7 ether linkage were synthesised
(Scheme 31). Thus, treatment of bromoacetic acid 100 in octanol with two
equivalents of sodium metal resulted in the displacement of the bromide from
the initially formed bromoacetate, via a modification of the Williamson ether
synthesis (Scheme 31).
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Scheme 31: Synthetic route to ether-containing 2-undecylpyrrole analogues
A subsequent acid/base extraction gave the expected C2-C4 ether linked acid
101 in good yield. The C5-C7 ether linked acid 104 was synthesised from methyl
5-bromovalerate 103, instead of the corresponding acid, to prevent cyclisation of
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the carboxylate anion to form the δ-lactone. Treatment of methyl 
5-bromovalerate 103 with one equivalent of sodium in pentanol gave the
expected C5-C7 ether linked methyl ester, which proved difficult to separate
from the residual pentanol. Therefore, the crude methyl ester was hydrolysed to
give the corresponding acid 104, which could be purified by acid/base
extraction. The ether-linked acids 101 and 104 were converted to the
corresponding 2-alkyl pyrroles 102 or 105 using the route described above for
the synthesis of 2-undecylpyrrole (Scheme 27).
2.6 Acid-catalysed coupling of MBC and analogues with
2-undecylpyrrole and analogues
Previously, bipyrrole aldehydes analogous to those synthesised here have been
condensed with alkyl pyrroles in a simple acid-catalysed reaction to complete
the synthesis of prodiginines such as undecylprodiginine (Scheme 32).72
Scheme 32: Condensation of MBC and 2-undecylpyrrole to give
undecylprodiginine72
Therefore, it was clear that we could synthesise undecylprodiginine and several
undecylprodiginine analogues using this approach. To this end, coupling of MBC
9 and each of the five A-ring analogues 62 to 65 with either synthetic
2-undecylpyrrole 10, or commercially available 2,4-dimethylpyrrole 106, in the
presence of methanolic HCl, provided the predicted triaromatic prodiginine
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analogues (Scheme 33). 2,4-dimethylpyrrole serves as a good choice for this
condensation for several reasons. Firstly, to a first approximation, the
condensation product can be considered similar to carbocyclic prodiginines like
streptorubin B and meta-cycloprodigiosin because it has the same substitution
pattern in the pyrrole C ring, bearing alkyl substituents on C-2 and C-4. Notably,
this substitution pattern is shared by the prodiginine analogue, obatoclax 7,
which is a current clinical candidate. The reaction was carried out in methanol
with a catalytic amount of HCl, and gave the desired triaromatic compounds 107
to 116 in varying yields after purification on silica gel. These couplings, even
though they are unoptimised and therefore not efficient, provided us with
sufficient material for full characterisation and proved to be useful, not only for
biological testing, but also as synthetic standards for the products of in vivo
RedH-catalysed reactions.
Scheme 33: Synthesis of undecylprodiginine and streptorubin B like analogues
with variation in the A-ring and C-rings
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3.0 Results and discussion: Mutasynthetic
production of undecylprodiginine and streptorubin
B analogues with MBC analogues
3.1 Mutasynthesis products of A-ring analogues of MBC
To probe the substrate specificity of RedH and RedG and to attempt to generate
prodiginine analogues, the MBC analogues varying in the prodiginine A-ring 62
to 65 (Figure 19) were fed to a S. coelicolor mutant blocked in MBC
biosynthesis.
The strain used was Streptomyces coelicolor, W39 (M511 redM::oriT-apr), in
which the redM gene, involved in the biosynthesis of MBC and consequently of
prodiginines, has been replaced by an apramycin resistance cassette.35 This
strain is known to be deficient in MBC production and hence does not produce
any prodiginine antibiotics.35
Figure 19: Structure of MBC and MBC A-ring analogues
Feeding of synthetic MBC 9 to S. coelicolor W39 was initially investigated in an
attempt to optimise the production of prodiginines by mutasynthesis in this
strain. Production levels of the products were monitored by LC-MS/MS analysis.
Feeding of MBC to S. coelicolor W39 showed that good levels of production of
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both undecylprodiginine (red trace) and streptorubin B (blue trace) can be
achieved (Figure 21 top). This experiment later proved to be a vital positive
control during analogue production.  By comparing the λmax values, retention
times and MS/MS fragment ions with authentic standards the compounds
detected in this experiment were confirmed to be undecylprodiginine and
streptorubin B respectively. An authentic standard of undecylprodiginine was
synthesised via acid-mediated condensation between MBC and
2-undecylpyrrole (as described in chapter 2), and an authentic standard of
streptorubin B was isolated from S. coelicolor M511. MBC was also fed to S.
coelicolor W33, in which redH, the gene encoding the protein responsible for the
condensation of MBC and 2-undecylpyrrole, has been replaced with an
apramycin resistance cassette (Figure 21 bottom). This experiment proved
useful as a control that revealed the background rate of non-enzymatic
condensation (due to acid catalysis resulting from the acidified methanol
extraction procedure used for prodiginine isolation).
Figure 20: Mutasynthetic pathway to undecylprodiginine 3 and streptorubin B 4
when S. coelicolor W39 is fed with MBC 9.
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Figure 21: Extracted ion chromatograms (EICs) from LC-MS analyses of
prodiginines produced by S. coelicolor W39 (top) and W33 (bottom) when fed with
MBC 9.
Feeding of MBC analogues 62 to 65 to S. coelicolor W39 resulted in the
production of the corresponding undecylprodiginine analogues in low levels
relative to the level of undecylprodiginine produced when feeding MBC to the
W39 mutant. The structures of these undecylprodiginine analogues were
EIC at m/z = 222, corresponding to 2-undecylpyrrole
EIC at m/z = 392, corresponding to streptorubin B
EIC at m/z = 394, corresponding to undecylprodiginine
0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5
0
1
2
3
4
8x10
Intens.
0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5
0
1
2
3
4
8x10
Intens.
W39 (M511
redM::oriT-
apr)
W33 (M511
redH::oriT-
apr)
10
3
4
3
10
61
confirmed by comparing the λmax values, retention times and MS/MS spectra with
authentic standards synthesised via acid catalysed condensation of the MBC
analogues 62 to 65 with 2-undecylpyrrole 10 (as described in section 2.6). The
MBC analogues were also fed to S. coelicolor W33. These experiments were
crucial to distinguish whether the prodiginine formation observed in the
experiments with the W39 mutant was due to an enzymatic condensation,
catalysed by RedH, or as a result of acid-mediated condensation during the
extraction.
MBC analogues 62 to 65 were fed to the S. coelicolor W33 and W39 mutants in
parallel, and the results of LC-MS/MS analyses were compared. Small amounts
of undecylprodiginine analogues were observed in all cases in the experiments
with the W33 (redH) mutant probably due to the isolation procedure in which
acidified methanol is added to extract prodiginines from the mycelium pellet.
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When feeding the thiophenyl analogue of MBC 64 to S. coelicolor W39 the level
of corresponding undecylprodiginine analogue 114 produced was significantly
higher (relative to the amount of residual 2-undecylpyrrole 10) than when this
analogue was fed to the W33 mutant indicating that RedH is able to utilise the
thiophenyl analogue of MBC (Figure 22 and Figure 23). However, no evidence
for formation of the corresponding streptorubin B thiophenyl analogue 117 could
be observed when 64 was fed to the W39 mutant (Figure 22 and Figure 23).
Figure 22: Mutasynthetic pathway to undecylprodiginine analogue 114 and
proposed streptorubin B analogue 117 when S. coelicolor W39 is fed with
thiophenyl analogue of MBC 64.
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Figure 23: Extracted ion chromatograms (EICs) from LC-MS analyses of
prodiginines produced by S. coelicolor W39 (top) and W33 (bottom) when fed with
thiophenyl analogue of MBC 64.
EIC at m/z = 222, corresponding to 2-undecylpyrrole
EIC at m/z = 409, corresponding to proposed streptorubin B analogue
EIC at m/z = 411, corresponding to undecylprodiginine analogue
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When feeding the furanyl analogue of MBC 65 to S. coelicolor W39, the level of
furanyl undecylprodiginine analogue 115 produced was significantly higher than
in S. coelicolor W33 (again relative to the amount of residual
2-undecylpyrrole 10). There was no evidence for the production of the furanyl
streptorubin B analogue 118 (Figure 24 and Figure 25).
Figure 24: Mutasynthetic pathway to undecylprodiginine analogue 115 and
proposed streptorubin B analogue 118 when S. coelicolor W39 is fed with furanyl
analogue of MBC 65.
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Figure 25: Extracted ion chromatograms (EICs) from LC-MS analyses of
prodiginines produced by S. coelicolor W39 (top) and W33 (bottom) when fed with
furanyl analogue of MBC 65.
EIC at m/z = 222, corresponding to 2-undecylpyrrole
EIC at m/z = 393, corresponding to proposed streptorubin B analogue
EIC at m/z = 395, corresponding to undecylprodiginine analogue
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Unlike for the other analogues, the quantity of the phenyl undecylprodiginine
analogue 112 (relative to residual 2-undecylpyrrole), was only modestly greater
when the phenyl analogue of MBC 62 was fed to the W39 mutant compared to
the W33 mutant. No evidence for the formation of a phenyl streptorubin B
analogue 119 could be seen when feeding the phenyl analogue of MBC 62 to S.
coelicolor W39 (Figure 26 and Figure 27).
Figure 26: Mutasynthetic pathway to undecylprodiginine analogue 112 and
proposed streptorubin B analogue 119 when S. coelicolor W39 is fed with phenyl
analogue of MBC 62.
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Figure 27: Extracted ion chromatograms (EICs) from LC-MS analyses of
prodiginines produced by S. coelicolor W39 (top) and W33 (bottom) when fed with
phenyl analogue of MBC 62.
EIC at m/z = 222, corresponding to 2-undecylpyrrole
EIC at m/z = 403, corresponding to proposed streptorubin B analogue
EIC at m/z = 405, corresponding to undecylprodiginine analogue
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The levels of undecylprodiginine analogues produced by feeding heterocyclic
MBC analogues 64 and 65 to S. coelicolor W39 were significantly higher than
when feeding the analogues to W33 (in which the condensing enzyme, RedH is
not present). This unequivocally demonstrates that they are substrates of RedH.
The reason for the smaller difference in observed prodiginine production
between the W39 mutant and the W33 mutant when feeding the phenyl
analogue of MBC 62 is not clear, it could be due to an increased in vivo stability
of 62 resulting in a higher level of ‘background’ non-enzymatic condensation
occurring as a result of the acidic extraction conditions used at the end of the
incubation. Another plausible explanation could be the decreased bioavailability
of the phenyl MBC analogue 62 compared to the thiophenyl and furanyl MBC
analogues 64 and 65. Alternatively, the difference could be due to the absence
in 62 of a heteroatom capable of donating a lone pair to the adjacent aromatic
ring, which may be important for the enzymatic activity of RedH.
In all cases, when MBC analogues are fed the levels of undecylprodiginine
analogues produced are considerably lower than when undecylprodiginine is
produced by feeding with MBC (where levels of undecylprodiginine production
are approaching that observed in wild type S. coelicolor).
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No streptorubin B analogues were produced when feeding furanyl, thiophenyl
and phenyl A-ring analogues of MBC to S. coelicolor W39 (Figure 22 to Figure
27). However, when the indolyl analogue of MBC 63 was fed to the W39 mutant
there was evidence for the formation of an indolyl streptorubin B analogue 122.
LC-MS analyses of extracts from the W39 mutant fed with the indolyl analogue
of MBC 63 showed a low level of a compound with m/z and MS/MS fragment
ions that would be expected for the indolyl streptorubin B analogue 122 (Figure
29).
Figure 28: Mutasynthetic pathway to undecylprodiginine analogue 113 and
proposed streptorubin B analogue 122 when S. coelicolor W39 is fed with indolyl
analogue of MBC 63.
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Figure 29: Extracted ion chromatograms (EICs) from LC-MS analyses of
prodiginines produced by S. coelicolor W39 (top) and W33 (bottom) when fed with
indolyl analogue of MBC 63.
Due to the small amount of the proposed indolyl analogue of streptorubin B
generated in these experiments, insufficient material has been isolated to allow
for the characterisation of this compound by NMR spectroscopy. Additionally,
EIC at m/z = 222, corresponding to 2-undecylpyrrole
EIC at m/z = 442, corresponding to proposed streptorubin B analogue
EIC at m/z = 444, corresponding to undecylprodiginine analogue
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because we have no amenable route for synthesis of the analogue 122,
comparison with an authentic standard has not been possible.
However, mass spectrometry has provided good evidence for the formation of
the indolyl streptorubin B analogue 122 by mutasynthesis. High resolution mass
spectrometry of the isolated compound gave a molecular formula corresponding
to that of 122 (Calculated for C29H35N3O: 442.2853 [M+H]+ Found: 442.2856). In
addition the fragmentation of the compound in MS/MS experiments (Figure 31)
can be compared to the characteristic and known fragmentation pattern of
streptorubin B (Figure 30). Several characteristic fragment ions of streptorubin B
are mirrored in the fragmentation of 122. Initial loss of 15 mass units has been
shown to be characteristic of heterocyclic methoxy groups,89 and is seen for
both streptorubin B (m/z 392 to 377) and the indolyl analogue (m/z 442 to 425).
The subsequent fragmentation of the alkyl chain can also be seen clearly, with
the sequential loss of units with m/z = 14, until just the triheterocyclic core plus
one or two -(CH2)- units remain for both streptorubin B (m/z 252 and 238) and
the indolyl analogue 122 (m/z 302 and 288).
The condensation of the indolyl analogue 122 of MBC with 2-undecylpyrrole
occurs at levels much below that seen when undecylprodiginine is produced by
feeding with MBC. Therefore suggesting that the potentially beneficial presence
of the A-ring N-H, previously suggested as an important though non-vital H-bond
donor (based on feeding of thiophenyl, phenyl and furanyl analogues of MBC),
may be off-set by a degree of steric constraint in this case.
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Figure 30: MS/MS fragmentation pattern of streptorubin B
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Figure 31: MS/MS fragmentation pattern of indolyl streptorubin B analogue 122
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3.2 Mutasynthesis products of B-ring analogues of MBC
Roseophilin contains a similar conjugated structure to that of the prodiginines.
The main difference is that a furan replaces one of the pyrrole rings. Reasoning
that roseophilin and the prodiginines could be biosynthesised via analogous
pathways, a B-ring furanyl analogue of MBC 71 was synthesised, as described
in section 2.3. This compound was fed to the W39 mutant to establish whether
S. coelicolor could utilise this compound to biosynthesise a roseophilin–
undecylprodiginine hybrid structure 120.
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Figure 32: Proposed mutasynthetic pathway to undecylprodiginine-roseophilin
hybrid 120 and carbocyclic derivative 121 when S. coelicolor W39 is fed with
B-ring furanyl analogue of MBC 71.
In contrast to the MBC A-ring analogues, when the B-ring MBC analogue 71
was fed to either S. coelicolor W33 or S. coelicolor W39, no prodiginine-like
compounds 120 or 121 were produced (Figure 33). It is unclear, at this stage,
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whether this is because the furanyl B-ring analogue is not a substrate for RedH
or simply because it cannot cross the membrane of S. coelicolor cells.
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Figure 33: Extracted ion chromatograms (EICs) from LC-MS analyses of
prodiginines produced by S. coelicolor W39 (top) and W33 (bottom) when fed with
B-ring furanyl analogue of MBC 71.
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The sequence of the putative roseophilin biosynthetic gene cluster of
Streptomyces griseoviridis has recently become available. We have tentatively
identified a gene which might be responsible for the conversion of a B-ring
pyrrole in a prodiginine to the corresponding B-ring furan within this gene
cluster. This would be consistent with the hypothesis that B-ring furanyl
analogues of MBC appear to not be substrates for RedH.
3.3 Summary of conclusions of mutasynthesis with MBC
analogues
Overall the mutasynthesis experiments with MBC analogues have proved a
success, resulting in the generation of evidence for the formation of an indolyl
streptorubin B analogue 122. It has also provided knowledge of the substrate
specificity of both RedH and RedG with respect to MBC and the MBC-derived
portion of undecylprodiginine.
These in vivo experiments do not allow a distinction to be made between factors
affecting the bioavailabilty of these compounds, or enzyme specificity. However,
RedH has been shown to catalyse the condensation of a variety of synthetic
MBC analogues with 2-undecylpyrrole, although with varying levels of efficiency.
The varying levels of production of these analogues suggests that perhaps the
pyrrole N-H of the MBC A-ring is important, but not vital, for the binding to or the
catalytic activity of RedH, and that the presence of a heteroatom in the MBC A-
ring which is capable of donating a lone pair to the neighbouring aromatic ring is
perhaps playing a key role in RedH substrate recognition or catalysis. The
condensation of the indolyl analogue of MBC with 2-undecylpyrrole to form the
corresponding undecylprodiginine analogue suggests that RedH does not
impose a strong steric constraint on the A-ring of MBC, however some level of
steric clash may account for the low level of conversion of indolyl MBC to indolyl
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undecylprodiginine even though there is an A-ring N-H bond. In addition, these
results perhaps suggest that the B-ring N-H of MBC may be required for
substrate recognition or catalytic activity of RedH, and that the structurally
related antibiotic roseophilin may be biosynthesised by conversion of prodiginine
B-ring pyrrole to a furan.
Finally RedG seems to impose a high degree of structural constraint on the
MBC-derived portion of undecylprodiginine in the oxidative carbocyclisation
reaction to form streptorubin B. It appears as though the MBC A-ring N-H bond
is vital for activity of RedG, and no other heteroatoms bearing lone pairs can act
as a viable mimic. Although it is difficult to comment on the efficiency of the
RedG cyclisation for the indolyl analogue because of the low activity of RedH it
appears as though RedG functions well, suggesting that RedG imposes little
steric constraint on the MBC derived portion of undecylprodiginine.
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4.0 Result and discussion: Mutasynthesis of
streptorubin B analogues using 2-undecylpyrrole
analogues
4.1 Initial feeding studies of 2-undecylpyrrole analogues
to a redL- mutant of S. coelicolor
We next investigated the mutasynthesis of streptorubin B (and
undecylprodiginine) analogues using analogues of 2-undecylpyrrole 10. A
variety of analogues were designed to further probe the substrate specificity of
RedH and RedG and to generate streptorubin B analogues that are currently
inaccessible by conventional synthesis. 2-undecylpyrrole analogues varying in
the alkyl chain attached to the pyrrole ring were synthesised as described in
chapter two.
The 2-undecylpyrrole analogues were fed to Streptomyces coelicolor W38, in
which the redL gene, known to be involved in the biosynthesis of 2-
undecylpyrrole, has been replaced by an apramycin resistance cassette.25 This
strain cannot make 2-undecylpyrrole and hence does not produce any
prodiginine antibiotics. Initial feeding studies with this strain were conducted with
the natural substrate, 2-undecylpyrrole, in order to determine the level of
undecylprodiginine and streptorubin B production. In addition, the 2-
undecylpyrrole analogue with a terminal (Δ-10′-11′) alkene in the alkyl chain was 
used to probe the ability of RedH and RedG to tolerate changes in the alkyl
chain of 2-undecylpyrrole.
Feeding 2-undecylpyrrole 10 to W38 (Figure 34) resulted in restoration of
undecylprodiginine 3 production to levels approaching that observed in wild-type
S. coelicolor M511. However, UV chromatograms monitoring absorbance at 533
nm from LC-MS analyses of extracts from this experiment showed that the ratio
of streptorubin B 4 to undecylprodiginine 3 is substantially reduced (Figure 35)
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compared with the ratio of streptorubin B/undecylprodiginine produced by S.
coelicolor M511 (Figure 36).
Figure 34: Restoration of undecylprodiginine and streptorubin B production in
S. coelicolor W38 when fed with 2-undecylpyrrole
0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0
0
200
400
600
[mAU]
Figure 35: UV chromatogram (533 nm) from LC-MS analysis of a mycelial extract
of S. coelicolor W38 fed with 2-undecylpyrrole
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Figure 36: UV chromatogram (533nm) from LC-MS analysis of a mycelial extract of
S. coelicolor M511
When the Δ-10′-11′ 2-undecylpyrrole analogue 89 was fed to S. coelicolor W38
(Figure 37), production of the corresponding undecylprodiginine analogue 123
was observed at levels approaching the levels of undecylprodiginine production
observed in wild-type S. coelicolor M511.
Figure 37: Mutasynthesis of undecylprodiginine 123 and streptorubin B 124
analogues with unsaturation in the alkyl chain.
In addition, evidence for the formation of the corresponding streptorubin B
analogue 124 was obtained from LC-MS analyses (Figure 38 and Figure 39).
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The UV chromatogram monitoring absorbance at 533 nm showed a peak with a
retention time similar to streptorubin B (Figure 39) and the extracted ion
chromatogram at m/z = 390 confirmed this peak had the expected molecular
mass for the analogue 124 (Figure 38).
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Figure 38: Extracted ion chromatograms at m/z = 390 (blue trace) and m/z = 392
(red trace) from LC-MS analysis of a mycelial extract of S. coelicolor W38 fed with
2-undecylpyrrole Δ-10′-11′ analogue 89 
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Figure 39: UV chromatogram (533 nm) from LC-MS analysis of a mycelial extract
of S. coelicolor W38 fed with 2-undecylpyrrole Δ-10′-11′ analogue 89
123
124
123
124
82
4.2 Use of S. coelicolor M511 redL::oriT-apr + redGH
(W116) to boost production levels of streptorubin B
analogues
The above experiments made it clear that isolation of the putative streptorubin B
analogue produced when the Δ-10′-11′ 2-undecylpyrrole analogue 89 was fed to
S. coelicolor W38 for characterisation by NMR spectroscopy would not be
practically possible. Even though the levels of prodiginines produced when
feeding 2-undecylpyrrole or Δ-10′-11′ 2-undecylpyrrole analogue 89 to
S. coelicolor W38 were both approaching that observed in wild-type S.
coelicolor, the ratio of streptorubin B to undecylprodiginine was vastly reduced in
both cases.
To overcome this problem, Paulina Sydor (another PhD student in the lab)
investigated the effect of over-expressing either RedG and/or RedH. When redG
is constitutively expressed in M511, RedG is expected to be over-produced in
the resulting strain in comparison to M511 and hence was proposed to increase
the ratio of streptorubin B in comparison to undecylprodiginine in the new strain.
However, she had previously shown that redG and redH integrated and
constitutively expressed together restore production of streptorubin B more
efficiently in a redG- mutant than when redG is expressed alone. Therefore she
created both S. coelicolor M511 + redG (which contains an extra copy of redG)
and S. coelicolor M511 + redGH (which contains an extra copy of both redG and
redH). Indeed, when analysing the mycelial extract of these two strains she
showed the ratio of streptorubin B to be increased more significantly in
S. coelicolor M511 + redGH than in M511 + redG.42
Therefore to overcome the problem of the low ratio of streptorubin B analogues,
Paulina Sydor created S. coelicolor M511 redL::oriT-apr + redGH (W116).42 This
mutant is deficient in 2-undecylpyrrole biosynthesis, but contains extra copies of
the redH and redG genes and is thus expected to over-produce both RedH and
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RedG in comparison to the wild-type strain M511. Overproduction of these two
proteins was expected to lead to an increase in the ratio of streptorubin B to
undecylprodiginine produced when the mutant is fed with 2-undecylpyrrole,
which could facilitate the isolation and purification of streptorubin B analogues.
To test this hypothesis, 2-undecylpyrrole and the Δ-10′-11′ 2-undecylpyrrole 
analogue 89 were fed to the S. coelicolor redL::oriT-apr + redGH mutant
(W116). Overall levels of prodiginine production in these experiments did not
significantly increase compared with earlier experiments, however, a striking
increase in the ratio of streptorubin B to undecylprodiginine was observed. In
both cases, when 2-undecylpyrrole 10 and the Δ-10′-11′ 2-undecylpyrrole 
analogue 89 were independently fed to S. coelicolor W116 the UV
chromatograms (Figure 41 and Figure 43) and the extracted ion chromatograms
at the corresponding masses (Figure 40 and Figure 42) from LC-MS analyses
showed higher levels of streptorubin B 4 and the streptorubin B analogue 124
than in previous experiments.
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Figure 40: Extracted ion chromatograms at m/z = 392 (blue trace) and m/z = 394
(red trace) from LC-MS analysis of a mycelial extract of S. coelicolor W116 fed
with 2-undecylpyrrole
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Figure 41: UV chromatogram (533 nm) from LC-MS analysis of a mycelial extract
of S. coelicolor W116 fed with 2-undecylpyrrole
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Figure 42: Extracted ion chromatograms at m/z = 390 (blue trace) and m/z = 392
(red trace) from LC-MS analysis of a mycelial extract of S. coelicolor W116 fed
with Δ-10′-11′ 2-undecylpyrrole analogue 89 
0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0
0
200
400
600
800
Intens.
[mAU]
Figure 43: UV chromatogram (533 nm) from LC-MS analysis of a mycelial extract
of S. coelicolor W116 fed with Δ-10′-11′ 2-undecylpyrrole analogue 89 
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It was not initially obvious why increasing the production of both RedH and
RedG should affect the ratio of undecylprodiginine and streptorubin B. RedH
catalyses the formation of undecylprodiginine which is then converted to
streptorubin B by RedG. However, given the number of undecylprodiginine
analogues observed in mutasynthesis experiments compared to the number of
analogues of streptorubin B produced, RedH appears to display more relaxed
substrate specificity than RedG. Perhaps condensation of 2-undecylpyrrole and
MBC catalysed by RedH is so fast that multiple turnovers are occurring before
one cyclisation reaction has been catalysed by RedG i.e. RedG is rate limiting in
the formation of streptorubin B. Therefore undecylprodiginine can not be
effectively passed from RedH to RedG and instead diffuses to and is trapped
within the cell membrane by virtue of its undecyl alkyl chain. Undecylprodiginine
is known to be membrane-bound in cells and its isolation involves mycelial
extraction. This binding within the membrane would prevent RedG, which
appears not to be membrane-bound, from accessing its substrate. The
difference in catalytic efficiency between RedH and RedG, resulting in the
trapping of undecylprodiginine in the membrane could explain the accumulation
of undecylprodiginine in wild-type S. coelicolor. It could be suggested that the
effect of this rate difference is amplified when using analogues of 2-
undecylpyrrole or when the timescale of ‘production’ of 2-undecylpyrrole is
altered from the constant level produced enzymatically in wild-type S. coelicolor
to the sudden addition of a large concentration of 2-undecylpyrrole when it is fed
to the redL mutant.
It is possible that decomposition of RedG has an influence on the
undecylprodiginine/streptorubin B ratio. Many iron containing enzymes which
activate molecular oxygen and hence generate very reactive intermediates are
known to be susceptible to self-inactivation via proposed superoxide/peroxide
mediated processes.90, 91, 92, 93, 94 If RedG does self-inactivate rapidly in vivo; the
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decrease in ratio of RedG to RedH over time may be the reason for the
accumulation of undecylprodiginine in S. coelicolor. As RedG inactivates, the
rate of turnover of undecylprodiginine to streptorubin B would decrease.
However, the production of undecylprodiginine would not (presuming RedH is
stable). Therefore this ‘excess’ undecylprodiginine can not all be bound and
turned-over by RedG but becomes imbedded within the cell membrane.
Furthermore, redH and redG are co-transcribed; therefore it is intriguing to
speculate that perhaps RedH and RedG may form a catalytic complex. Perhaps
RedG is more active in complex with RedH, or self-inactivates less quickly. It is
also conceivable that undecylprodiginine could be channelled from RedH to
RedG in a catalytic complex, thus reducing loss of undecylprodiginine to the
membrane. If RedH and RedG are both overexpressed constitutively, in the
redL::oriT-apr + redGH mutant (W116) a higher level of active RedG may be
maintained within the cell. Thus increasing the rate of turnover of
undecylprodiginine to streptorubin B.
Whatever the cause of the increased ratio of streptorubin B to
undecylprodiginine when RedH and RedG are constitutively expressed in the
RedL- mutant, it allowed us to isolate the streptorubin B analogue produced
when the Δ-10′-11′ 2-undecylpyrrole analogue 89 is fed to S. coelicolor W116 in
sufficient quantity for analysis by NMR and CD spectroscopies. Initial purification
of the prodiginine mixture from the extract as the free bases was carried out by
flash column chromatography on basic alumina. This was followed by HPLC
separation of the hydrochloride salts of the streptorubin B analogue and the
undecylprodiginine analogue.
NMR spectroscopic analysis of the isolated product provided strong evidence for
the formation of a streptorubin B analogue by the mutasynthesis approach.
Comparison of the 1H-NMR spectrum of compound 124 (Figure 44) with that of
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streptorubin B 4 (Figure 45) indicated that 124 contains the same carbocyclic
ring as streptorubin B 4.
Figure 44: 1H-NMR spectrum of unsaturated streptorubin B analogue 124
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Figure 45: 1H-NMR spectrum of streptorubin B 4
A peak at -1.54 ppm, characteristic of the ansa-bridged 10-membered
carbocycle of streptorubin B, resulting from unusually heavy shielding of one of
the hydrogen attached to C-4′ by the nearby pyrrole π electrons, is observed in 
the 1H-NMR spectrum of compound 124 (Figure 46a). Examination of the region
between 7.5 and 6.0 ppm in the 1H-NMR spectrum of compound 124 shows the
same pattern of peaks for the pyrrole protons as in streptorubin B, illustrating an
equivalent pyrrole substitution pattern (Figure 46c). Signals corresponding to the
monosubstituted alkene can also be seen with the expected intensities and
multiplicities at 5.86 ppm (1H, multiplet), 5.07 ppm (1H, doublet, J = 18 Hz) and
5.01 ppm (1H, doublet, J = 10 Hz) (Figure 46c). In addition, the chemical shifts
and multiplicities of the signals corresponding to the three protons alpha to the
pyrrole C-ring system in streptorubin B are mirrored in the unsaturated analogue
124 (Figure 46b).
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Figure 46: Comparison of diagnostic regions of the 1H-NMR spectrum of
streptorubin B 4 (blue trace) and the streptorubin B Δ-10′-11′ analogue 124 (red 
trace)
As discussed previously, streptorubin B 4 displays a very intense and distinctive
circular dichroism spectrum due to the large optical activity of this compound,
probably resulting from the ansa-bridged carbocycle. In order to establish if the
level of stereocontrol RedG imparts on the carbocyclisation is affected with
a) b)
c)
H-4′ H-1′b H-1′a H-7′ 
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undecylprodiginine analogues, the CD spectrum of compound 124 was
recorded.
CD spectrum of 124 (in MeOH, c = 0.165 mM)
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Figure 47: Circular dichroism spectrum of Δ-10′-11′ streptorubin B analogue 124 
The CD spectrum of the streptorubin B Δ-10′-11′ analogue 124 (Figure 47) is
very similar to that of natural streptorubin B (Figure 49). The fact that the peak
for the analogue is slightly less intense might indicate that the same level of
stereocontrol is not achieved with this analogue as with the natural compound.
The peak height is normalised to prodiginine concentration as calculated by UV
analysis with the known extinction coefficient 100500 M-1 cm-1. At this time the
absolute stereochemistry of the carbocyclisation of these analogues has not
been studied in detail. However, preliminary chiral HPLC analyses (which have
been complicated by some decomposition of the cyclic material) show one major
peak for compound 124 which has a poorly resolved shoulder and some other
minor constituents, one of which ~ 39 minutes has a retention time similar to
ent-streptorubin B (seen at ~34 minutes in analyses of streptorubin B, as
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discussed in chapter 5) and this may account for the slightly reduced peak
magnitude in the CD spectrum of 124. These experiments appear to indicate
that the analogue 124 is enantiomerically enriched (if not enantiomerically pure)
and that the major enantiomer has the same absolute stereochemistry as
streptorubin B.
B39_13_01_251.d: UV Chromatogram, 470 nm
Strep B natural_12_01_250.d: UV Chromatogram, 470 nm
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Figure 48: Comparison of the chiral HPLC analyses of streptorubin B (bottom
trace) and streptorubin B Δ-10′-11′ analogue 124 (top trace) 
92
CD spectrum of streptorubin B (in MeOH c = 0.114 mM)
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Figure 49: Circular dichroism spectrum of natural streptorubin B isolated from S.
coelicolor M511
4.3 Mutasynthesis of further streptorubin B analogues
by feeding other 2-undecylpyrrole analogues to
S. coelicolor W116
The isolation of the streptorubin B Δ-C10′-C11′ analogue 124 from S. coelicolor
W116 fed with the Δ-C10′-C11′ analogue of 2-undecylpyrrole prompted us to 
investigate the feeding of the other synthetic 2-undecylpyrrole analogues
described in chapter 2 to the W116 mutant. These experiments aimed to further
probe the substrate specificity of both RedH and RedG and to generate further
streptorubin B analogues which might facilitate exploration of the structure-
activity relationship of these compounds.
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4.3.1 Shortened alkyl chain analogues
4.3.1.1 2-decylpyrrole 86
Feeding of 2-decylpyrrole 86 to S. coelicolor W116 resulted in the production of
decylprodiginine 125 and its carbocyclic derivative 126 as indicated by extracted
ion chromatograms at m/z = 378 and 380 (Figure 51) and the UV chromatogram
at 533 nm (Figure 52) from LC-MS analyses of mycelial extracts (Figure 50).
About 30 % of the 2-undecypyrrole analogue 86 was consistently and
reproducibly converted to prodiginine analogues in these experiments, a value
that proved typical for feeding experiments with 2-undecylpyrrole analogues.
Figure 50: Mutasynthesis of decylprodiginine 125 and the corresponding
streptorubin B analogue 126.
94
0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0
0.0
0.5
1.0
1.5
8x10
Figure 51: Extracted ion chromatograms at m/z = 378 (blue trace) and m/z = 380
(red trace) from LC-MS analysis of a mycelial extract of S. coelicolor W116 fed
with 2-decylpyrrole 86
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Figure 52: UV chromatogram (533 nm) from LC-MS analysis of a mycelial extract
of S. coelicolor W116 fed with 2-decylpyrrole 86
The ratio of compounds 125 and 126 produced in this experiment was ~1:4
based on the UV chromatogram at 533 nm from LC-MS analysis. The
streptorubin B analogue 126 was isolated in the same way as analogue 124 and
characterised by 1H-NMR spectroscopy. This analysis indicated that compound
126 has a very similar structure to streptorubin B 4 (Figure 53). The signals for
the pyrrole protons (Figure 54b), the protons alpha to the pyrrole C-ring (Figure
54c) and one of the protons attached to C-4′ (at -1.54 ppm) (Figure 54a) all 
matched those observed in the 1H-NMR spectrum of streptorubin B. The peak
125
126
125
126
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at -1.54 ppm strongly indicates that the analogue contains a 10-membered
carbocycle. A different ring size might have been obtained if the methyl terminus
of the alkyl chain of undecylprodiginine is an important feature for substrate
recognition and thus determines the site of cyclisation by the RedG enzyme.
Figure 53: 1H-NMR spectrum of streptorubin B analogue 126
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Figure 54: Comparison of diagnostic regions of the 1H-NMR spectra of
streptorubin B 4 (blue trace) and streptorubin B analogue 126 (red trace)
CD spectroscopy was used to investigate the absolute stereochemistry of
streptorubin B analogue 126. Comparison of the CD spectrum of compound 126
(Figure 55) with that of streptorubin B 4 (Figure 49) showed they are virtually
identical, strongly indicating that the absolute stereochemistry of the two
compounds are the same and that they are enantiomerically enriched to the
same extent. This conclusion is confirmed by preliminary chiral HPLC analyses,
a) b)
c)
H-4′ 
H-1′b H-1′a H-7′ 
H-A5 H-A3 H-C3
H-A4
H-B4
H-1′′
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which identified only one major species (Figure 56). Taken together the CD and
1H-NMR spectroscopic data indicate that a single streptorubin B analogue is
produced in this experiment, with an n-propyl side chain in place of the n-butyl
side chain on the carbocycle.
CD spectrum of 126 (in MeOH c = 0.206 mM)
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Figure 55: Circular dichroism spectrum of chain streptorubin B analogue 126
Streptorubin B natural_11_01_272.d: UV Chromatogram, 470 nm
Strep B natural_12_01_250.d: UV Chromatogram, 470 nm
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Figure 56: Comparison of the chiral HPLC analyses of streptorubin B (bottom
trace) and streptorubin B analogue 126 (top trace)
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4.3.1.2 2-octylpyrrole 85
Our success in forming a shorter chain analogue of streptorubin B with
2-decylpyrrole led us to test the shortest extreme of chain length tolerated in the
oxidative cyclisation by investigating the mutasynthesis of a streptorubin B
analogue with 2-octylpyrrole. LC-MS/MS analyses of extracts from the
incubation of 2-octylpyrrole 85 with S. coelicolor W116 identified a compound
that generates an ion with m/z corresponding to that predicted for
octylprodiginine analogue 127 (Figure 58). However, no ion with m/z
corresponding to that predicted for streptorubin B analogue 128 could be
detected (Figure 58). The UV chromatogram at 533 nm also showed only one
peak, suggesting only octylprodiginine 127 was produced in this experiment
(Figure 57).
Figure 57: Mutasynthesis of octylprodiginine 127 and the putative corresponding
streptorubin B analogue 128.
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Figure 58: Extracted ion chromatograms at m/z = 350 (blue trace) and m/z = 352
(red trace) from LC-MS analysis of a mycelial extract of S. coelicolor W116 fed
with 2-octylpyrrole 85
Octylprodiginine 127 was produced in levels approaching the levels of
undecylprodiginine in wild-type S. coelicolor as was the case for all
2-undecylpyrrole analogues investigated. High resolution mass spectrometry of
the isolated compound gave a molecular formula corresponding to that of 127
(Calculated for C22H29N3O: 352.2383 [M+H]+ Found: 352.2379). Also when the
fragmentation of the compound in MS/MS experiments (from LC-MS analyses)
is compared to the known fragmentation pattern of undecylprodiginine it is clear
that several characteristic fragment ions are common between both.
Consequently, although the mutasynthesis experiments with 2-octylpyrrole 85
did not produce a streptorubin B analogue it did provide insight into the
substrate specificities of RedH and RedG. RedH seems to tolerate the shorter
alkyl chain in 2-octylpyrrole, seemingly efficiently catalysing the formation of
octylprodiginine 127. In contrast, RedG appears to require a substrate with an
alkyl chain that is longer than eight carbons in order to catalyse carbocycle
formation.
127
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4.3.2 Elongated alkyl chain analogues
4.3.2.1 2-dodecylpyrrole 87
The knowledge that RedH and RedG can tolerate shorter alkyl chains than
those of their natural substrates stimulated us to investigate whether these
enzymes can utilise substrates with longer alkyl chains than their natural
substrates. To this end 2-dodecylpyrrole 87 was synthesised (as described in
chapter two). When this compound was fed to S. coelicolor W116 peaks
corresponding to dodecylprodiginine 129 and a carbocyclic derivative 130 were
observed in both extracted ion chromatograms at m/z at 406 and 408 (Figure
60) and UV chromatograms at 533 nm (Figure 61) from LC-MS/MS analyses
(Figure 59).
Figure 59: Mutasynthesis of dodecylprodiginine 129 and the corresponding
streptorubin B analogue 130.
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Figure 60: Extracted ion chromatograms at m/z = 378 (blue trace) and m/z = 380
(red trace) from LC-MS analysis of a mycelial extract of S. coelicolor W116 fed
with 2-dodecylpyrrole 87
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Figure 61: UV chromatogram (533 nm) from LC-MS analysis of a mycelial extract
of S. coelicolor W116 fed with 2-dodecylpyrrole 87
The putative streptorubin B analogue 130 was purified by flash column
chromatography on alumina and reverse phase HPLC and analysed by 1H-NMR
spectroscopy. The spectrum (Figure 62) clearly showed that the compound has
a close structural relationship to streptorubin B (Figure 45), with a couple of key
differences. The characteristic peak at -1.54 ppm indicative of a 10-membered
ansa-bridged carbocycle was present (Figure 63a), however the intensity of this
peak was lower than expected. Upon further investigation of the 1H-NMR
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spectrum of 130 an additional signal, not seen in the spectrum of streptorubin B
was observed at 0.23 ppm (Figure 63b). This signal has the same chemical shift
as a distinctive signal in the 1H-NMR spectrum of metacycloprodigiosin
(streptorubin A), which possesses a 12-membered ansa-bridged carbocycle.
These two characteristic signals suggest that 130 is a mixture of compounds
containing either a 10-membered (as in streptorubin B) or 12-membered (as in
streptorubin A) carbocyclic ring in an approximate 60:40 ratio (from the
intensities of the 1H-NMR integrations).
The signals for H-5, H-4 and H-3 of the A-ring and H-4 of the B-ring all had
identical chemical shifts to the corresponding signals for streptorubin B (Figure
63d). However, two signals, only one of which had the same chemical shift as
the corresponding proton in streptorubin B, were observed for H-1′′ (7.12 and 
7.09 ppm) and H-3 of the C-ring (6.51 and 6.33 ppm) (Figure 63d).
A similar picture emerged when analysing the signals due to H-1′ and H-7′, 
alpha to the pyrrole C-ring (Figure 63c). Two signals are observed for H-7′ in 
130, only one of which has the same chemical shift as the corresponding signal
in streptorubin B. There also appears to be two overlapping signals for each of
the protons attached to C-1′. These observations suggest that a second 
carbocyclic compound in addition to the analogue 130 is present. However,
these data alone do not allow the structure of the second carbocyclic compound
to be elucidated. The second carbocyclic compound could result from loss of
ring size control by RedG due to the increase in alkyl chain length. Indeed, the
additional signals observed for H-1′′ and H-3 of the C-ring in the spectrum of 130
have similar chemical shifts to signals in the 1H-NMR spectrum of
metacycloprodigiosin (streptorubin A), which contains a 12-membered
ansa-bridged carbocycle. This combined with the presence of a signal at 0.23
ppm, suggests that the second carbocyclic compound present contains a
103
10-membered ansa-bridged carbocycle analogous to that observed in
metacycloprodigiosin.
Figure 62: 1H-NMR spectrum of streptorubin B analogue 130
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Figure 63: Comparison of diagnostic regions of the 1H-NMR spectrum of
streptorubin B 4 (blue trace) and streptorubin B analogue 130 (red trace).
Integration values are given below each peak.
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To investigate the absolute stereochemistry of the streptorubin B analogue(s), a
CD spectrum was recorded. The spectrum (Figure 64) differs significantly from
that for streptorubin B 4 (Figure 49) and the other analogues reported in this
thesis. The large absorbance at 533 nm is no longer present. However it is
interesting to note that the baseline is not flat in this region. This CD-spectrum
could result from a mixture of two constitutional isomers with opposite absolute
stereochemistries (although a completely flat baseline would be expected for a
1:1 mixture of enantiomers).
Preliminary chiral HPLC analyses of the mixture of carbocyclic compounds
obtained from the mutasynthesis experiment with 2-dodecylpyrrole gives three
major peaks (Figure 65). One of which shows a similar retention time to
streptorubin B (peak A), and the other two (peaks B and C) which together have
an intensity approximately equal to that of peak A have a retention times similar
to that of ent-streptorubin B (seen at ~34 mintues in analyses of streptorubin B
as discussed in chapter 5). This suggests that the mixture of compounds (in
addition to 130) that results from this experiment have opposite absolute
stereochemistries. Together, analyses of 130 suggest that a mixture of
compounds which contain either 10-membered or 12-membered ansa-bridged
carbocycles and which have opposite absolute stereochemistry results from the
mutasynthesis experiment with 2-dodecylpyrrole 87.
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CD spectrum of 130 (in MeOH c = 0.186 mM)
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Figure 64: Circular dichroism spectrum of streptorubin B analogue 130
B45_15_01_253.d: UV Chromatogram, 470 nm
Strep B natural_12_01_250.d: UV Chromatogram, 470 nm
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Figure 65: Comparison of the chiral HPLC analyses of streptorubin B (bottom
trace) and streptorubin B analogue 130 (top trace).
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4.3.2.2 2-octadecylpyrrole 88
The mutasynthesis experiments with 2-dodecylpyrrole show that both RedH and
RedG can tolerate slight increases in alkyl chain length in their substrates,
although the regioselectivity of the RedG-catalysed reaction appears to be
affected. In order to probe the upper length limit of alkyl chains tolerated by
RedH and RedG, 2-octadecylpyrrole 88 was fed to S. coelicolor W116.
However, no prodiginine-like compounds (e.g. 131 or 132) were produced in this
experiment. This negative result might not reflect a limit to the substrate
specificity of RedH or RedG, because the long alkyl chain in 2-octadecylpyrrole
may adversely affect its cellular uptake.
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Figure 66: Structures of the mutasynthesis products expected to result from the
feeding of 2-octadecylpyrrole to S. coelicolor W116.
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4.3.3 Analogues containing methyl branches in the C-ring
alkyl chain
4.3.3.1 2-(10′-methylundecyl)pyrrole 99 
To probe the effect of steric changes near the site of carbocyclisation on the
reaction catalysed by RedG an analogue of 2-undecylpyrrole with a methyl
group at C-10′ 99 was synthesised (as described in chapter 2) and fed to S.
coelicolor W116. Compounds with the predicted chromatographic properties for
undecylprodiginine analogue 133 and streptorubin B analogue 134 were
detected in extracted ion chromatograms (at m/z 406 and 408) (Figure 68) and
in UV chromatograms (at 533 nm) (Figure 69) in LC-MS/MS analyses of culture
extracts.
Figure 67: Mutasynthesis of undecylprodiginine analogue 133 and the
corresponding streptorubin B analogue 134.
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Figure 68: Extracted ion chromatograms at m/z = 406 (blue trace) and m/z = 408
(red trace) from LC-MS analysis of a mycelial extract of S. coelicolor W116 fed
with 2-(10′-methylundecyl)pyrrole 99 
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Figure 69: UV chromatogram (533 nm) from LC-MS analysis of a mycelial extract
of S. coelicolor W116 fed with 2-(10′-methylundecyl)pyrrole 99  
The putative streptorubin B analogue was isolated from the culture extracts by
liquid chromatography on alumina and reverse phase and analysed by 1H-NMR
spectroscopy (Figure 70). The 1H-NMR spectrum of the isolated carbocyclic
compound very closely matched that of streptorubin B (Figure 45) suggesting
the compound had structure 134. The signal at -1.54 ppm, characteristic of the
10-membered ansa-bridged ring of streptorubin B is present in the spectrum of
134 (Figure 71a). Examination of the region between 7.5 and 6.0 ppm shows
133
134
133
134
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that the pyrrole protons give identical signals to those observed for streptorubin
B (Figure 71b). Finally the signals for the protons attached to C-1′ and C-7′ of 
134 are very similar to the signals for the corresponding protons in streptorubin
B (Figure 71c). The extra signal resulting from the additional methyl group in 134
is not clearly discernible in the 1H-NMR spectrum, but the increased complexity
in the signals at around 1 ppm indicates its presence. Also, correlations between
protons attached to C-12′ and C-11′ can be seen through to the protons 
attached to C-7′. 
Figure 70: 1H-NMR spectrum of streptorubin B analogue 134
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Figure 71: Comparison of diagnostic regions of the 1H-NMR spectra of
streptorubin B 4 (blue trace) and streptorubin B analogue 134 (red trace)
To investigate the absolute stereochemistry of streptorubin B analogue 134 its
CD spectrum was recorded (Figure 72). It is similar to the spectrum for
streptorubin B (Figure 49). However the magnitude of the absorbance at 533 nm
is reduced relative to streptorubin B. It is not clear whether this reduction in
absorbance is due to partial loss of stereocontrol in the RedG-catalysed
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H-4′ 
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carbocyclisation reaction or whether it results directly from the change in
structure. Preliminary chiral HPLC analyses of 134 are very similar to those for
streptorubin B and show only one major peak for this compound, indicating that
the absolute stereochemistry of these two compounds is the same and that they
are enantiomerically enriched to a very similar extent. This suggests that 134
has the same level of enantiopurity as natural streptorubin B. Therefore
indicating that the methyl branched substituent on the carbocycle may alter the
magnitude of the Cotton effect displayed by this compound.
CD spectrum of 134 (in MeOH c = 0.149 mM)
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Figure 72: Circular dichroism spectrum of streptorubin B analogue 134
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B50_17_01_255.d: UV Chromatogram, 470 nm
Strep B natural_12_01_250.d: UV Chromatogram, 470 nm
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Figure 73: Comparison of the chiral HPLC analyses of streptorubin B (bottom
trace) and streptorubin B analogue 134 (top trace)
The results of the NMR and CD spectroscopic analyses together with the results
of the preliminary chiral HPLC analyses suggest strongly that a single
streptorubin B analogue with the same absolute stereochemistry and an
additional methyl group at C-10′ is the sole carbocyclic product of this 
mutasynthesis experiment.
4.3.3.2 2-(9′-methylundecyl)pyrrole 98 
In order to further probe the substrate tolerances of RedG,
2-(9′-methylundecyl)pyrrole 98 was fed to S. coelicolor W116 (Figure 74). The
compound was synthesised (as described in chapter 2) and fed as a racemate
to investigate whether RedG shows any enantioselectivity. LC-MS/MS analyses
of the resulting mycelial extract showed the presence of a compound with the
m/z and UV absorbance predicted for the undecylprodiginine analogue 135 and
two compounds with the m/z and UV absorbances predicted for the
streptorubin B analogue 136 (Figure 75 and Figure 76).
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Figure 74: Mutasynthesis of undecylprodiginine analogue 135 and the
corresponding streptorubin B analogue 136.
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Figure 75: Extracted ion chromatograms at m/z = 406 (blue trace) and m/z = 408
(red trace) from LC-MS analysis of a mycelial extract of S. coelicolor W116 fed
with 2-(9′-methylundecyl)pyrrole 98 
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Figure 76: UV chromatogram (533 nm) from LC-MS analysis of a mycelial extract
of S. coelicolor W116 fed with 2-(9′-methylundecyl)pyrrole 98 
These two peaks corresponding to putative streptorubin B analogues were
initially proposed to arise from the diastereomeric nature of these analogues,
resulting from the racemic mixture of 98 that was fed. Both of these putative
streptorubin B analogues were isolated and analysed by 1H-NMR spectroscopy.
136a (retention time 11 minutes) displayed a very similar 1H-NMR spectrum
(Figure 77) to the spectrum of streptorubin B (Figure 45). It possesses the
characteristic signal at -1.54 ppm indicative of the presence of a 10-membered
ansa-bridged carbocycle in 136a (Figure 78a). Signals in the aromatic region of
the spectrum of 136a are very similar to the signals in the corresponding region
of the spectrum of streptorubin B (Figure 78c). The protons alpha to the pyrrole
C-ring resonate at similar frequencies in both spectra (Figure 78b). However
closer inspection of the aromatic and “benzylic” regions of the spectrum of 136a
allows identification of clear peak doubling at 6.50-6.55 ppm and 3.20-3.30 ppm.
Similar signal doubling was observed in the 1H-NMR spectrum of
dodecylprodiginine analogue 130 in which a mixture of compounds is present
(Figure 63), suggesting that 136a is a mixture of two closely related compounds.
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Unlike with dodecylprodiginine analogue 130, the spectrum of 136a does not
show several significantly different signals for the pyrrole protons nor does it
show the doubling of all the signals corresponding to protons alpha to the
pyrrole C-ring. Only the signal at 6.52 ppm, which corresponds to H-3 of the C-
ring and the signal at 3.20 ppm, which corresponds to H-7′ are duplicated. Both 
of these protons are proximal to the carbocycle and the duplicated signals are
shifted to a lesser extent than seen for the duplicated signals in
dodecylprodiginine analogue 130. It is reasonable to propose that the signal
doubling in the spectrum of 136a results from the presence of a mixture of
diastereoisomers due to a mixture at C9′ (arising from the racemic 
2-(9′-methylundecyl)pyrrole used in this experiment). 
Figure 77: 1H-NMR spectrum of streptorubin B analogue 136a
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Figure 78: Comparison of diagnostic regions of the 1H-NMR of streptorubin B 4
(blue trace) and streptorubin B analogue 136a (red trace). Integrals are indicated
below each signal.
Preliminary chiral HPLC analysis of the apparent mixture of streptorubin B
analogues 136a results in the separation of the two compounds, (which are
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c)
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inseparable by normal reverse-phase HPLC) and indicated that they are present
in an approximately 50:50 ratio (Figure 79). This confirms that the mixture of two
compounds observed in the 1H-NMR spectrum corresponds to two
diastereoisomers of the anticipated streptorubin B analogue 136. This raises two
questions: (1) Is the CD spectrum of the mixture different from the spectrum of
streptorubin B; and (2) if both diastereoisomers are accounted for by the peak
136a at ~11 min in the LC-MS analysis, what is the structure of the other
compound with m/z = 408 (compound 136b) and a retention time of 15 minutes?
B48_16_01_254.d: UV Chromatogram, 470 nm
Strep B natural_12_01_250.d: UV Chromatogram, 470 nm
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Figure 79: Comparison of the chiral HPLC analyses of streptorubin B (bottom
trace) and streptorubin B analogue 136a (top trace)
A CD spectrum of the diastereomeric mixture 136a was recorded (Figure 80). It
closely resembles the spectra of streptorubin B analogues 124 and 134
described previously. It shows an intense positive absorbance at 533 nm as
seen for streptorubin B (Figure 49). The intensity of the absorbance is lower
than that seen for streptorubin B. However, it is approximately equal to the
intensity of the absorbance at 533 nm for the other analogues, suggesting that
the diastereomeric mixture in 136a has little, if any, effect on the CD spectrum.
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Presumably the ‘axial’ chirality associated with the carbocycle is the major
reason for the intense absorbance at 533 nm in the CD spectrum and other
chiral elements in the structure have little effect. However, the above results
suggest that more detailed studies of the stereochemical outcome of the
carbocyclisation of undecylprodiginine analogues are required.
CD spectrum of 136a (in MeOH c = 0.167 mM)
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Figure 80: Circular dichroism spectrum of streptorubin B analogue 136a
We next sought to address the question: what is the second compound with
m/z = 406 and retention time ~15 min (136b). The compound proved difficult to
separate from the corresponding undecylprodiginine analogue 135 on a
preparative scale. However, some initial 1H-NMR studies were carried out on the
material obtained.
The 1H-NMR spectrum of 136b bears a close resemblance to that of
undecylprodiginine 3. The pattern of the signals corresponding to the pyrrole
protons in 136b is essentially identical to that seen for undecylprodiginine 3. The
large triplet at 2.91 ppm corresponding to the two non-diastereotopic protons
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alpha to the pyrrole C-ring system is also seen in the spectrum of
undecylprodiginine 3 (Figure 81). These features of the 1H-NMR spectrum both
indicate that 136b is not a carbocyclic derivative of undecylprodiginine. A
complex multiplet appears in the alkenyl region of the 1H-NMR spectrum of 136b
at ~5.2 ppm, which (when analysed in deuterated chloroform to avoid the
overlap of this signal with the residual solvent peak of deuterated methylene
chloride) from the integration corresponds to two protons (Figure 82). This
multiplet shows connectivity in 2D COSY spectra to the alkyl chain protons of
136b. Therefore it appears that the reduction in mass of this compound relative
to the undecylprodiginine analogue results from a desaturation of the alkyl chain
rather than oxidative carbocyclisation. This presumably arises via a second
hydrogen radical abstraction catalysed by RedG (Figure 83). It appears that the
RedG catalysed carbocyclisation is perturbed by the methyl group beta to the
site of cyclisation. Thus, initial alkyl radical generation can be followed by either:
(a) cyclisation analogous to that seen in streptorubin B formation and a
subsequent abstraction of a pyrrole-derived proton by RedG; or (b) abstraction
of a second alkyl hydrogen atom by RedG on the carbon atom adjacent to the
site of initial radical formation to form the observed double bond(s). Further
experiments will be required to establish the regio/stereochemistry of the double
bond(s) in 136b. Therefore the mutasynthesis experiment with
2-(9′-methylundecyl)pyrrole 98 results in the formation of a mixture of
unsaturated compounds 136b, in addition to the predicted analogues of
undecylprodiginine 135 and streptorubin B 136a (Figure 84).
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Figure 81: Comparison of the 1H-NMR spectra (CD2Cl2, 400 MHz) of 136b (red
trace) and undecylprodiginine (blue trace). Note that the alkene protons are
partially obscured by the CH2Cl2 signal.
122
Figure 82: Aromatic/alkene C-H region of the 1H-NMR spectrum (CDCl3, 400MHz) of
compound 136b (note that the seventh aromatic C-H signal is obscured by the
chloroform signal).
Figure 83: Divergence of pathways from a putative radical intermediate in
RedG-catalysed oxidation of methylated undecylprodiginine 135
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Figure 84: Summary of compounds obtained from mutasynthesis experiments
with 2-(9′-methylundecyl)pyrrole 
4.3.4 2-undecylpyrrole analogues containing ether
linkages in the alkyl chain
4.3.4.1 2-(3′-oxa-undecyl)pyrrole 102 
The incorporation of heteroatoms such as nitrogen, oxygen or sulphur into the
streptorubin B carbocycle could lead to a significant change in physico-chemical
properties due to the electronegativity and lone pairs of the heteroatoms. To test
whether RedH and RedG can tolerate a heteroatom in the alkyl chains of their
substrates an analogue containing an oxygen atom at C-3′ was fed to 
S. coelicolor W116 (Figure 85). Extracted ion chromatograms at m/z = 394 and
396 (Figure 86) and UV chromatograms at 533 nm (Figure 87) from LC-MS/MS
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analyses indicated that the predicted undecylprodiginine analogue 137 and
streptorubin B analogue 138 were both produced. It should be noted in this case
that the undecylprodiginine analogue 137 is eluted as a mixture of
interconverting configurational isomers probably resulting from rotation about the
C1′′-C2 of the B-ring carbon-carbon double bond. The compounds associated 
with each peak were separately collected from the HPLC separation. When
re-analysed by HPLC, each compound gave the same mixture of two peaks as
when first analysed. LC-MS analyses of this experiment were performed with
methanol in place of acetonitrile because of severe problems with acetonitrile
supply. This is the likely origin of the two peaks for 137 (similar peak duplication
is observed for undecylprodiginine under certain HPLC conditions).
Figure 85: Mutasynthesis of undecylprodiginine analogue 137 and the
corresponding streptorubin B analogue 138.
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Figure 86: Extracted ion chromatograms at m/z = 394 (blue trace) and m/z = 396
(red trace) from LC-MS analysis of a mycelial extract of S. coelicolor W116 fed
with 2-(3′-oxa-undecyl)pyrrole 102  
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Figure 87: UV chromatogram (533 nm) from LC-MS analysis of a mycelial extract
of S. coelicolor W116 fed with 2-(3′-oxa-undecyl)pyrrole 102   
Isolation of the putative streptorubin B analogue 138 proved to be difficult due to
decomposition during purification. It is not clear what the mechanism of
decomposition is. It is possible that 2-(3′-oxa-undecyl)pyrrole 102 is largely
decomposing in vivo before incorporation into the corresponding prodiginine
analogues. Alternatively, the prodiginine analogues themselves might be
decomposing. Indeed, both of these decomposition routes could be occurring
simultaneously. It is interesting to note that (3′-oxa-2-undecyl)pyrrole 102
137
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137
137
138
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decomposes significantly faster than all the other 2-undecylpyrrole analogues
synthesised in this study. Even at reduced temperatures, it quickly degrades to a
black oil, via a presumed polymerisation pathway that is similar to the acid-
catalysed polymerisation of pyrrole.
Due to the insufficient amount of material isolated, a satisfactory 1H-NMR
spectrum of 138 could not be obtained. However, the compound was
investigated by high resolution mass spectrometry to confirm the molecular
formula of the isolated compound (Calculated for C24H31N3O2: 394.2489 [M+H]+
Found: 394.2490), and analyses of this compound in MS/MS experiments
showed several ions corresponding to analogous characteristic fragments in the
MS/MS spectrum of streptorubin B.
In addition, the CD spectrum of 138 was recorded (Figure 88) and is very similar
to the CD spectrum of streptorubin B (Figure 49). The large positive absorbance
at 533 nm results from the hydrochloride salt of the conjugated tripyrrole ring
system and implies that the analogue contains an ansa-bridged carbocycle with
a stereocentre. This illustrates well the sensitivity of CD spectroscopy
particularly for the identification of compounds which display large Cotton effects
like the prodiginines. It allows detection of carbocyclic prodiginines at levels well
below the detection limit of high-field NMR spectroscopy.
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CD spectrum of 138 (in MeOH c = 0.138 mM)
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Figure 88: Circular dichroism spectrum of the putative streptorubin B analogue
138
The evidence from CD spectroscopy combined with the LC-MS/MS data allows
a tentative identification of the expected oxygen-containing streptorubin B
analogue 138 as a product of the mutasynthesis experiment with
2-(3′-oxa-undecyl)pyrrole 102. However the lack of NMR data precludes the
conclusive structural assignment of this compound at the present time.
4.3.4.2 2-(6′-oxa-undecyl)pyrrole 105 
In light of the above results it was thought useful to probe whether other polar
linkages could be tolerated elsewhere within the alkyl chain of the substrates of
RedG and RedH. Therefore, a 2-undecylpyrrole analogue with an oxygen atom
directly adjacent to the site of carbocyclisation, 2-(6′-oxa-undecyl)pyrrole 105,
was fed to S. coelicolor W116 (Figure 89). LC-MS/MS analyses (Figure 90 and
Figure 91) revealed that only one compound with a m/z corresponding to the
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undecylprodiginine analogue 139 was produced. No compound with the m/z
corresponding to carbocyclic analogue 140 could be detected.
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Figure 89: Mutasynthesis of undecylprodiginine analogue 139 and the proposed
corresponding streptorubin B analogue 140.
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Figure 90: Extracted ion chromatograms at m/z = 394 (blue trace) and m/z = 396
(red trace) from LC-MS analysis of a mycelial extract of S. coelicolor W116 fed
with 2-(6′-oxa-undecyl)pyrrole 105 
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Figure 91: UV chromatogram (533 nm) from LC-MS analysis of a mycelial extract
of S. coelicolor W116 fed with 2-(6′-oxa-undecyl)pyrrole 105 
High resolution mass spectrometry was used to confirm the molecular formula of
the isolated compound 139, (Calculated for C24H33N3O2: 396.2646 [M+H]+
Found: 396.2649). In addition, the fragmentation of the compound in MS/MS
experiments was compared to the known fragmentation pattern of
undecylprodiginine (as with the other undecylprodiginine analogues observed)
and showed several common characteristic ions.
Interestingly, the UV chromatogram showed that another compound with a
retention time of approximately 5 minutes (m/z = 264) had been produced with a
λmax of 533 nm, which is very characteristic of prodiginine hydrochloride salts.
The structure of this compound has tentatively been assigned as 144 (Figure
92) in which the carbon chain from C-7′ to C-11′ has been cleaved from the 
corresponding undecylprodiginine analogue 139. Unfortunately 144 has at this
stage not been isolated from the cell culture due to the relatively small amount of
material being produced precluding the isolation of this compound within the
time-restraints at the end of this research. However, the MS/MS fragmentation
pattern of this compound does support the structural assignment as 144. It is
proposed that this cleavage occurs as a result of the action of RedG. The C-7′ 
??
139
130
radical could rebound onto the Fe(III)-OH species to generate a C-7′ hydroxyl 
group 142. The resulting hemiacetal 142 would be unstable and could
decompose to give n-pentanal and 144.
Figure 92: Proposed mechanism for the de-alkylation of undecylprodiginine
analogue 139 catalysed by RedG
4.3.4 Summary of conclusions of mutasynthesis with
2-undecylpyrrole analogues
Several analogues of streptorubin B have been isolated via the proposed
mutasynthetic approach during this research project. Generation of the
compounds has informed us about the degree of substrate tolerances displayed
by both RedH and RedG and has also given us rapid access to a variety of
analogues of streptorubin B for potential structure-activity relationship analyses.
RedH shows a quite broad substrate tolerance, catalysing the condensation of
nearly all of the 2-undecylpyrrole analogues tested with MBC to generate the
corresponding undecylprodiginine analogues. Of the analogues tested only
2-octadecylpyrrole was not accepted by RedH, suggesting that very long C-ring
alkyl chains are not tolerated, although the unknown cell membrane permeability
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properties of this compound may account for the lack of condensation by RedH.
In addition to the corresponding undecylprodiginine analogues of the
streptorubin B analogues generated (Figure 94), RedH accepted and catalysed
the condensation of 2-octylpyrrole 85 and 2-(6′-oxa-undecyl)pyrrole 105 with
MBC to give the predicted undecylprodiginine analogues 128 or 139 (Figure 93).
Figure 93: Undecylprodiginine analogues from mutasynthesis experiments with
2-undecylpyrrole analogues where no streptorubin B analogues were observed
RedG also shows a notable degree of substrate tolerance, catalysing the
carbocyclisation of a variety of structurally diverse undecylprodiginine analogues
(produced in vivo by the action of RedH) to give the predicted streptorubin B
analogues in most cases (Figure 94).
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Figure 94: Streptorubin B analogues from mutasynthesis experiments with
2-undecylpyrrole analogues
At this stage the stereochemistry of the carbocyclisation catalysed by RedG
needs further study, however, the analogues synthesised here appear to nearly
all show the same absolute stereochemistry as streptorubin B and a similar
degree of enantiomeric enrichment. The only exception is analogue 130 which
was isolated from the experiment with 2-dodecylpyrrole, in which a there
appears to be a mixture of compounds with either 10-membered (as in
streptorubin B) or 12-membered (as in streptorubin A) carbocyclic rings (in an
approximate 60:40 ratio respectively from 1H-NMR integrations) which have
opposite stereochemistry.
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5.0 Results and discussion: Stereochemical
elucidation of Streptorubin B
5.1 Introduction
As described previously, the relative stereochemistry of the major
configurational/conformational isomer of streptorubin B hydrochloride (resulting
from restricted rotation in the carbocycle) has been elucidated by NOESY
experiments.46 However, the absolute stereochemistry of streptorubin B (i.e. the
configuration of the C-7′ stereocentre was unknown at the outset of this project) 
(Figure 95).
Figure 95: Selected spectroscopic properties of streptorubin B. Red arrows
indicate key correlations observed in the NOESY spectrum of streptorubin B
hydrochloride salt (left). The signals for the diastereotopic C-4′ hydrogens are 
separated by 2.7 ppm in the 1H-NMR spectrum of streptorubin B hydrochloride
salt (right)
At the beginning of this project knowledge of the absolute stereochemistry of
chiral prodiginines was very limited. Roseophilin 8 was the only member of the
family with known absolute configuration. This was determined by
enantioselective total synthesis by Tius and co-workers. Subsequent
comparison of the CD spectra of their synthetic material with the natural product
allowed the absolute stereochemistry of roseophilin to be assigned as R, R
(Figure 96).59
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Figure 96: Enantioselective total synthesis of roseophilin reported by Tius and
co-workers.
Recently, the enantioselective total synthesis of metacycloprodigiosin
(streptorubin A) was reported (Figure 97).53
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However, the absolute stereochemistry of the natural compound was not
reported due to the lack of an authentic sample for comparison purposes. In
collaboration with the authors of this report, we have determined the absolute
stereochemistry of the major enantiomer of metacycloprodigiosin
(streptorubin A) as R by CD-spectroscopic comparisons with an authentic
standard isolated from S. longispororuber (Figure 98).
Comparison of CD spectra of synthetic (R )-metacycloprodigiosin and
metacycloprodigiosin from S. longispororuber
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Figure 98: Comparison of circular dichroism spectrum of synthetic (R)-
metacycloprodigiosin and metacycloprodigiosin from S. longispororuber
Both metacycloprodigiosin (streptorubin A) and roseophilin have the same
absolute configuration and large negative Cotton effects in their CD spectra. In
contrast, streptorubin B displays a large positive Cotton effect in its CD
spectrum. Thus, from this comparison we propose that streptorubin B is
pseudoenantiomeric to metacycloprodigiosin/roseophilin and, as a consequence
has a 4′-S configuration (Figure 99).
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Figure 99: Comparison of the absolute stereochemistries of roseophilin and
metacycloprodigiosin (streptorubin A) with the proposed absolute
stereochemistry of streptorubin B. Numbering indicates the substituent priorities
at the chiral centres for each compound.
5.2 Stereochemical elucidation of streptorubin B by
mutasynthesis with stereospecifically deuterium labelled
2-undecylpyrrole
Making use of the knowledge of the relative stereochemistry of streptorubin B
and its biosynthetic pathway, we decided to use a mutasynthetic approach to
determine the absolute stereochemistry of streptorubin B. Feeding of 2-
undecylpyrrole with a stereospecific deuterium label at C-4′ 145 to a mutant of
S. coelicolor blocked in 2-undecylpyrrole biosynthesis (e.g. W116), should result
in production of streptorubin B, labelled stereospecifically on C-4′ of the 
carbocycle (Figure 100). It is known that the signals for the two protons attached
to C-4′ of streptorubin B are well resolved in the 1H-NMR spectrum due to the
shielding influence of the pyrrole π-electrons on one of the protons (Figure 95).  
Thus it should then be straightforward to determine which of the C-4′ hydrogen 
atoms of streptorubin B has been labelled with deuterium in this experiment
using 1H and 2H-NMR spectroscopy. From these data we should then be able to
assign the absolute stereochemistry of streptorubin B.
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Figure 100: Possible stereochemical outcomes from feeding
(R)-[C-4′-D1]-2-undecylpyrrole to S. coelicolor W116. The proton/deuteron
expected to have a chemical shift of -1.54 ppm in each case is highlighted in red
(note that the absolute stereochemical descriptor for C-4′ in [C-4′-D1]-
2-undecylpyrrole and [C-4′-D1]-streptorubin B changes due to a change in the
substituent priorities).
5.3 Synthesis of (R)- and (S)-[C-4′-D1]-2-undecylpyrrole
The stereoselective syntheses of (R)- and (S)-[C-4′-D1]-2-undecylpyrrole
employed L-glutamic acid 146 as the starting material. This was converted to the
lactone 147 by diazotisation of the amino group with nitrous acid generated in
situ from sodium nitrite and hydrochloric acid (Scheme 34). Cyclisation of the
resulting diazo compound proceeds via a double inversion mechanism (due to
neighbouring group participation by the carboxylic acid alpha to the azide),
resulting in retention of stereochemistry. Subsequent chemoselective reduction
of the carboxyl group in 147 to the corresponding hydroxyl group without
reducing the lactone was effected with BH3.SMe2 to yield the desired alcohol
148. Tosylation of 148 afforded 149 in excellent yield.95 This intermediate was
reacted with sodium methoxide, generated in situ by the addition of one
equivalent of sodium metal to dry methanol, to open the lactone. The resulting
alkoxide displaced the tosylate to give the epoxide 150. Opening of the epoxide
150 at the least-hindered carbon with the cuprate derived from n-hexyl lithium
and copper cyanide yielded lactone (R)-151.96 This lactone is a known natural
product, which has been identified as a flavour compound from fruits and as a
sex pheromone in insects, and consequently has a known optical rotation.97, 98
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Comparison of the optical rotation of the synthetic lactone with literature values
for the natural product confirmed the absolute configuration of this compound.
Scheme 34: Synthesis of (R)-4-heptylbutyrolactone 151
With gram quantities of (R)-151 in hand, the opening of the lactone to give either
the desired deuterated acid (S)-152 or a precursor of this acid was explored. As
expected, no displacement of the carboxylate was observed when the lactone
was reacted with lithium aluminium deuteride. Only the doubly-deuterated diol
153 was recovered from this reaction (Scheme 35).
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Scheme 35: Attempted direct ring opening of lactone (R)-151
A step-wise route to deuterated acid 152 via the reduction of lactone (R)-151
with lithium aluminium hydride to the diol 154, followed by selective protection of
the primary alcohol, tosylation of the secondary alcohol, displacement of the
tosylate with LiAlD4, deprotection and oxidation of the primary alcohol to the
carboxylic acid (Scheme 36) was also considered as an alternative to the route
outlined in Scheme 35. Initial reduction of (R)-151 to the desired diol 155 was
successful. However this route was not pursued further because a more concise
route was devised.
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Scheme 36: Synthesis of the desired deuterated acid 152 via reduction of lactone
(R)-151 to the corresponding diol.
During the course of exploratory chemistry aimed at the synthesis of (S)-152
from (R)-151, the lactone was opened with trimethyl aluminium and dimethyl
amine to give the corresponding hydroxy amide 159 (Scheme 37).99 However,
the tosylation of the hydroxyl group (required for subsequent deuteride
displacement) did not give the expected tosyl amide 160. Instead this tosylation
reaction resulted in reformation of the lactone, presumably via the imine 161
formed by intramolecular displacement of tosylate by the oxygen of the amido
group. This sequence of reactions occurs with inversion and was subsequently
applied to the synthesis of (S)-151 (the enantiomer of the initial lactone).
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Scheme 37: Unanticipated conversion of (R)-151 to (S)-151 via tosyl amide 160
The lactone could also be opened by reaction of (R)-151 with excess
iodotrimethylsilane, a reagent known to convert esters to the corresponding
acids.100, 101 Seemingly, initial silylation of the oxygen atom of the carbonyl group
activates the lactone towards subsequent SN2 ring-opening by iodide (Scheme
38).102 The resulting iodo silyl ester 162 can be hydrolysed to the corresponding
iodo acid 163. However, this compound proved to be somewhat unstable due to
the propensity for recyclisation to the lactone via intramolecular displacement of
the iodide by the carbonyl group (Scheme 38).
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Scheme 38: Synthesis of iodo acid 163 via iodo trimethylsilyl ester 162 by the
reaction of lactone (R)-151 with iodotrimethylsilane. The iodo acid was prone to
recyclisation to the lactone via elimination of HI.
To overcome the problem of the instability of 163, silyl ester 162 was converted
to the methyl ester 164 by the addition of excess methanol to the reaction
mixture after complete ring-opening had occurred (Scheme 39). When using
exactly one equivalent of iodotrimethylsilane to open the lactone, subsequent
ester formation with methanol does not occur, instead an excess of
iodotrimethylsilane is required to effect ester formation. Therefore, it seems that
the formation of catalytic hydriodic acid, as a result of the reaction between the
remaining iodotrimethylsilane and the added methanol catalyses the formation
of the methyl ester. The iodo methyl ester (S)-164 is stable to column
chromatography on silica gel and shows no propensity towards instability.
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Scheme 39: Formation of iodo methyl ester (S)-164 from intermediate iodo silyl
ester (S)-162 resulting from iodotrimethylsilane mediated cleavage of lactone (R)-
151.
Chemoselective displacement of iodide in (S)-164, without reduction of the
ester, was achieved with sodium borodeuteride in dimethyl sulphoxide (this polar
aprotic solvent is known to dramatically increase the rate of SN2
displacements)103, 104 affording the deuterated ester (R)-165. Base-mediated
ester hydrolysis was followed by conversion of the resulting acid (R)-152 to the
desired labelled 2-undecylpyrrole (R)-145 (Scheme 40), by the route described
previously for synthesis of 2-undecylpyrrole from pyrrole and undecanoic acid.
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Scheme 40: Synthesis of (R)-[C-4′-D1]-2-undecylpyrrole (R)-145 from lactone (R)-
151
Conversion of (S)-151, obtained from (R)-151 via the inversion procedure
described above (Scheme 37), to (S)-[C-4′-D1]-2-undecylpyrrole (S)-145 was
accomplished via the route used to convert (R)-151 to (R)-145 (Scheme 41).
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5.4 Feeding of stereoselectively labelled 2-
undecylpyrroles to S. coelicolor W116
Both enantiomers of labelled 2-undecylpyrrole 145 were fed separately to the
S. coelicolor W116 mutant, which is unable to biosynthesise 2-undecylpyrrole.
Analysis of the labelled streptorubin B purified from these experiments gave
somewhat unexpected results. Although LC-MS analyses indicated that C-4′ 
singly labelled streptorubin B was produced in both experiments, a signal at
-1.54 ppm was observed in the 1H-NMR spectrum of both labelled compounds
(Figure 101 and Figure 102). The multiplicity of this signal was the same in both
cases, but markedly different to that observed for unlabelled streptorubin B.
However, the integral value for this signal was very different for the two
compounds.
Figure 101: Comparison of 1H-NMR spectra of labelled streptorubin B isolated
from S. coelicolor W116 fed with (R)-[C-4′-D1]-2-undecylpyrrole (bottom trace) and
streptorubin B isolated from S. coelicolor M511 (top trace)
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Figure 102: Comparison of 1H-NMR spectra of labelled streptorubin B isolated
from S. coelicolor W116 fed with (S)-[C-4′-D1]-2-undecylpyrrole (bottom trace) and
streptorubin B isolated from S. coelicolor M511 (top trace)
Feeding of (R)-[C-4′-D1]-2-undecylpyrrole (R)-145 resulted in streptorubin B with
an integral value of 0.7 for the signal at -1.54 ppm relative to a value of ~1 for
each of the pyrrole protons (Figure 101). In contrast, feeding of
(S)-[C-4′-D1]-2-undecylpyrrole (S)-145 yielded labelled streptorubin B in which
the signal at -1.54 ppm had an integral value of approximately 0.3 relative to a
value of ~1 for each of the pyrrole protons (Figure 102).
2H-NMR spectra of each labelled form of streptorubin B were recorded to
confirm that a mixture of streptorubin B diastereomers was produced in both
experiments. These experiment showed two peaks for each compound, one at
1.16 and one at -1.54 ppm (Figure 103 and Figure 104), confirming that a
mixture of diastereomers results from both experiments (Figure 105).
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Figure 103: 2H-NMR spectrum of labelled streptorubin B isolated from
S. coelicolor fed with (R)-[C-4′-D1]-2-undecylpyrrole
Figure 104: 2H-NMR spectrum of labelled streptorubin B isolated from
S. coelicolor fed with (S)-[C-4′-D1]-2-undecylpyrrole
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Figure 105: Apparent percentage of streptorubin B diastereomers resulting from
feeding of (R)-[C-4′-D1]-2-undecylpyrrole to S. coelicolor W116 (note that
assignment of absolute stereochemistry of alkyl chain C4 reverses due to a
change in the substituent priorities after cyclisation).
5.5 Investigation of why streptorubin B diastereoisomers
are produced and absolute stereochemical assignment of
streptorubin B
The above results indicated that either (a) the RedG-catalysed carbocyclisation
was not enantiospecific, but only enantioselective, giving a 70:30 ratio of
enantiomers, or (b) partial epimerisation of the labelled 2-undecylpyrroles had
occurred during the final steps of the synthesis.
To establish the enantiopurity of streptorubin B, a sample isolated from S.
coelicolor was analysed by HPLC on a homochiral stationary phase. The free
150
base of streptorubin B was analysed on a ChiralPak IA column (Chiral
Technologies Europe). Diethylamine (0.1 %) was added to the mobile phase of
hexane/isopropanol to ensure formation of the free base. Recently, the
synthesis of racemic streptorubin B has been completed by Thomson and co-
workers by an analogous route to that previously described for their total
synthesis of metacycloprodigiosin (streptorubin A).54, 53 Racemic streptorubin B
was also analysed under the same conditions.
A major species, eluting at 9 minutes (peak A) was observed in the
chromatogram of natural streptorubin B isolated from S. coelicolor; together with
two minor species, eluting at 12 minutes (peak B), and 40 minutes (peak C)
respectively (Figure 106b). The areas under the peaks corresponding to the
minor species were both ~5 % of the area under the peak for the major species.
Comparison of the chromatograms for natural (enantioenriched) and synthetic
(racemic) streptorubin B identified peaks A and C as the streptorubin B
enantiomers (Figure 106a and Figure 106b). However, the identity of the
species corresponding to peak B was unclear. It was thought that perhaps it
may correspond to a minor diastereomer.
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Strep B (plusminus)_11_01_249.d: UV Chromatogram, 470 nm
Strep B natural_12_01_250.d: UV Chromatogram, 470 nm
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Figure 106: UV chromatograms from HPLC analyses on a homochiral stationary
phase monitoring absorbance at 470 nm (λmax of prodiginine free base) of (a)
racemic synthetic streptorubin B and (b) streptorubin B isolated from S.
coelicolor.
To test this hypothesis, peak A was collected and left to stand for seven days at
room temperature. Reanalysis of the sample after this time showed that ~ 3 % of
peak A had been converted to peak B (Figure 107), this reequilibration of peak
A seems to confirm the hypothesis that peak B corresponds to a minor
diastereomer of the major enantiomer of streptorubin B. It therefore appears that
dia-streptorubin B resulting from the slow rotation of the carbocyclic ring across
the plane of the tri-pyrrole ring system of streptorubin B occurs as a minor
component of the natural product. The rate of the equilibration to a ~ 5 % portion
of dia-streptorubin B appears to be quite slow (as illustrated by the reanalysis of
freshly isolated peak A Figure 107b). The ratio of dia-streptorubin B to
streptorubin B presumably is governed by the influence of a favourable steric
interaction observed in dia-streptorubin that is not seen in streptorubin B
between the butyl side chain and the proton attached to C-1′′ (Figure 108). The 
identity of the species corresponding to the peak with retention time of 10
minutes in analyses of racemic streptorubin B (Figure 106a) is yet to be
(a)
(b) A
(streptorubin B)
B
(dia-streptorubin B)
C
(ent-streptorubin B)
152
confirmed, due to time constraints at the end of this research. However, it is
possible that this may prove to be ent-dia-streptorubin B or perhaps simply a
small impurity from the synthetic preparation of racemic streptorubin B by
Thomson and co-workers.
Strep B natural_12_01_250.d: UV Chromatogram, 470 nm
Strep B peak 1 fresh_21_01_262.d: UV Chromatogram, 470 nm
Strep B peak 1 (after 1 w eek)_12_01_276.d: UV Chromatogram, 470 nm
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Figure 107: UV chromatograms from HPLC analyses on a homochiral stationary
phase monitoring absorbance at 470 nm (λmax of prodiginine free base) of (a)
streptorubin B isolated from S. coelicolor (b) reanalysis of freshly isolated
streptorubin B peak A (c) reanalysis of streptorubin B peak A after seven days at
room temperature
(a)
(b)
(c)
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Figure 108: Structures of different isomeric forms of streptorubin B
Figure 109: 3D-model of streptorubin B (left) and dia-streptorubin B (right),
showing the different steric constraints of each.
The related carbocyclic prodiginine metacycloprodigiosin (streptorubin A) was
also investigated using the same chiral HPLC method. We have shown that
metacycloprodigiosin (streptorubin A) and streptorubin B are inseparable by
HPLC on a conventional reverse phase column. Therefore it can be reasoned
that any differences in the retention times of metacycloprodigiosin (streptorubin
A) and streptorubin B on a homochiral HPLC column are due to absolute
stereochemical differences, rather than structural differences. In addition, both
enantiomers of metacycloprodigiosin (streptorubin A) have been recently
synthesised by Thomson and co-workers via a previously described route.53
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Samples of both enantiomers of metacycloprodigiosin (streptorubin A) provided
by Thomson and co-workers were analysed independently.
Analysis of synthetic (9′-R)-metacycloprodigiosin (streptorubin A) showed a
major species with a retention time of 19 minutes (peak E) and a minor species
with a retention time of 9 minutes (peak D). The area under the minor peak was
~ 5 % of that under the major peak (Figure 110c). In contrast, analysis of
(9′-S)-metacycloprodigiosin afforded a major species with a retention time of 9
minutes and a minor species with a retention time of 19 minutes (Figure 110b).
Analysis of (±)-metacycloprodigiosin gave two species in a 1:1 ratio with
retention times of 9 and 19 minutes (Figure 110a). Comparison of these
chromatograms with chromatogram of natural metacycloprodigiosin isolated
from S. longispororuber showed that the major enantiomer of the natural product
has the 9′-R-configuration (Figure 110d), as we had previously deduced from
CD spectroscopic analyses. The presence of the opposite enantiomer in the
samples of synthetic 9′-S- and 9′-R-metacycloprodigiosin indicates that the
syntheses are only highly enantioselective rather than enantiospecific.
Interestingly, the natural metacycloprodigiosin appears to consist of a mixture of
both 9′ configurations in an approximate ratio of 85:15, indicating that the 
configuration previously identified by CD spectroscopic analyses corresponds
only to the major enantiomer present in the natural product.
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Strep A (plusminus)_13_01_242.d: UV Chromatogram, 470 nm
Strep A (S)_15_01_243.d: UV Chromatogram, 470 nm
Strep A natural (R)_14_01_241.d: UV Chromatogram, 470 nm
streptorubin A fresh_13_01_287.d: UV Chromatogram, 470 nm
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Figure 110: UV chromatograms from HPLC analyses on a homochiral stationary
phase monitoring absorbance at 470 nm (λmax of prodiginine free base) of (a)
racemic synthetic metacycloprodgiodin (b) synthetic (S)-metacycloprodigiosin
(c) synthetic (R)-metacycloprodigiosin (d) natural metacycloprodigiosin isolated
from S. longispororuber
Finally, the samples of deuterium-labelled streptorubin B from the feeding
experiments with (S)-[C-4′-D1]-2-undecylpyrrole and
(R)-[C-4′-D1]-2-undecylpyrrole were analysed using the homochiral HPLC
method previously described, to rule out differences in the ratio of the
enantiomers and diastereomers resulting from the presence of the label. Both
analyses gave results comparable with the results for natural streptorubin B
isolated from S. coelicolor, with a major peak at 9 minutes, and minor peaks 12
and 34 minutes (Figure 111).
D (ent-streptorubin A)
(a)
(b)
(c)
(d) E (Streptorubin A)
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streptorubin B_11_01_281.d: UV Chromatogram, 470 nm
B42 D labelled_14_01_290.d: UV Chromatogram, 470 nm
B42 D labelled_14_01_290.d: UV Chromatogram, 470 nm
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Figure 111: UV chromatograms from HPLC analyses on a homochiral stationary
phase monitoring absorbance at 470 nm (λmax of prodiginine free base) of (a)
natural streptorubin B isolated from S. coelicolor (b) deuterium labelled
streptorubin B isolated from feeding experiments with
(S)-[C-4′-D1]-2-undecylpyrrole (c) deuterium labelled streptorubin B isolated from
feeding experiments with (R)-[C-4′-D1]-2-undecylpyrrole
The above results indicate that a ~90:10 ratio of labelled products would be
expected from the mutasynthesis experiments with stereospecifically deuterium
labelled 2-undecylpyrrole. Thus, the 70:30 mixture observed in the
mutasynthesis experiments must result from partial epimerisation during the
synthesis. Chiral HPLC analyses of key intermediates in the synthesis of the
deuterium-labelled 2-undecylpyrroles 145 should allow the source of this
racemisation to be discovered. Thus, analysis of the lactones (S)- and (R)-151,
the iodo esters (S)- and (R)-164 and/or the deuterated acids (S)- and (R)-145
(Figure 112) should pin down in which step the epimerisation is occurring. The
(b)
(a)
(c)
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deuterated acids, as suspected, proved inseparable by chiral HPLC using a
variety of eluents. The iodo esters also proved inseparable using the chiral
HPLC system.
Figure 112: Key intermediates in synthetic pathway to labelled 2-undecylpyrrole
However, indirect analysis of the stereochemical purity of the iodo esters (S)-
and (R)-164 was possible by exposing them to aqueous sodium hydroxide,
which resulted in ester hydrolysis and iodide displacement by the resulting
carboxylate, thus reforming the lactones (R)- and (S)-151 respectively (Scheme
42).
Scheme 42: Base mediated reformation of lactone (R)-151 from iodo ester (S)-164
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The reformed lactones (R)- and (S)-151 were isolated in good yield from these
reactions. When a 1:1 mixture of the (R)- and (S)- lactones was analysed by
HPLC on a homochiral stationary phase, good separation of the enantiomers
was observed (Figure 113b). Independent analyses of the lactones derived from
the cyclisation of (S)- and (R)-164 showed each to be enantiomerically pure
(Figure 113a and Figure 113c). Further support for this conclusion came from
optical rotation measurements of each recyclised lactone, which were identical
to the optical rotations measured for the original lactones from which the iodo
esters (S)- and (R)-164 were derived.
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Figure 113: UV chromatogram from HPLC analyses on a homochiral stationary
phase monitoring absorbance at 225 nm for (a) (R)-151 (b) (±)-151 (c) (S)-151
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The above results indicate that partial epimerisation is occurring during the
reaction of the iodo esters 164 with sodium borodeuteride. We assumed that this
reaction would occur with clean inversion by a SN2 mechanism. However, on
close inspection of the literature there is some evidence that iodide
displacement with sodium borohydride does not proceed with inversion, but
instead can result in racemisation.105 It is important to note that in those studies
the substrates were all tertiary alkyl iodides, which are likely to substitute via SN1
mechanisms. The conversion of (R)- and (S)-164 to (S)- and (R)-165,
respectively does not result in complete racemisation, but in an 80:20 mixture of
enantiomers. The most likely explanation is that the reaction proceeds via a
combination of SN1 (40 %) and SN2 (60 %) mechanisms.
An alternative explanation is that intramolecular displacement of iodide by the
lone pair of the methyl ester, followed by attack of deuteride on the resulting
methylated lactone (which would result in overall double inversion of the
stereocentre) competes with the predicted SN2 mechanism (Scheme 43 and
Scheme 44). Equally, this double inversion pathway can be thought of as the
same as a SN1 mechanism, except that co-ordination of the oxygen lone pair is
shielding one face of the cation, thus resulting in overall retention of
stereochemistry (Scheme 45).
Scheme 43: Anticipated iodide displacement mechanism
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Scheme 44: Possible competing mechanism resulting in partial racemisation via
methylated lactone
Scheme 45: Alternative competing mechanism resulting in partial racemisation via
shielding of one face of intermediate cation
Another possibility is that the small amount of iodide generated initially in the
reaction causes rapid racemisation of the remaining alkyl iodide by displacement
of iodide with iodide, prior to displacement by deuteride. If this is the case then
the iodide displacement with deuteride may proceed exclusively via a SN2
process but the alkyl iodide would only remain enantiopure until the
concentration of iodide in the reaction mixture was low.
If any of the proposed double displacement processes predominate over the
SN2 process, (R)-165 would be the major product from (R)-164. However, if the
SN2 mechanism is predominant then (S)-165 would be the major product from
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(R)-164. This uncertainty regarding the absolute configuration of the major
enantiomer in samples of 164, makes it impossible to assign the absolute
stereochemistry of streptorubin B based solely on the results of the
mutasynthesis experiments with [C-4′-D1]-2-undecylpyrrole.
Based on all the above analyses, including the comparison of CD spectra of
carbocycle prodiginines, we tentatively conclude that the formation of compound
145 proceeds ~60 % via the SN2 pathway and ~40 % via the SN1 pathway to
give the desired deuterium labelled intermediates in ~60 % ee, which are
incorporated into streptorubin B, ent-streptorubin B and dia-streptorubin B as
shown in Figure 114. Thus, allowing the tentative assignment (based on this
conclusion) of the absolute configuration of streptorubin B as 4′-S.
Figure 114: Tentative stereochemical assignment of streptorubin B from
mutasynthesis experiments as illustrated with (R)-[C-4′-D1]-2-undecylpyrrole (note
that assignment of absolute stereochemistry of alkyl chain C4 reverses due to a
change in the substituent priorities after cyclisation).
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6.0 Conclusions and perspectives
6.1 Mutasynthesis of streptorubin B analogues – probing
substrate tolerances of RedH and RedG
A proof-of-principle of the mutasynthetic approach for production of streptorubin
B analogues has been achieved. The experiments carried out during the course
of this research have probed the substrate specificity of the enzymes required
for the condensation and subsequent carbocyclisation of the late stage
intermediates 2-undecylpyrrole and MBC. They have also revealed varying
degrees of substrate tolerance of RedH and RedG.
RedH appears to show relatively relaxed substrate specificity. Analogues of
undecylprodiginine in which either the A-ring or the C-ring alkyl chain have been
altered can be produced. Although the condensation of MBC analogues with
2-undecylpyrrole does occur such analogues appear to be poorly tolerated by
RedH and the levels of undecylprodiginine analogues produced are vastly
reduced compared to the levels of undecylprodiginine produced by feeding
MBC. In contrast, RedH appears not to discriminate against 2-undecylpyrrole
alkyl chain analogues. Even quite dramatic reductions in length and changes in
structure such as the inclusion of heteroatoms, increases in steric bulk and units
of unsaturation are tolerated. It seems only quite extreme alterations to
2-undecylpyrrole are not tolerated by RedH. However, due to the in vivo nature
of the mutasynthesis experiments, the question of whether it is enzyme
substrate tolerance or cell membrane permeability that determines whether
these compounds are incorporated arises.
The substrate tolerance of RedG appears somewhat more limited. It seems that
an N-H group is required on the undecylprodiginine A-ring for RedG to catalyse
carbocyclisation (as illustrated by the feeding of MBC analogues), perhaps
because this indicates a crucial hydrogen bond between substrate and enzyme.
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However, RedG has been demonstrated to carbocyclise a variety of analogues
with alterations in the C-ring alkyl chain. A selection of potentially limiting factors
including the steric size, alkyl chain hydrophobicity and introduction of
π-electrons have been probed. 
6.2 Mutasynthesis of streptorubin B analogues – access
to new compounds versus total synthesis
Synthetic access to streptorubin B has proved challenging, particularly in an
enantioselective fashion. Therefore, the total synthesis of a large array of
streptorubin B analogues for the development of a structural-activity relationship
for potential therapeutic applications is a daunting prospect.
However, the work carried out during this investigation has shown the potential
of a mutasynthetic strategy for providing rapid access to a large number of
streptorubin B analogues. A variety of different functionalities have been
incorporated into analogues by this approach and these should influence the
interactions of the characteristic 10-membered carbocycle of streptorubin B with
molecular targets. It could therefore prove interesting to investigate the effect of
these structural changes on the biological properties of the compounds.
The synthetic routes to both 2-undecylpyrrole and MBC that have been
developed should be applicable to the production of a multitude of further
analogues in addition to those that have already been synthesised. The
optimisation of culture conditions and purification techniques throughout this
work led to the rapid production of several streptorubin B analogues in milligram
quantities towards the end of the investigation. Therefore, with both synthetic
methodologies and culture and purification conditions established, a new
method of routine production of streptorubin B analogues can be envisaged by:
(1) synthesis of new MBC and 2-undecylpyrrole analogues using the simple
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chemistry developed; and (2) subsequent feeding of the MBC/2-undecylpyrrole
analogues to appropriate S. coelicolor mutants, followed by isolation of
streptorubin B analogues using established protocols. This methodology should
allow access to streptorubin B analogues at a rate comparable to the most
efficient total synthesis routes.
6.3 In vitro application of RedH and RedG
Future overproduction of soluble and active RedH and RedG proteins may
provide a useful method for accessing further analogues of streptorubin B via
chemoenzymatic synthesis. The mutasynthetic approach established has been
necessitated by the lack of availability of functional recombinant RedH and
RedG. The large size of RedH has hindered its overproduction in soluble form,
whereas RedG, like many other Rieske non-heme iron-dependent oxygenases
has proved to be unstable under standard aerobic protein purification conditions.
The vast majority of the protein after purification has lost the iron-sulphur cluster,
which is required for activity, and any attempts to reconstitute this cluster have
thus far proved unsuccessful.
An in vitro chemoenzymatic synthesis strategy for the production of streptorubin
B analogues can be envisaged to be advantageous in several ways. Currently
all probing of substrate specificity of RedH and RedG is hampered by the
requirement for the compounds used to permeate the membranes of S.
coelicolor cells. This problem would be negated by an in vitro approach and
negative results could be taken as true reflections of enzyme specificity. The
poor turnover of undecylprodiginine to streptorubin B when fed to S. coelicolor
mutants (presumably because its hydrophobic nature causes it to become
embedded in the cell membrane) has also presented an obstacle to efficiently
probing the substrate specificity of RedG. This has necessitated feeding of MBC
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and 2-undecylpyrrole analogues rather than undecylprodiginine analogues. Thus
the preferences of RedH can not be deconvoluted from those of RedG. In
addition an in vitro approach could be used to optimise the production of
carbocyclised streptorubin B derivatives either by increasing the ratio of RedG to
RedH, or by recycling isolated undecylprodiginine analogues by re-exposure to
RedG. Alternatively, an in vitro approach should allow streptorubin B analogues
to be produced directly by synthesising and feeding undecylprodiginine
analogues. It is known that the synthesis of undecylprodiginine (or an analogue)
is feasible by an acid-mediated condensation of 2-undecylpyrrole (or an
analogue) and MBC (or an analogue), and similar condensations have been
carried out successfully during this research.
6.4 Probing the mechanism of carbocyclisation by RedG
This thesis has shown that RedG can be applied to generate analogues of
streptorubin B by mutasynthesis. However, the mechanism of the remarkable
carbocyclisation catalysed by RedG is unknown. The carbocyclisation is
proposed to proceed via formation of an alkyl radical at C-7′ before either: (1) 
subsequent hydroxylation via radical rebound followed by nucleophilic
displacement of the resulting hydroxyl group by C-4 of the pyrrole C-ring; or (2)
by attack of the C-7′ radical on C-4 of the pyrrole C-ring followed by abstraction 
of a second pyrrole-derived hydrogen radical.
Mechanistic studies targeting radical intermediates often employ mechanistic
probes, typically using substrates that when the radical is formed, suffer a
characteristic skeletal rearrangement. In many cases radical intermediates
undergo further reaction very rapidly and the probe used is therefore required to
undergo a very fast rearrangement in order to trap the radical. In this case the
involvement of an alkyl radical intermediate at C-7′ could be probed by 
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synthesising a 2-undecylpyrrole analogue with a cyclopropane appended to C5′-
C6′ or C8′-C9′ via a Simmons-Smith type cyclopropanation of an unsaturated 
2-undecylpyrrole intermediate.106, 107 Analyses of the mycelial extract of a S.
coelicolor mutant deficient in 2-undecylpyrrole production (e.g. W116) fed with
cyclopropanated 2-undecylpyrrole analogues, would reveal whether a skeletal
rearrangement consistent with a radical intermediate has occurred (Figure 115).
Figure 115: Mechanism of the proposed skeletal rearrangement of
cyclopropanated undecylprodiginine analogue
6.5 Further experiments to confirm the absolute
stereochemistry of streptorubin B
The investigation of the absolute stereochemistry of streptorubin B was
hampered by partial epimerisation during the displacement of iodide with sodium
borodeuteride in the preparation of 2-undecylpyrrole stereospecifically labelled
at C-4′. This unfortunately gave an unclear result in the mutasynthesis 
experiment and allowed only a tentative assignment of the absolute
stereochemistry of streptorubin B to be proposed. An alternative synthesis of
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labelled 2-undecylpyrrole should allow definitive determination of the absolute
stereochemistry. The synthetic route that was considered, but not pursued in
favour of a more concise route, should prove successful. Complete reduction of
the key lactone intermediate (R)-151 (used in the original synthesis) to the diol
followed by selective protection of the primary hydroxyl group, and activation of
the remaining hydroxyl group by tosylation, should allow SN2 displacement of
the tosylate with deuteride to be carried out without any competing SN1
displacement. Specifically, this revised route should favour the suppression of
any epimerisation because (1) tosylate is a poorer leaving group and a poorer
nucleophile than iodide (pKa ArSO3H = -6.4, pKa HI = - 10); (2) LiAlD4 is a more
reactive nucleophile than NaBD4.
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Scheme 46: Proposed alternative synthetic route to labelled 2-undecylpyrrole
avoiding partial epimerisation due to competing SN1 mechanism in displacement
of a leaving group with deuteride.
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7.0 Experimental Section
7.1 General Experimental
Dry toluene, dichloromethane, methanol and acetonitrile were produced by
distillation from calcium hydride under argon, and stored over 4 Å molecular
sieves. THF was dried in a still over potassium for 3 days before use. Dry
triethylamine, diisopropylamine and 2,2,6,6-tetramethylpiperidine were obtained
by distillation from sodium hydroxide pellets under argon and stored over
sodium hydroxide pellets. All other reagents and solvents were used as
supplied. Petroleum ether refers to the fraction of light petroleum boiling
between 40 °C and 60 °C. Solvents were evaporated using a Buchi Rotavapor
R-200 equipped with a Buchi Vacuubrand pump.
Flash column chromatography was conducted on Fluka Silica Gel (40-63 μm, 60 
Å), or Basic aluminum oxide (activated basic Brockman 1 standard grade 150
mesh). TLC was performed on aluminium backed plates pre-coated with Merck
silica gel 60 F254, visualised by UV radiation. Phosphomolybdic acid, potassium
permanganate, bromocresol green and vanillin were also used for visualisation
of TLC plates.
IR spectra were recorded using a Perkin-Elmer Avatar 320 Fourier
Transformation spectrometer. Only selected absorptions are reported, in units of
wavenumbers (νmax/cm-1).
Melting points were recorded on a Stuart Scientific SMP10 instrument.
1H-NMR spectra were recorded at 300, 400 or 700 MHz using Bruker DPX300,
DPX400 or AV700 spectrometers respectively. Chemical shifts (δH) are quoted
in ppm with reference to the residual solvent peak. The data in parentheses
follow the order (i) multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; m,
multiplet, (ii) number of equivalent protons, (iii) coupling constant (J): in Hz to the
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nearest 0.5 Hz, (iv) assignment. COSY was used in selected cases to aid
assignment.
13C-NMR spectra were recorded on Bruker DPX300, DPX400 and AV700
spectrometers at 75, 100 or 175 MHz. HMBC and HMQC spectra were recorded
to aid assignments. Chemical shifts (δC) are quoted in ppm with reference to the
residual solvent peak. The assignment is given in parentheses.
2H-NMR spectra were recorded on Bruker AV500 and AV700 spectrometers at
76.7 MHz or 107.45 MHz.
CD spectra were recorded on a Jasco J-815 CD spectrometer.
CHN analysis was performed by Warwick Analytical Services using an Exeter
Analytical CE 440.
Low resolution ESI mass spectra were recorded using a Bruker Esquire 2000
spectrometer. High resolution mass spectra were recorded on a Bruker
microTOF spectrometer equipped with an ESI source.
LC-MS was carried out on an Agilent 1100 HPLC instrument with the outflow
connected via a splitter (10% to mass spectrometer, 90% to waste) to a Bruker
Daltonics esquire HCT plus mass spectrometer equipped with an ESI source.
Semi-preparative HPLC was carried out on an Agilent 1200 instrument.
HPLC analyses on a homochiral stationary phase were carried out on an Agilent
1100 instrument.
Optical rotation were recorded on an Optical Activity Ltd. AA-1000, using a cell
of pathlength 10 cm, according to the equation [α]D
25 = (100 α)/lc. Where l = path 
length and c = concentration in g/100 ml.
S. coelicolor strains W33, W38, W39 and W116 were all created and provided
by Anna Stanley from work during her PhD research at the University of
Warwick.
S. coelicolor strain W116 was created and provided by Paulina Sydor from work
during her PhD research at the University of Warwick.
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(5-Bromo-3-methoxy-pyrrol-2-ylidenemethyl)-diethyl-amine 5275
N
OMe
NBr 1
2 3
4
5
6
8
7
9
10
To a mixture of diethylformamide (1.50 ml, 13.25 mmol, 3.0 equiv) and
chloroform (5 ml) at 0 °C a solution of phosphorus oxybromide (3.17 ml, 11.06
mmol, 2.5 equiv) in chloroform (15 ml) was added dropwise under argon and the
resulting yellowish suspension was stirred at 0 °C for 30 min under argon.
A solution of 4-methoxy-3-pyrrolin-2-one (0.50 g, 4.42 mmol, 1.0 equiv) was
added dropwise to the previous solution at 0 °C. The resulting mixture was
warmed to room temperature then heated to 65 °C for 5 hours.
After pouring the mixture onto ice, the aqueous layer was adjusted to
pH 7-8 with NaOH (aq., 2 N). Ethyl acetate (20 ml) was added and the mixture
was filtered over Celite to remove phosphorus salts. The aqueous layer was
separated and extracted with ethyl acetate (2 x 20 ml). The combined organic
layers were washed with brine (2 x 20 ml), dried over magnesium sulphate and
evaporated in vacuo to obtain a brown oil. The compound was purified though a
pad of silica using 20% ethyl acetate/hexane as eluent, to leave a yellow oil,
which solidified on standing.
Yield: 0.9564 g (83 %)
1H-NMR (CDCl3, 400MHz) δ: 1.22 (t, 3H, 7.1 Hz, H-7 or H-9), 1.23 (t, 3H, 7.1, H-
7 or H-9), 3.30 (q, 2H, 7.1, H-6 or H-8), 3.67 (s, 3H, H-10), 4.05 (q, 2H, 7.1, H-6
or H-8), 5.52 (s, 1H, H-2), 6.91 (s, 1H, H-5).
13C-NMR (CDCl3, 100MHz) δ: 12.55 (C7 or C9), 14.82 (C7 or C9), 44.55 (C6 or 
C8), 51.18 (C6 or C8), 58.01 (C10), 96.39 (C2), 120.77 (C1), 133.53 (C4),
138.67 (C5), 165.34 (C3).
IR (νmax/cm-1): 2973, 2936, 1629, 1516
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m.p.: 38-39°C
HRMS: m/z calculated for C10H15Br79N2O: 259.0446 [M+H]+. Found: 259.0448
4-Methoxy-1H,1′H-[2,2′]bipyrrolyl-5-carbaldehyde 973
H
N
H
N
O
H
OMe
1
2
3
4
5
6
78
9
10
Pd(OAc)2 (0.30 mmol, 0.1 equiv) and triphenylphosphine (1.35 mmol, 0.45
equiv) were added to toluene (1 ml) under argon. The resulting bright yellow
solution was stirred for 30 min at 70 °C. A degassed solution of (5-Bromo-3-
methoxy-pyrrol-2-ylidenemethyl)-diethyl-amine (3.00 mmol, 1.0 equiv) and
N-BOC-pyrrole boronic acid (3.30 mmol, 1.1 equiv) in 10 % water/dioxane (15
ml) was added to the suspension of Pd(PPh3)4. Sodium carbonate (9.00 mmol,
3.0 equiv) was added and the mixture was stirred for 3.5 hrs at 100 °C. The
solution was treated with sodium methoxide (3.00 mmol, 1.0 equiv) and stirred
for 15 min at 100 °C, then treated again with sodium methoxide (3.00 mmol, 1.0
equiv) and stirred for 10 min more at 100 °C.
The mixture was poured onto water (50 ml) and the pH was lowered to pH 7 with
HCl (aq., 2 N) and stirred for 15 min. The brown precipitate was recovered by
filtration over a fritted disc funnel and washed with water (2 x 15 ml), and
acetone (2 x 10 ml) to leave a yellow solid.
0.433 g (75 %)
1H-NMR (DMSO-d6, 400MHz) δ: 3.82 (s, 3H, H-10), 6.11 (d, 1H, 4.4Hz, H-7), 
6.26 (s, 1H, H-4), 6.76 (d, 1H, 4.4 Hz, H-9), 6.90 (t, 1H, 4.4Hz, H-8), 9.32 (s, 1H,
H-1), 11.21 (br s, 1H, N-H), 11.41 (br s, 1H, N-H)
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13C-NMR (DMSO-d6, 175MHz) δ: 57.70 (C-10), 90.82 (C-4), 108.26 (C-9), 
109.24 (C-7), 117.87 (C-2), 120.64 (C-8), 123.66 (C-6), 133.63 (C-5), 159.05 (C-
3), 171.54 (C-1).
IR (νmax/cm-1): 3243, 3188, 3038, 2950, 2840, 1593, 1544
m.p.: 284 °C [lit. 275 °C]73
HRMS: m/z calculated for C10H10N2O2: 191.0821 [M+H]+. Found: 191.0824
5-(1H-Indol-2-yl)-3-methoxy-1H-pyrrole-2-carbaldehyde 6377
H
N
H
N
O
H
OMe
1
2
3
4
56
789
10
11
12
13
14
Pd(OAc)2 (0.30 mmol, 0.1 equiv) and triphenylphosphine (1.35 mmol, 0.45
equiv) were added to toluene (1 ml) under argon. The resulting bright yellow
solution was stirred for 30 min at 70 °C. A degassed solution of (5-Bromo-3-
methoxy-pyrrol-2-ylidenemethyl)-diethyl-amine (3.00 mmol, 1.0 equiv) and
N-BOC-indole boronic acid (3.30 mmol, 1.1 equiv) in 10 % water/dioxane (15 ml)
was added to the suspension of Pd(PPh3)4. Sodium carbonate (9.00 mmol, 3.0
equiv) was added and the mixture was stirred for 3.5 hrs at 100 °C. The solution
was treated with sodium methoxide (3.00 mmol, 1.0 equiv) and stirred for 15 min
at 100 °C, then treated again with sodium methoxide (3.00 mmol, 1.0 equiv) and
stirred for 10 min more at 100 °C.
The mixture was poured onto water (50ml) and the pH lowered to 7 with
HCl(aq., 2 N) and stirred for 15 minutes. The resulting brown precipitate was
recovered by filtration and washed with water (2 x 15 ml) and then dissolved in
acetone. The solvent was then removed in vacuo and the resulting solid was
treated with chloroform and diethyl ether (1:2, 5 ml) and the solution let stand for
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10 minutes until a solid as obtained. The desired product was then obtained as a
yellow solid by filtration and washed with diethyl ether (2 x 5 ml).
0.562 g (78 %)
1H-NMR (DMSO-d6, 400MHz) δ: 3.92 (s, 3H, H-14), 6.59 (s, 1H, H-7), 7.04 (t, 
1H, 5.0 Hz, H-11), 7.10 (s, 1H, H-4), 7.15 (t, 1H, 5.0 Hz, H-10), 7.41 (d, 1H, 5.0
Hz, H-12), 7.53 (d, 1H, 5.0 Hz, H-9), 9.49 (s, 1H, H-1), 11.51 (br s, 1H, N-H),
11.92 (br s, 1H, N-H)
13C-NMR (DMSO-d6, 100MHz) δ: 57.92 (C-14), 93.24 (C-4), 100.76 (C-7), 
111.23 (C-12), 118.67 (C-2), 119.75 (C-11), 120.32 (C-9), 122.31 (C-10), 128.12
(C-8), 129.41 (C-6) , 131.78 (C-13), 136.72 (C-5), 157.91 (C-3), 172.98 (C-1).
IR (νmax/cm-1): 3254, 3234, 3215, 2943, 1588, 1525.
m.p.: >300 °C
HRMS: m/z calculated for C14H12N2O2: 241.0977 [M+H]+. Found: 241.0981
General procedure for other bicyclic aldehydes
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Pd(OAc)2 (0.30 mmol, 0.1 equiv) and triphenylphosphine (1.35 mmol, 0.45
equiv) were added to toluene (1 ml) under argon. The resulting bright yellow
solution was stirred for 30 min at 70 °C. A degassed solution of (5-Bromo-3-
methoxy-pyrrol-2-ylidenemethyl)-diethyl-amine (3.00 mmol, 1.0 equiv) and the
required boronic acid (3.30 mmol, 1.1 equiv) in 10 % water/dioxane (15 ml) was
added to the suspension of Pd(PPh3)4. Sodium carbonate (9.00 mmol, 3.0
equiv) was added and the mixture was stirred for 3.5 hrs at 100 °C. The solution
was treated with sodium methoxide (3.00 mmol, 1.0 equiv) and stirred for 15 min
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at 100 °C, then treated again with sodium methoxide (3.00 mmol, 1.0 equiv) and
stirred for 10 min more at 100 °C.
The mixture was poured onto water (50 ml) and the pH lowered to 7 with HCl
(aq., 2 N) and stirred for 15 min. The resulting mixture was extracted with ethyl
acetate (3 x 75 ml). The combined organic fractions were washed with brine,
dried over magnesium sulphate and evaporated to leave an oily residue which
was purified by chromatography through basic alumina.
3-methoxy-5-phenyl-1H-pyrrole-2-carbaldehyde 62
Product was purified by flash column chromatography (basic alumina, 10% ethyl
acetate in hexane) to leave a red solid.
0.1411g (70%)
1H-NMR (Acetone-d6, 400MHz) δ:  3.89 (s, 3H, H-10), 6.52 (s, 1H, H-4), 7.30 (t, 
1H, 7.5 Hz, H-9), 7.38 (t, 2H, 7.5 Hz, H-8), 7.84 (d, 2H, 7.5 Hz, H-7), 9.51 (s, 1H,
H-1), 10.52 (br s, 1H, N-H)
13C-NMR (Acetone-d6, 175MHz) δ: 58.29 (C-10), 94.10 (C-4), 120.25 (C-2), 
126.09 (C-7), 129.13 (C-9), 129.57 (C-8), 131.80 (C-6), 138.36 (C-5), 159.06 (C-
3), 174.19 (C-1)
IR (νmax/cm-1): 3246, 2821, 1617, 1561
m.p.: 137-138 °C
HRMS: m/z calculated for C12H11NO2: 202.0868 [M+H]+. Found: 202.0872
3-methoxy-5-(thiophen-2-yl)-1H-pyrrole-2-carbaldehyde 64
Product was purified by flash column chromatography (basic alumina, 10% ethyl
acetate in hexane) to leave a red solid.
0.1834 g (56 %)
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1H-NMR (Acetone-d6, 400MHz) δ: 3.88 (s, 3H, H-10), 6.29 (s, 1H, H-4), 7.16 (dd, 
1H, 4.0, 3.0 Hz, H-8), 7.51 (d, 1H, 4.0 Hz, H-7), 7.67 (d, 1H, 3.0 Hz, H-9), 9.52
(s, 1H, H-1), 10.49 (br s, 1H, N-H)
13C-NMR (Acetone-d6, 175MHz) δ: 58.27 (C-10), 94.24 (C-4), 119.45 (C-2), 
125.43 (C-9), 126.67 (C-7), 128.73 (C-8), 133.32 (C-6), 134.26 (C-5), 158.52 (C-
3), 173.94 (C-1)
IR (νmax/cm-1): 3205, 3081, 2951, 1614, 1577, 1530
m.p.: 160-161 °C
HRMS: m/z calculated for C10H9NO2S: 208.0432 [M+H]+. Found: 208.0436
5-(furan-2-yl)-3-methoxy-1H-pyrrole-2-carbaldehyde 65
Product was purified by flash column chromatography (basic alumina, 10% ethyl
acetate in hexane) to leave a red solid.
0.1861 g (60 %)
1H-NMR (Acetone-d6, 400MHz) δ: 3.93 (s, 3H, H-10), 6.32 (s, 1H, H-4), 6.57 (dd, 
1H, 4.0, 3.0 Hz, H-8), 6.97 (d, 1H, 4.0 Hz, H-9), 7.57 (d, 1H, 3.0 Hz, H-7), 9.53
(s, 1H, H-1), 10.55 (br s, 1H, N-H)
13C-NMR (Acetone-d6, 175MHz) δ: 58.38 (C-10), 93.32 (C-4), 108.0 (C-9), 
112.66 (C-8), 119.88 (C-2), 130.24 (C-6), 144.14 (C-7), 147.71 (C-5), 158.95 (C-
3), 174.24 (C-1)
IR (νmax/cm-1): 3207, 2924, 1601, 1546
m.p.: 185-186 °C
HRMS: m/z calculated for C10H9NO3: 192.0661 [M+H]+. Found: 192.0665
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General procedure for N-BOC heterocycle boronic acids
nBuLi (1.5 M in hexanes) (1.10 equiv) was added slowly to a solution of
2,2,6,6-tetramethylpiperidine (1.10 equiv) in THF at -78 °C under argon. After
stirring for 10 min the mixture was allowed to warm to 0 °C over 30 min and then
cooled again to -78 °C. A solution of the corresponding N-BOC heterocycle (1.0
equiv) in THF was added slowly so as the temperature remained below -65 °C.
After the reaction mixture was stirred for 2 hrs at -78 °C, trimethyl borate (3.0
equiv) in THF was added and the mixture was allowed to warm to room
temperature overnight.
Subsequently HCl (aq., 0.3 N) was added, the volatile solvent was removed in
vacuo and the residue extracted with diethyl ether. Combined organic phases
were washed with water and dried over magnesium sulphate. The solution was
slowly concentrated until a solid began to precipitate and then cooled to 0 °C
before filtering off solid and washing with cold diethyl ether. Thorough drying of
the resulting solid afforded the boronic acid as an off-white solid.
N-BOC pyrrole-2-boronic acid 53
0.6879g (72%)
1H-NMR (CDCl3, 400MHz) δ: 1.56 (s, 9H, H-1), 6.14 (t, 1H, 4.0 Hz, H-6), 7.03 (d, 
1H, 4.0 Hz, H-5), 7.37 (d, 1H, 4.0 Hz, H-7), 7.55 (br s, 2H, variable with
concentration, B-OH2)
13C-NMR (CDCl3, 100MHz) δ: 27.95 (C-1), 85.57 (C-2), 112.06 (C-6), 127.04 (C-
5), 128.75 (C-7), 132.12 (C-4), 152.31 (C-3)
177
IR (νmax/cm-1): 3336, 3171, 2984, 1704, 1554
HRMS: m/z calculated for C9H14BNO4: 212.1094 [M+H]+. Found: 212.1099
N-BOC indol-2-boronic acid 59
1.7054 g (88 %)
1H-NMR (CDCl3, 400MHz) δ: 1.66 (s, 9H, H-1), 7.15 (t, 1H, 5.5 Hz, H-8), 7.21 (s, 
2H, variable with concentration, B-OH2), 7.27 (t, 1H, 5.5 Hz, H-9), 7.42 (s, 1H,
H-5), 7.49 (d, 1H, 5.5 Hz, H-7), 7.91 (d, 1H, 5.5 Hz, H-10)
13C-NMR (CDCl3, 100MHz) δ: 29.50 (C-1), 85.67 (C-2), 115.17 (C-9), 116.44 (C-
8), 120.94 (C-10), 122.64 (C-7), 125.90 (C-5), 127.60 (C-6), 132.89 (C-4),
136.43 (C-11), 154.11 (C-3).
IR (νmax/cm-1): 3337, 3146, 2972, 1692
HRMS: m/z calculated for C13H16BNO4: 262.1251 [M+H]+. Found: 262.1253
5-Dimethylaminomethylene-4-methoxy-5H-furan-2-one 7482
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A solution of 4-methoxy-2(5H)-furanone (2.00 g, 17.53 mmol, 1.0 equiv) in
dimethyl formamide dimethyl acetal (20 ml) was made up in a round bottom
flask equipped for distillation. The mixture was heated in an oil bath at 110 °C
with slow, continuous distillation of methanol. After 3 hours the mixture was
cooled to room temperature and the excess of solvent-reagent was removed in
vacuo to leave a yellow/brown solid. Product was purified by flash column
chromatography (silica, ethyl acetate) to leave a yellow solid.
2.750 g (92 %)
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1H-NMR (CDCl3, 400MHz) δ: 3.06 (s, 6H, H-6), 3.87 (s, 3H, H-7), 4.89 (s, 1H, H-
2), 6.06 (s, 1H, H-5)
13C-NMR (CDCl3, 100MHz) δ: 42.45 (C-6), 58.43 (C-7), 80.59 (C-2), 120.19 (C-
4), 122.78 (C-5), 169.98 (C-3), 171.38 (C-1)
IR (νmax/cm-1): 2990, 2901, 2822, 1704, 1655, 1555
m.p.: 57 – 58 °C [lit. 57 – 58 °C]82
HRMS: m/z calculated for C8H11NO3: 170.0817 [M+H]+. Found: 170.0820
5-Bromo-3-methoxy-furan-2-carbaldehyde 70
O
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To 5-Dimethylaminomethylene-4-methoxy-5H-furan-2-one (1.00 g, 5.90 mmol,
1.0 equiv) in chloroform (15 ml) at 0 °C was added a solution of phosphorus
oxybromide in chloroform (15 ml) dropwise. The resulting blue/green mixture
was then stirred under reflux over night. The reaction was quenched with water
and the aqueous layer adjusted to pH 14 (NaOH aq. 2 N). The organic layer was
separated and the aqueous layer was extracted with dichloromethane (3 x 50
ml). The combined organic fractions were washed with Na2CO3 (aq., 20 ml, sat.)
and brine (20 ml). The organic layer was then dried over magnesium sulphate
and evaporated to dryness, to yield an unstable white solid.
0.2854 g (24 %)
1H-NMR (CDCl3, 400MHz) δ: 4.06 (s, 3H, H-6), 6.92 (s, 1H, H-2), 9.43 (s, 1H, H-
5)
13C-NMR (CDCl3, 100MHz) δ: 63.19 (C-1), 95.66 (C-4), 119.55 (C-1), 131.44 (C-
2), 168.73 (C-3), 182.10 (C-5).
m.p.: 58- 60 °C
HRMS: m/z calculated for C6H5Br79O3: 204.9500 [M+H]+. Found: 204.9509
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2-(5-Formyl-4-methoxy-furan-2-yl)-pyrrole-1-carboxylic acid tert-butyl ester
75
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Pd(OAc)2 (0.30 mmol, 0.1 equiv) and triphenylphosphine (1.35 mmol, 0.45
equiv) were added to toluene (1 ml) under argon. The resulting bright yellow
solution was stirred for 30 min at 70 °C. A degassed solution of
5-Bromo-3-methoxy-furan-2-carbaldehyde (1.00 mmol, 1.0 equiv) and N-
BOC-pyrrole boronic acid (1.10 mmol, 1.1 equiv) in 10 % water/dioxane (15 ml)
was added to the suspension of Pd(PPh3). Sodium carbonate (3.00 mmol, 3.0
equiv) was added and the mixture was stirred for 3.5 hrs at 100 °C. The solution
was treated with sodium methoxide (1.00 mmol, 1.0 equiv) and stirred for 15 min
at 100 °C, then treated again with sodium methoxide (1.00 mmol, 1.0 equiv) and
stirred for 10 min more at 100 °C.
The mixture was poured onto water (50 ml) and the pH was lowered to 7 with
HCl (aq., 2 N) and stirred for 15 min. The resulting mixture was extracted with
ethyl acetate (3 x 75 ml). The combined organic fractions were washed with
brine, dried over magnesium sulphate and evaporated to leave an oily residue.
Purification of the residue by column chromatography through basic alumina (20
% ethyl acetate/hexane) yielded a green vicious oil.
0.2423 g (83 %)
1H-NMR (Acetone-d6, 400MHz) δ: 1.44 (s, 9H, H-12), 4.01 (s, 3H, H-10), 6.34 (t, 
1H, 3.5 Hz, H-8), 6.70 (dd, 1H, 1.5, 3.5 Hz, H-9), 6.85 (s, 1H, H-4), 6.91 (dd, 1H,
1.5, 3.5 Hz, H-7).
HRMS: m/z calculated for C15H18NO5: 292.1185 [M+H]+. Found: 292.1192
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3-Methoxy-5-(1H-pyrrol-2-yl)-furan-2-carbaldehyde 71
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To a solution of 2-(5-Formyl-4-methoxy-furan-2-yl)-pyrrole-1-carboxylic acid tert-
butyl ester (0.199 g, 0.684 mmol) in THF (5 ml) was added lithium hydroxide
(0.164 g, 6.84 mmol, 10 equiv) in methanol (5 ml) under argon and the resulting
solution was stirred at room temperature and monitored by TLC. On completion
of the reaction the solvent was removed and the resulting yellow solid was
washed with water to yield the desired product as a yellow/green solid.
0.113 g (87 %)
1H-NMR (Acetone-d6, 400MHz) δ: 4.03 (s, 3H, H-10), 6.23 (dd, 1H, 2.5 Hz, 1.0 
Hz, H-8), 6.75 (d, 1H, 2.5 Hz, H-9), 6.76 (s, 1H, H-4), 7.02 (d, 1H, 2.5 Hz, H-7),
9.47 (s, 1H, H-1), 11.11 (br s, 1H N-H)
13C-NMR (Acetone-d6, 175MHz) δ: 59.72 (C-10), 95.02 (C-4), 109.84 (C-5), 
111.28 (C-8), 111.38 (C-9), 121.85 (C-6), 123.16 (C-7), 136.54 (C-1), 153.31 (C-
2), 161.27 (C-3).
m.p.: 154 – 155 °C
IR (νmax/cm-1): 3255, 3179, 3121, 2931, 2834, 1620, 1589, 1563
HRMS: m/z calculated for C10H9NO3: 192.0661 [M+H]+. Found: 192.0667
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2-(1-Hydroxy-undecyl)-pyrrole-1-carboxylic acid tert-butyl ester 78
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To 2,2,6,6-tetramethylpiperidine (0.676 ml, 4.00 mmol, 1.0 equiv) in THF (5 ml)
under argon, was added nBuLi (1.6M, 2.50 ml, 4.00 mmol, 1.0 equiv) dropwise
at -78 °C. The resulting mixture was stirred at -78 °C for 10 min, warmed to 0 °C
over 30 min and then cooled to -78 °C before addition of N-BOC pyrrole (0.669
ml, 4.00 mmol, 1.0 equiv) in THF (10ml). After stirring for 1 hour, undecanal
(0.823 ml, 4.00 mmol, 1.0 equiv) was added dropwise. The reaction was stirred
for 3 hrs at -78 °C before quenching at -78 °C by addition of NaOH (aq, 1 N, 10
ml), the solution was immediately allowed to warm to room temperature, diethyl
ether (20 ml) was added and the organic layer separated. The organic layer was
then washed with water (2 x 10 ml), NaOH (aq, 1 N, 5 ml) and brine (2 x 10 ml),
before drying over magnesium sulphate. Removal of the solvent in vacuo left a
reddish oil, which was purified by flash column chromatography (silica, 5% ethyl
acetate in hexane) to leave a colourless oil.
0.3202 g (23 %)
1H-NMR (CDCl3, 400MHz) δ: 0.82 (t, 3H, 7.0 Hz, H-15), 1.21 (m, 16H, H-7-H-14), 
1.49 (s, 9H, H-17), 1.76 (m, 2H, H-6), 3.92 (t, 1H, 7.5 Hz, H-5), 4.77 (quartet,
1H, 7.5 Hz, H-16), 6.02 (t, 1H, 6.5 Hz, H-2), 6.11 (d, 1H, 6.5 Hz, H-3), 7.12 (d,
1H, 6.5 Hz, H-1)
HRMS: m/z calculated for C20H35NO3: 338.2617 [M+H]+. Found: 338.2612
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2-(1-Methoxy-undecyl)-1H-pyrrole 80
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To a solution of 2-(1-Hydroxy-undecyl)-pyrrole-1-carboxylic acid tert-butyl ester
(0.300 g, 0.89 mmol, 1.0 equiv) in THF (10 ml) was added lithium hydroxide
(0.164 g, 6.84 mmol, 7.5 equiv) in methanol (5 ml) under argon and the resulting
solution was stirred overnight at room temperature. Volatiles were then removed
in vacuo and the residue was partitioned between HCl (aq, 0.1 N, 20 ml) and
diethyl ether (20 ml). The resulting aqueous layer was separated and extracted
with diethyl ether (2 x 20 ml). The combined organic fractions were washed with
brine (20 ml), dried over magnesium sulphate and evaporated to dryness in
vacuo to leave the title compound.
0.078 g (35 %)
1H-NMR (CDCl3, 400MHz) δ: 0.82 (t, 3H, 7.0 Hz, H-15), 1.21 (m, 16H, H-7-H-14), 
1.76 (m, 2H, H-6), 4.01 (s, 3H, H-16) 3.92 (t, 1H, 7.5 Hz, H-5), 5.91 (t, 1H, 6.5
Hz, H-2), 6.01 (d, 1H, 6.5 Hz, H-3), 6.82 (d, 1H, 6.5 Hz, H-1)
HRMS: m/z calculated for C20H35NO3: 338.2617 [M+H]+. Found: 338.2612
1-(1H-Pyrrol-2-yl)-undecan-1-one 83
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Undecanoic acid (1.00g, 5.37mmol, 1.0 equiv), 2,2-dipyridyldisulfide (2.37 g,
10.74 mmol, 2.0 equiv) and triphenyl phosphine (2.82 g, 10.74 mmol, 2.0 equiv)
were stirred in dry toluene (9 ml) at room temperature under argon for 24 hours.
This reaction mixture was then cooled to -78 °C and treated dropwise with
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pyrrolylmagnesium chloride (0.35 M, 92.0 ml, 32.2 mmol, 6.0 equiv; prepared
from 16.1 ml, 2.0 M ethylmagnesium chloride in dry THF diluted with 75 ml
toluene and 2.23 ml pyrrole, -40°C to -10°C, 10 min). TLC indicated the reaction
was complete after 45 min at which time the reaction was quenched at -78 °C
with NH4Cl (sat. aq., 10 ml) and the products were extracted with diethyl ether (3
x 100 ml). The combined organic phases were washed with 5% potassium
carbonate (3 x 20 ml), water (20 ml) and brine (20 ml), then dried over
magnesium sulphate and evaporated to dryness to leave off-white solid. The
product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
1.02 g (81%)
1H-NMR (CDCl3, 400MHz) δ: 0.81 (t, 3H, 7.5 Hz, H-15), 1.22 (m, 14H, H-8-H-14), 
1.66 (quintet, 2H, H-7, 7.0 Hz), 2.69 (t, 2H, 7.0 Hz, H-6), 6.22 (m, 1H, H-2), 6.81
(m, 1H, H-3), 6.92 (m, 1H, H-1), 9.81 (br s, 1H, N-H).
13C-NMR (CDCl3, 100MHz) δ: 15.05 (C-15), 22.70, 25.36, 29.33, 29.40, 29.52, 
29.55, 29.60 and 31.91 (C-7-C-14), 38.07 (C-6), 110.49 (C-2), 116.06 (C-3),
124.48 (C-1), 132.11 (C-4), 191.32 (C-5)
IR (νmax/cm-1): 3280, 2915, 2850, 1642, 1546
m.p.: 48 - 49 °C
HRMS: m/z calculated for C15H25NO: 236.2014 [M+H]+. Found: 236.2009
2-Undecyl-1H-pyrrole 10
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To sodium borohydride (0.457 g, 12.10 mmol, 6.0 equiv) in refluxing isopropanol
(20 ml) was added 1-(1H-Pyrrol-2-yl)-undecan-1-one (0.474 g, 2.01 mmol, 1.0
equiv) and the resultant mixture left to reflux overnight. The mixture was diluted
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with water and stirred until completely dissolution, then volatiles were removed
in vacuo, and the residue was extracted with ethyl acetate (3 x 20 ml).
Combined organic fractions were then dried over magnesium sulphate and
evaporated to dryness to leave a pale yellow oil that solidifies on standing. The
product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
0.4173 g (94%)
1H-NMR (CDCl3, 400MHz) δ: 0.81 (t, 3H, 7.5 Hz, H-15), 1.22 (m, 16H, H-7-H-14), 
1.56 (quintet, 2H, H-6, 7.0 Hz), 2.52 (t, 2H, 7.0 Hz, H-5), 5.81 (m, 1H, H-3), 6.03
(m, 1H, H-2), 6.61 (m, 1H, H-1)
13C-NMR (CDCl3, 100MHz) δ: 14.14 (C-15), 22.72, 27.76, 29.37, 29.42, 29.48, 
29.61, 29.65, 29.68, 29.71 and 31.94 (C-5-C-14), 104.86 (C-3), 108.26 (C-2),
115.96 (C-1), 132.91 (C-4).
IR (νmax/cm-1): 3350, 2915, 2846
m.p.: 43 – 44 °C [lit: 42 – 43 °C]
HRMS: m/z calculated for C15H27N: 222.2222 [M+H]+. Found: 222.2219
Octyloxy-acetic acid 101
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To dry octanol (20 ml) was added sodium metal (0.29 g, 12.5 mmol, 2.5 equiv)
under argon and the resulting solution was stirred overnight until all the sodium
had dissolved. To the resulting pale yellow solution was added bromoacetic acid
(0.69 g, 5.0 mmol, 1 equiv). The reaction was stirred overnight before removal of
the solvent by reduced pressure distillation. The residue was then partitioned
between ethyl acetate (50 ml) and NaHCO3 (1M, 50 ml). The organic layer was
separated and extracted with further portions of NaHCO3 (1M, 2 x 50 ml). The
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combined aqueous fractions were then acidified with HCl (conc.) and extracted
with diethyl ether (3 x 50 ml). The combined organic fractions were then dried
over magnesium sulphate and evaporated to dryness to leave colourless oil.
Yield: 0.823 g (87 %)
1H-NMR (CDCl3, 400MHz) δ: 0.87 (t, 3H, 7.0 Hz, H-10), 1.21 – 1.35 (m, 10H, H-
5-H-9), 1.60 (quintet, 2H, 7.0 Hz, H-4), 3.57 (t, 2H, 7.0 Hz, H-3), 4.12 (s, 2H, H-
2)
13C-NMR (CDCl3, 100MHz) δ: 14.18 (C-10), 22.60, 25.87, 29.18, 29.33, 29.37 
and 31.77 (C-4-C-9), 67.65 (C-3), 72.09 (C-2), 175.38 (C-1)
IR (νmax/cm-1): 3072 (broad), 2953, 2923, 2854, 1727
HRMS: m/z calculated for C10H20O3: 189.1485 [M+H]+. Found: 189.1487
5-Pentyloxy-pentanoic acid 104
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To dry pentanol (15 ml) was added sodium metal (0.25 g, 11.0 mmol, 1.0 equiv)
under argon and the resulting solution stirred overnight until all the sodium had
dissolved. To the resulting pale yellow solution was added 5-bromovaleric acid
methyl ester (2.15 g, 11.0 mmol, 1 equiv). The reaction was stirred overnight
before removal of the solvent by reduced pressure distillation. The residue was
refluxed in a vigorously stirred solution of THF (75 ml) and NaOH (aq, 2M, 75
ml) overnight. The aqueous layer was then separated and acidified with HCl
(conc.). The acidified aqueous layer was then extracted with diethyl ether (3 x 50
ml) and the combined organic fractions dried over magnesium sulphate and
evaporated to leave the desired product as crude yellow oil. The product was
purified by acid/base extraction according to the following. The crude product
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was dissolved in diethyl ether (50 ml) and extracted with NaHCO3 (1M, 3 x 50
ml). The combined aqueous fractions were then acidified with HCl (conc.) and
extracted with diethyl ether (3 x 50 ml). The combined organic fractions were
then dried and evaporated to leave a pale yellow oil.
Yield: 0.878 g, (44 %)
1H-NMR (CDCl3, 400MHz) δ: 0.86 (t, 3H, 7.0 Hz, H-10), 1.32 (m, 4H, H-8, H-9), 
1.51 – 1.77 (m, 6H, H-3, H-4, H-7), 2.36 (t, 2H, 7.5 Hz, H-2), 3.33 (m, 4H, H-6
and H-5).
13C-NMR (CDCl3, 100MHz) δ: 14.58 (C-10), 21.47, 22.48, 28.27, 28.92 and 
29.27 (C-3-C-4 and C-7-C-9), 33.74 (C-2), 70.19 (C-5 or C-6), 70.99 (C-5 or C-
6), 179.44 (C-1)
IR (νmax/cm-1): 3075 (broad), 2931, 2858, 1707
HRMS: m/z calculated for C10H20O3: 189.1485 [M+H]+. Found: 189.1483
10-Methyl-undec-7-enoic acid ethyl ester 95
To ethyl 7-bromoheptanoate (2.0 ml, 10.28 mmol, 1.0 equiv) in toluene (20 ml)
was added triphenyl phosphine (3.24 g, 12.34 mmol, 1.2 equiv) and the resulting
mixture refluxed for 48 hours. The toluene was then removed in vacuo with
vigorous stirring and the resulting viscous oil was suspended in THF (80 ml).
The resulting suspension was cooled to 0 °C and nBuLi (1.6 M, 6.4 ml, 10.28
mmol, 1.0 equiv) was added dropwise to give a pale orange solution to which
isovaleraldehyde (1.07 ml, 10.28 mmol, 1.0 equiv) was added at 0 °C. The
resulting mixture was allowed to warm to room temperature and stirred
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overnight. The reaction was quenched by the addition of NH4Cl (sat., 40 ml) and
the resulting aqueous layer was extracted with diethyl ether (3 x 50 ml).
Combined organic fractions were washed with brine (50 ml), dried over
magnesium sulphate and concentrated in vacuo. The residue was purified by
flash column chromatography (silica, 2 % ethyl acetate/hexane) to leave a
colourless oil
Yield: 1.63 g (70 %)
1H-NMR (CDCl3, 400MHz) δ: 0.82 (d, 6H, 6.5 Hz, H-13, H-14), 1.19 (t, 3H, 7.5 
Hz, H-1), 1.29 (m, 4H, H-6, H-7), 1.49 (doublet of quartets, 1H, 6.0 Hz, 7.0 Hz,
H-12), 1.55 (m, 2H, H-5), 1.82 (t, 2H, 5.0 Hz, H-11), 1.95 (t, 2H, 5.0 Hz, H-8),
2.21 (t, 2H, 7.0 Hz, H-4), 4.05 (quartet, 2H, 7.5 Hz, H-2), 5.31 (m, 2H, H-9, H-10)
13C-NMR (CDCl3, 100MHz) δ: 14.23 (C-1), 22.34 (2C, C-13 and C-14), 24.89, 
27.07, 28.80 and 29.33 (C-5-C-7 and C-12), 30.30 (C-4), 34.32 (C-8), 36.36 (C-
11), 60.11 (C-2), 129.25 (C-9 or C-10), 130.18 (C-9 or C-10), 173.78 (C-3).
IR (νmax/cm-1): 2953, 2854, 1755, 1625, 1095
HRMS: m/z calculated for C14H26O2: 227.2006 [M+H]+. Found: 227.2009
9-Methyl-undec-7-enoic acid ethyl ester 94
To ethyl 7-bromoheptanoate (2.0 ml, 10.28 mmol, 1.0 equiv) in toluene (20 ml)
was added triphenyl phosphine (3.24 g, 12.34 mmol, 1.2 equiv) and the resulting
mixture refluxed for 48 hours. The toluene was then removed in vacuo with
vigorous stirring and the resulting viscous oil was suspended in THF (80 ml).
The resulting suspension was cooled to 0 °C and nBuLi (1.6 M, 6.4 ml, 10.28
mmol, 1.0 equiv) was added dropwise to give a pale orange solution to which 2-
methylbutyraldehyde (1.07 ml, 10.28 mmol, 1.0 equiv) was added at 0 °C. The
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resulting mixture was allowed to warm to room temperature and stirred
overnight. The reaction was quenched by the addition of NH4Cl (sat., 40 ml) and
the resulting aqueous layer was extracted with diethyl ether (3 x 50 ml).
Combined organic fractions were washed with brine (50 ml), dried over
magnesium sulphate and concentrated in vacuo. The residue was purified by
flash column chromatography (silica, 2 % ethyl acetate/hexane) to leave a
colourless oil.
Yield: 1.75 g (75 %)
1H-NMR (CDCl3, 400MHz) δ: 0.77 (t, 3H, 7.0 Hz, H-14,), 0.85 (d, 3H, 7.0 Hz, H-
13,), 1.18 (t, 3H, 7.5 Hz, H-1), 1.29 (m, 6H, H-12, H-6, H-7), 1.56 (m, 2H, H-5),
1.96 (m, 2H, H-8), 2.22 (overlapping m and t, 3H, H-4, H-11), 4.05 (quartet, 2H,
7.5 Hz, H-2), 5.06 (dd, 1H, 5.5 Hz, 7.0 Hz, H-10), 5.24 (m, 1H, H-9)
13C-NMR (CDCl3, 100MHz) δ: 11.94 (C-14), 14.23 (C-1), 21.04 (C-13), 24.88, 
27.27, 28.80 and 29.52 (C-5-C-7 and C-12), 30.25 (C-4), 33.38 (C-11), 34.32
(C-8), 60.11 (C-2), 128.20 (C-9), 136.40 (C-10), 173.77 (C-3).
IR (νmax/cm-1): 2964, 2821, 1765, 1612, 1082, 905
HRMS: m/z calculated for C14H26O2: 227.2006 [M+H]+. Found: 227.2004
10-Methyl-undecanoic acid ethyl ester
To a solution of 10-Methyl-undec-7-enoic acid ethyl ester (0.922 g, 4.07 mmol,
1.0 equiv) in ethanol was added Pd/C (10 %, 1.0 g) and the stirred mixture was
evacuated in vacuo and flushed with hydrogen gas 5 times. The resulting
suspension was stirred and maintained under hydrogen atmosphere overnight.
The reaction was poured over Celite which was then washed with ethanol (2 x
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50 ml). The combined washings were then evaporated in vacuo and the
resulting residue was purified by flash column chromatography (silica, 2 % ethyl
acetate/hexane) to leave the desired compound as a colourless oil.
Yield: 0.922 g (99 %)
1H-NMR (CDCl3, 400MHz) δ: 0.85 (d, 6H, 6.5 Hz, H-13, H-14), 1.15 (dt, 3H, 7.0 
Hz, 7.5 Hz, H-11), 1.25 (m, 12H, H-6-H-10 and H-1), 1.50 (doublet of quartets,
1H, 6.0 Hz, 7.0 Hz, H-12), 1.61 (m, 2H, H-5), 2.28 (t, 2H, 7.0 Hz, H-4), 4.11
(quartet, 2H, 7.5 Hz, H-2)
13C-NMR (CDCl3, 100MHz) δ: 15.45 (C-1), 22.75 (2C, C-13 and C-14), 24.73 (C-
5), 27.45, 29.18, 29.29, 29.44 and 29.75 (C-6-C-10), 27.87 (C-12), 33.84 (C-4),
38.15 (C-11), 60.54 (C-2), 174.47 (C-3)
IR (νmax/cm-1): 2953, 2854, 1755, 1095
HRMS: m/z calculated for C14H26O2: 229.2162 [M+H]+. Found: 229.2168
9-Methyl-undecanoic acid ethyl ester
To solution of 9-Methyl-undec-7-enoic acid ethyl ester (0.658 g, 4.07 mmol, 1.0
equiv) in ethanol was added Pd/C (10 %, 1.0 g) and the stirred mixture was
evacuated in vacuo and flushed with hydrogen gas 5 times. The resulting
suspension was stirred and maintained under hydrogen atmosphere overnight.
The reaction was poured over Celite which was then washed with ethanol (2 x
50 ml). The combined washings were then evaporated in vacuo and the
resulting residue was purified by flash column chromatography (silica, 2 % ethyl
acetate/hexane) to leave the desired compound as a colourless oil.
Yield: 0.658 g (99 %)
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1H-NMR (CDCl3, 400MHz) δ: 0.82 - 0.84 (overlapping m, 6H, H-13 and H-14), 
1.09 (m, 2H, H-12), 1.18 (t, 3H, 7.5 Hz, H-1), 1.27 (m, 11H, H-6-H11), 1.57
(quintet, 2H, 6.5 Hz, H-5), 2.28 (t, 2H, H-4), 4.05 (quartet, 2H, 7.5 Hz).
13C-NMR (CDCl3, 100MHz) δ: 11.56 (C-13 or C-14), 14.86 (C-1), 19.25 (C-13 or 
C-14), 24.56 (C-5), 29.12, 29.25, 29.35 and 29.87 (C-6-C-10 and C-12), 34.26
(C-4), 34.78 (C-12), 61.23 (C-2), 173.75 (C-3).
IR (νmax/cm-1): 2955, 2853, 1752, 1093
HRMS: m/z calculated for C14H26O2: 229.2162 [M+H]+. Found: 229.2165
10-Methyl-undecanoic acid 97
To a solution of 10-Methyl-undecanoic acid ethyl ester (0.922g, 4.07 mmol) in
THF (50 ml) was added NaOH (aq, 2N, 50 ml) and the resulting immiscible
liquids stirred vigorously under reflux (75 °C) overnight. The aqueous layer was
then separated and acidified (HCl. aq, 10 N). Acidified aqueous layer then
extracted with diethyl ether (3 x 50 ml) and the combined organic extracts were
washed with brine (40 ml), dried over magnesium sulphate and evaporated in
vacuo to leave the desired compound as a white solid.
Yield: 0.644 g (80 %)
1H-NMR (CDCl3, 400MHz) δ: 0.86 (d, 6H, 7.0 Hz, H-11, H12), 1.15 (m, 2H, H-9), 
1.26 (m, 10H, H-8-H-4), 1.50 (doublet of quartets, 1H, 6.0 Hz, 7.0 Hz, H-10),
1.62 (quintet, 2H, 6.5 Hz, H-3), 2.34 (t, 2H, 6.5 Hz, H-2)
13C-NMR (CDCl3, 100MHz) δ: 22.63 (2C, C-11 and C-12), 24.67 (C-3), 27.38, 
29.08, 29.26, 29.47, 29.86 (C-4-C-8), 27.97 (C-10), 34.04 (C-2), 39.04 (C-9),
180.67 (C-1)
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IR (νmax/cm-1): 2987, 2951, 2887, 1712
HRMS: m/z calculated for C14H26O2: 201.1849 [M+H]+. Found: 201.1853
9-Methyl-undecanoic acid 96
To a solution of 9-Methyl-undecanoic acid ethyl ester (0.658 g, 4.07 mmol) in
THF (50 ml) was added NaOH (aq, 2N, 50 ml) and the resulting immiscible
liquids stirred vigorously under reflux (75 °C) overnight. The aqueous layer was
then separated and acidified (HCl. aq, 10 N). Acidified aqueous layer then
extracted with diethyl ether (3 x 50 ml) and the combined organic extracts were
washed with brine (40 ml), dried over magnesium sulphate and evaporated in
vacuo to leave the desired compound as a white solid.
Yield: 0.422 g (77 %)
1H-NMR (CDCl3, 400MHz) δ: 0.82 - 0.84 (overlapping m, 6H, H-11 and H-12), 
1.09 (m, 2H, H-10), 1.26 (m, 11H, H-4-H9), 1.63 (quintet, 2H, 6.5 Hz, H-3), 2.33
(t, 2H, H-2)
13C-NMR (CDCl3, 100MHz) δ: 11.36 (C-11 or C-12), 19.18 (C-11 or C-12), 24.68 
(C-3), 27.02, 29.07, 29.29, 29.49 and 29.78 (C-4-C-8), 34.13 (C-2), 34.39 (C-9),
36.59 (C-10), 180.57 (C-1)
IR (νmax/cm-1): 2979, 2953, 2888, 1713
HRMS: m/z calculated for C14H26O2: 201.1849 [M+H]+. Found: 201.1842
General Method for formation of acyl pyrrole from carboxylic acids
Carboxylic acid (1.0 equiv), 2,2-dipyridyldisulfide (2.0 equiv) and triphenyl
phosphine (2.0 equiv) were stirred in dry toluene at room temperature under
argon for 24 hours. This reaction mixture was then cooled to -78°C and treated
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dropwise with pyrrolylmagnesium chloride (0.35M, 3.0 equiv; prepared from 2.0
M ethylmagnesium chloride in dry THF diluted with toluene and pyrrole, -40°C to
-10°C, 10 min). After 45 minutes the reaction was quenched at -78 °C with
NH4Cl (sat. aq., 10 ml) and the products extracted with diethyl ether. Combined
organic phases were washed with 5% potassium carbonate, water and brine,
then dried over magnesium sulphate and evaporated to dryness to leave the
desired 2-acyl pyrrole. The product was typically purified by passage through a
plug of silica (40% ethyl acetate/hexane) before purification by flash column
chromatography as described below.
1-(1H-Pyrrol-2-yl)-undec-10-en-1-one
H
N
O
1
2 3
4 5
6 8 10 12 14
7 9 11 13 15
Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
Yield: 1.65 g (87 %)
1H-NMR (CDCl3, 400MHz) δ: 1.20-1.40 (m, 10H, H-7-H-11), 1.70 (quintet, 2H, 
7.5 Hz, H-12), 2.05 (q, 2H, 7.5 Hz, H-13), 2.75 (t, 2H, 7.5 Hz, H-6), 4.90 (dd, 2H,
8.0 Hz, 10.5 Hz, H-15), 5.81 (m, 1H, H-14), 6.30 (m, 1H, H-2), 6.90 (m, 1H, H-3),
7.05 (m, 1H, H-1), 9.05 (br s, 1H)
13C-NMR (CDCl3, 100MHz) δ: 25.36 (C-12), 28.92, 29.10, 29.25, 29.35 and 
29.41 (C-7-C-11), 33.81 (C-13), 38.05 (C-6), 110.48 (C-2), 114.15 (C-15),
116.16 (C-3), 124.60 (C-1), 132.10 (C-4), 139.22 (C-14), 191.33 (C-5).
IR (νmax/cm-1): 3280, 2920, 2848, 1639, 1547
m.p.: 33- 34 °C
HRMS: m/z calculated for C15H23NO: 234.1852 [M+H]+. Found: 234.1856
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1-(1H-Pyrrol-2-yl)-octan-1-one
H
N
O
1
2 3
4 5
6 8 10 12
7 9 11
Purified by flash column chromatography (silica, 10% ethyl acetate in hexane) to
leave a white solid.
Yield: 1.49 g, 96 %
1H-NMR (CDCl3, 400MHz) δ: 0.85 (t, 3H, 7.0 Hz, H-12), 1.15 – 1.35 (m, 8H, H-8-
H-11), 1.70 (quintet, 2H, 7.5 Hz, H-7), 2.75 (t, 2H, 7.5 Hz, H-6), 6.25 (m, 1H, H-
2), 6.90 (m, 1H, H-3), 7.00 (m, 1H, H-1), 10.0 (br s, 1H)
13C-NMR (CDCl3, 100MHz) δ: 14.25 (C-12), 22.65, 25.41, 29.14, 29.46 and 
31.73 (C-7-C-11), 38.08 (C-6), 110.45 (C-2), 116.24 (C-3), 124.71 (C-1), 132.10
(C-4), 191.42 (C-5)
IR (νmax/cm-1): 3276, 2955, 2917, 2851, 1640, 1546
m.p.: 31- 33 °C
HRMS: m/z calculated for C12H19NO: 194.1539 [M+H]+. Found: 194.1543
1-(1H-Pyrrol-2-yl)-octadecan-1-one
H
N
O
1
2 3
4 5
6 8 10 12 14
7 9 11 13 15
16
17
18
19
20
21
22
Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
Yield: 0.7652 g (29 %)
1H-NMR (CDCl3, 400MHz) δ: 0.90 (t, 3H, 7.0 Hz, H-22), 1.25 – 1.40 (m, 28H, 
H-8-H-21), 1.75 (quintet, 2H, 7.0 Hz, H-7), 2.80 (t, 2H, 7.0 Hz, H-6), 6.30 (m, 1H,
H-2), 6.95 (m, 1H, H-3), 7.00 (m, 1H, H-1), 9.40 (br s, 1H).
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13C-NMR (CDCl3, 100MHz) δ: 14.12 (C-22), 22.69, 25.29, 28.93, 29.23, 29.36, 
29.39, 29.44, 29.46, 29.52, 29.62, (5 carbons missing due to overlapping
signals, C-7-C-21), 38.04 (C-6), 110.52 (C-2), 115.83 (C-3), 124.15 (C-1),
132.09 (C-4), 191.15 (C-5)
IR (νmax/cm-1): 3286, 2916, 2847, 1640
m.p.: 77 – 79 °C
HRMS: m/z calculated for C22H39NO: 334.3104 [M+H]+. Found: 334.3101
2-Octyloxy-1-(1H-pyrrol-2-yl)-ethanone
H
N O
O
1
2 3
4 5
6
8 10 12 14
7 9 11 13
Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a low-melting point solid.
Yield: 0.747 (76 %)
1H-NMR (CDCl3, 400MHz) δ: 0.87 (t, 3H, 7.0 Hz, H-14), 1.27 - 1.38 (m, 10H, 
H-9-H-13), 1.65 (quintet, 2H, 7.5 Hz, H-8), 3.52 (t, 2H, 7.5 Hz, H-7), 4.49 (s, 2H,
H-6), 6.27 (m, 1H, H-2), 7.06 (m, 2H, H-3 and H-1), 10.09 (br s, 1H).
13C-NMR (CDCl3, 100MHz) δ: 14.10 (C-14), 22.66, 26.06, 29.25, 29.41 and 
29.65 (C-9-C-13), 31.82 (C-8), 72.11 (C-7), 73.70 (C-6), 110.78 (C-2), 116.90
(C-3), 125.06 (C-1), 129.98 (C-4), 187.35 (C-5)
IR (νmax/cm-1): 3287, 2928, 2913, 2849, 1740, 1633
m.p.: 34 - 35 °C
HRMS: m/z calculated for C14H23NO2: 238.1802 [M+H]+. Found: 238.1806
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5-Pentyloxy-1-(1H-pyrrol-2-yl)-pentan-1-one
Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a low-melting point solid.
Yield: 0.6114 (78 %)
1H-NMR (CDCl3, 400MHz) δ: 0.89 (t, 7.0 Hz, H-14), 1.31 (m, 4H, H-12-H-13), 
1.58 (m, 2H, H-11), 1.64 (m, 2H, H-7), 1.81 (m, 2H, H-8), 2.81 (t, 2H, 7.0 Hz, H-
6), 3.40 (t, 2H, 7.0 Hz, H-9), 3.44 (t, 2H, 7.0 Hz, H-10), 6.26 (m, 1H, H-2), 6.92
(m, 1H, H-3), 7.04 (m, 1H, H-1), 10.12 (br s, 1H).
13C-NMR (CDCl3, 100MHz) δ: 14.05 (C-14), 22.07, 22.56, 28.39, 29.44, 29.46 
(C-7, C-8 and C-11-C-13), 37.69 (C-6), 70.51 (C-10), 71.04 (C-9), 110.44 (C-2),
116.35 (C-3), 124.83 (C-1), 132.03 (C-4), 191.03 (C-5).
IR (νmax/cm-1): 3275, 2930, 2856, 1739, 1633
m.p.: 25 – 26 °C
HRMS: m/z calculated for C14H23NO2: 238.1802 [M+H]+. Found: 238.1801
1-(1H-Pyrrol-2-yl)-decan-1-one
H
N
O
1
2 3
4
5
6 8 10 12 14
7 9 11 13
Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
Yield: 1.55 g (87 %)
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1H-NMR (CDCl3, 400MHz) δ: 0.88 (t, 3H, 7.5 Hz, H-14), 1.27 (m, 12H, H-8-H-13), 
1.73 (quintet, 2H, 7.0 Hz, H-7), 2.77 (t, 2H, 7.0 Hz, H-6), 6.27 (m, 1H, H-2), 6.93
(m, 1H, H-3), 7.04 (m, 1H, H-1)
13C-NMR (CDCl3, 100MHz) δ: 14.13 (C-14), 22.69, 25.44, 29.31, 29.49 and 
31.90 (1 signal missing due to overlapping signals, C-7-C-13), 38.08 (C-6),
110.42 (C-2), 116.37 (C-3), 124.87 (C-1), 132.09 (C-4), 191.49 (C-5)
IR (νmax/cm-1): 3279, 2953, 2863, 1631, 1547
m.p.: 32 – 34 °C
HRMS: m/z calculated for C14H23NO: 222.1852 [M+H]+. Found: 222.1856
1-(1H-Pyrrol-2-yl)-dodecan-1-one
H
N
O
1
2 3
4 5
6 8 10 12 14
7 9 11 13 15
16
Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
Yield: 1.78 (89 %)
1H-NMR (CDCl3, 400MHz) δ: 0.88 (t, 3H, 7.5 Hz, H-16), 1.26 (m, 16H, H-8-H-15), 
1.71 (quintet, 2H, 7.0 Hz, H-7), 2.73 (t, 2H, 7.0 Hz, H-6), 6.27 (m, 1H, H-2), 6.90
(m, 1H, H-3), 7.01 (m, 1H, H-1)
13C-NMR (CDCl3, 100MHz) δ: 14.14 (C-16), 22.73, 25.49, 29.39, 29.51, 29.55, 
29.67, 31.96 (2 signals missing due to overlapping C-7-C-15), 38.08 (C-6),
110.37 (C-2), 116.59 (C-3), 125.15 (C-1), 132.07 (C-4), 191.58 (C-5)
IR (νmax/cm-1): 3285, 2955, 2859, 1635, 1539
m.p.: 56 – 57 °C
HRMS: m/z calculated for C16H27NO: 250.2165 [M+H]+. Found: 250.2168
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10-Methyl-1-(1H-pyrrol-2-yl)-undecan-1-one
1
2 3
4
H
N 5
6
7
8
9
10
11
12
13
14
16
O
15
Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
Yield: 0.609 g (76 %)
1H-NMR (CDCl3, 400MHz) δ: 0.86 (d, 6H, 7.0 Hz, H-15, H-16), 1.15 (m, 2H, H-
13), 1.25 (m, 10H, H-12-H-8), 1.51 (doublet of quartets, 1H, 6.0 Hz, 7.0 Hz, H-
14), 1.71 (quintet, 2H, 6.5 Hz, H-7), 2.75 (t, 2H, 6.5 Hz, H-6), 6.27 (m, 1H), 6.90
(m, 1H), 7.01 (m, 1H)
13C-NMR (CDCl3, 100MHz) δ: 23.18 (2C), 25.95, 28.48, 30.06, 30.23, 30.41 and 
30.52 (C7-C-12), 27.91 (C14), 38.57 (C-6), 39.55 (C-13), 110.85 (C-2), 116.98
(C-3), 125.54 (C-1), 132.72 (C-4), 192.01 (C-5)
IR (νmax/cm-1): 3279, 2983, 2865, 1652, 1548
m.p.: 42- 45 °C
HRMS: m/z calculated for C16H27NO: 250.6165 [M+H]+. Found: 250.2162
9-Methyl-1-(1H-pyrrol-2-yl)-undecan-1-one
1
2 3
4
H
N 5
6
7
8
9
10
11
12
13
14
16
O 15
Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a colourless oil.
Yield: 0.453 g (82 %)
1H-NMR (CDCl3, 400MHz) δ: 0.84 – 0.85 (overlapping 2 x m, 6H, H-15 and H-
16), 1.09 (m, 2H, H-14), 1.27 (m, 11H, H-8-H-13), 1.71 (quintet, 2H, 7.0 Hz, H-
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7), 2.75 (t, 2H, 7.0 Hz, H-6), 6.27 (m, 1H, H-2), 6.90 (m, 1H, H-3), 7.01 (m, 1H,
H-1)
13C-NMR (CDCl3, 100MHz) δ: 11.32 (C-15 or C-16), 19.13 (C15 or C-16), 25.36, 
26.98, 29.42, 29.44 and 29.78 (1 signal missing due to overlapping, C-7-C-12),
34.30 (C-13), 36.53 (C-14), 37.97 (C-6), 110.25 (C-2), 116.42 (C-3), 124.99 (C-
1), 131.96 (C-4), 191.44 (C-5)
IR (νmax/cm-1): 3286, 2971, 2869, 1687, 1553
HRMS: m/z calculated for C16H27NO: 250.6165 [M+H]+. Found: 250.6171
R-(4-D1)-1-(1H-Pyrrol-2-yl)-undecan-1-one
H
N
O
D
1
2 3
4 5
6
8
10 12 14
7 9 11 13 15
Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
Yield: 0.265 g (79 %)
1H-NMR (CDCl3, 400MHz) δ: 0.81 (t, 3H, 7.5 Hz, H-15), 1.22 (m, 13H, H-8-H-14), 
1.68 (q, 2H, H-7, 7.0 Hz), 2.69 (t, 2H, 7.0 Hz, H-6), 6.22 (m, 1H, H-2), 6.81 (m,
1H, H-3), 6.92 (m, 1H, H-1), 9.81 (br s, 1H, N-H).
13C-NMR (CDCl3, 100MHz) δ: 14.01 (C-15), 22.59, 25.26, 29.28, 29.39, 29.50 
and 31.80 (1 signal missing due to overlapping, C7 and C9-C14), 28.98 (3
signals, C-8), 37.92 (C-6), 110.22 (C-2), 116.41 (C-3), 124.99 (C-1), 131.95 (C-
4), 191.44 (C-5)
IR (νmax/cm-1): 3279, 2935, 2865, 1665, 1542
m.p.: 49 – 50 °C
HRMS: m/z calculated for C15H24DNO: 237.2072 [M+H]+. Found: 237.2075
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S-(4-D1)-1-(1H-Pyrrol-2-yl)-undecan-1-one
H
N
O
1
2 3
4 5
6
8
10 12 14
7 9 11 13 15
D
Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
Yield: 0.354 g (88 %)
1H-NMR (CDCl3, 400MHz) δ: 0.81 (t, 3H, 7.5 Hz, H-15), 1.22 (m, 13H, H-8-H-14), 
1.68 (q, 2H, H-7, 7.0 Hz), 2.69 (t, 2H, 7.0 Hz, H-6), 6.22 (m, 1H, H-2), 6.81 (m,
1H, H-3), 6.92 (m, 1H, H-1), 9.81 (br s, 1H, N-H).
13C-NMR (CDCl3, 100MHz) δ: 14.26 (C-15), 22.14, 25.24, 29.29, 29.37, 29.52 
and 31.82 (1 signal missing due to overlapping, C7 and C9-C14), 28.96 (3
signals, C-8), 37.93 (C-6), 110.22 (C-2), 116.43 (C-3), 124.99 (C-1), 131.96 (C-
4), 191.44 (C-5)
IR (νmax/cm-1): 3279, 2935, 2865, 1665, 1542
m.p.: 48-49 °C
HRMS: m/z calculated for C15H24DNO: 237.2072 [M+H]+. Found: 237.2070
General procedure for reduction of acyl pyrrole to alkyl pyrroles
To sodium borohydride (6.0 equiv) in refluxing isopropanol was added the
corresponding 2-acyl pyrrole (1.0 equiv) and the resultant mixture left to reflux
overnight. The mixture was diluted with water and stirred until complete
dissolution, the volatiles were then removed in vacuo, and the residue was
extracted with ethyl acetate. The combined organic fractions were then dried
over magnesium sulphate and evaporated to dryness to leave the title
compound as a yellow oil that typically solidifies on standing. The product was
then purified by flash column chromatography as described below.
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2-Undec-10-enyl-1H-pyrrole 89
H
N
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Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
Yield: 1.00 g (82 %)
1H-NMR (CDCl3, 400MHz) δ: 1.25-1.42 (m, 12H, H-6-H-11), 1.61 (quintet, 2H, 
7.5 Hz, H-12), 2.07 (q, 2H, 7.5 Hz, H-13), 2.60 (t, 2H, 7.0 Hz, H-5), 4.98 (dd, 2H,
8.0 Hz, 10.5 Hz, H-15), 5.72 (m, 1H, H-14), 5.95 (m, 1H, H-3), 6.16 (m, 1H, H-2),
6.63 (m, 1H, H-1), 7.90 (br s, 1H, N-H)
13C-NMR (CDCl3, 100MHz) δ: 27.79 (C-5), 29.00, 29.19, 29.25, 29.37, 29.46, 
29.58 and 29.74 (C-6-C-12), 33.88 (C-13), 104.90 (C-3), 108.27 (C-2), 114.19
(C-15), 116.01 (C-1), 132.91 (C-4), 139.29 (C-14).
IR (νmax/cm-1): 3352, 2916, 2846
m.p.: 28 – 29 °C
HRMS: m/z calculated for C15H25N: 220.2060 [M+H]+. Found: 220.2064
2-Decyl-1H-pyrrole 86
H
N
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Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
Yield: 0.173 (93 %)
1H-NMR (CDCl3, 400MHz) δ: 0.88 (t, 3H, 7.5 Hz, H-14), 1.26 (m, 14H, H-7-H-13), 
1.56 (quintet, 2H, 7.0 Hz, H-6), 2.59 (t, 2H, 7.0 Hz, H-5), 5.91 (m, 1H, H-3), 6.13
(m, H-2), 6.66 (m, H-1)
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13C-NMR (CDCl3, 100MHz) δ: 14.14 (C-14), 22.70, 27.76, 29.36, 29.42, 29.61, 
29.63, 29.70 and 31.93 (1 signal missing due to overlapping, C-5-C-13), 104.86
(C-3), 108.25 (C-2), 115.96 (C-1), 132.92 (C-4)
IR (νmax/cm-1): 3349, 2935, 2842
m.p.: 38 – 40 °C
HRMS: m/z calculated for C14H25N: 208.2060 [M+H]+. Found: 208.2065
2-Dodecyl-1H-pyrrole 87
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Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
Yield: 0.159 g (85 %)
1H-NMR (CDCl3, 400MHz) δ: 0.88 (t, 3H, 7.0 Hz, H-16), 1.26 (m, 18H, H-7-H-15), 
1.62 (quintet, 2H, 7.0 Hz, H-6), 2.59 (t, 2H, 7.0 Hz, H-5), 5.91 (m, 1H, H-3), 6.13
(m, 1H, H-2), 6.65 (m, 1H, H-1).
13C-NMR (CDCl3, 100MHz) δ: 14.09 (C-16), 22.67, 27.71, 29.33, 29.38, 29.44, 
29.57, 29.65 and 31.90 (3 signals missing due to overlapping, C-5-C-15), 104.80
(C-3), 108.18 (C-2), 115.91 (C-1), 132.86 (C-4).
IR (νmax/cm-1): 3351, 2931, 2854
m.p.: 51 – 53 °C
HRMS: m/z calculated for C16H29N: 236.2373 [M+H]+. Found: 236.2378
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2-(2-Octyloxy-ethyl)-1H-pyrrole 102
Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a colourless oil.
Yield: 0.279 g (79 %)
1H-NMR (CDCl3, 400MHz) δ: 0.94 (t, 3H, 7.0 Hz, H-14), 1.35 (m, 10H, H-9-H-13), 
1.67 (quintet, 2H, 7.0 Hz, H-8), 2.90 (t, 2H, 7.0 Hz, H-5), 3.50 (t, 2H, 7.0 Hz, H-
7), 3.68 (t, 2H, 7.0 Hz, H-6), 5.96 (m, 1H, H-3), 6.15 (m, 1H, H-2), 6.71 (m, 1H,
H-1), 8.67 (br s, 1H)
13C-NMR (CDCl3, 100MHz) δ: 14.16 (C-14), 22.73, 26.33, 27.99, 29.34, 29.49, 
29.84, 31.89 (C-5 and C-8-C-13), 70.86 (C-6), 71.32 (C-7), 105.37 (C-3), 107.75
(C-2), 116.58 (C-1), 130.77 (C-4).
IR (νmax/cm-1): 3389, 2922, 2852, 1735
HRMS: m/z calculated for C14H25NO: 224.2009 [M+H]+. Found: 224.2007
2-(5-Pentyloxy-pentyl)-1H-pyrrole 105
Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a colourless oil.
Yield: 0.2286 g (79 %)
1H-NMR (CDCl3, 400MHz) δ: 0.96 (t, 3H, 7.0 Hz, H-14), 1.37 (m, 4H, H-12-H-13), 
1.44 (m, 2H, H-6), 1.61 -1.70 (m, 6H, H-7-H-8 and H-11), 2.63 (t, 2H, 7.0 Hz, H-
5), 3.45 (m, 4H, H-9 and H-10), 5.95 (m, 1H, H-3), 6.16 (m, 1H, H-2), 6.67 (m,
1H, H-1), 8.09 (br s, 1H)
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13C-NMR (CDCl3, 100MHz) δ: 14.11 (C-14), 22.61, 25.93, 27.63, 28.43, 29.49, 
29.52, 29.56 (C-5-C-8 and C-11-C-13), 70.82 (C-10), 71.08 (C-9), 104.92 (C-3),
108.18 (C-2), 116.09 (C-1), 132.67 (C-4).
IR (νmax/cm-1): 3391, 2932, 2832, 1741
HRMS: m/z calculated for C14H25NO: 224.2009 [M+H]+. Found: 224.2013
2-Octyl-1H-pyrrole 85
H
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Product was purified by flash column chromatography (silica, 5% ethyl acetate in
hexane) to leave a low melting point white solid.
Yield: 0.820 g, 75 %
1H-NMR (CDCl3, 400MHz) δ: 0.95 (t, 3H, 7.0 Hz, H-12), 1.30 – 1.47 (m, 10H, H-
7-H-11), 1.72 (quintet, 2H, 7.5 Hz, H-6), 2.64 (t, 2H, 7.5 Hz, H-5), 5.93 (m, 1H,
H-3), 6.22 (m, 1H, H-2), 6.71 (m, 1H, H-1) 7.85 (br s, 1H)
13C-NMR (CDCl3, 100MHz) δ: 13.12 (C-12), 22.75, 29.34, 29.49, 29.50, 29.63, 
29.76, 31.96 (C-5-C-11), 104.89 (C3), 108.26 (C-2), 116.03 (C-1), 132.96 (C-4).
IR (νmax/cm-1): 3378, 2922, 2852
m.p.: 25 - 26 °C
HRMS: m/z calculated for C12H21N: 180.1747 [M+H]+. Found: 180.1744
2-Octadecyl-1H-pyrrole 88
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Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
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Yield: 0.665 g (91 %)
1H-NMR (CDCl3, 400MHz) δ: 0.89 (t, 3H, 7.0 Hz, H-22), 1.25 – 1.40 (m, 30H, H-
7-H-21), 1.60 (quintet, 2H, 7.0 Hz, H-6), 2.56 (t, 2H, 7.0 Hz, H-5), 5.83 (m, 1H,
H-3), 6.12 (m, 1H, H-2), 6.61 (m, 1H, H-1), 7.82 (br s, 1H).
13C-NMR (CDCl3, 100MHz) δ: 14.27 (C-22), 22.82, 27.86, 29.50, 29.53, 29.59, 
29.72, 29.80, 29.81, 29.83 (7 carbon missing due to overlapping signals, C-6-C-
21), 32.06 (C-5), 104.92 (C-3), 105.14 (C-2), 116.56 (C-1), 132.96 (C-4)
IR (νmax/cm-1): 3348, 2955, 2913, 2846
m.p.: 71 – 71 °C
HRMS: m/z calculated for C22H41N: 320.3312 [M+H]+. Found: 320.3316
2-(10-Methyl-undecyl)-1H-pyrrole 99
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Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a colourless oil.
Yield: 0.086 g (91 %)
1H-NMR (CDCl3, 400MHz) δ: 0.86 (d, 6H, 7.0 Hz, H-15, H-16), 1.15 (m, 2H, H-
13), 1.25 (m, 10H, H-7-H-12), 1.51 (doublet of quartets, 1H, 6.0 Hz, 7.0 Hz, H-
14), 1.54 (quintet, 2H, 6.5 Hz, H-6), 2.56 (t, 2H, 6.5 Hz, H-5), 5.86 (m, 1H, H-3),
6.13 (m, 1H, H-2), 6.69 (m, 1H, H-1)
13C-NMR (CDCl3, 100MHz) δ: 23.32 (2C, C-15 and C-16), 25.41, 28.98, 30.09, 
30.19, 30.27, 30.35, 30.41 and 30.59 (C5-C-12), 27.96 (C14), 39.57 (C-13),
104.87 (C-3), 108.99 (C-2), 115.55 (C-1), 132.72 (C-4)
IR (νmax/cm-1): 3365, 2984, 2945, 2819
HRMS: m/z calculated for C16H29N: 236.2373 [M+H]+. Found: 236.2375
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2-(9-Methyl-undecyl)-1H-pyrrole 98
1
2 3
4
H
N
5
6
7
8
9
10
11
12
13
14
16
15
Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a colourless oil.
Yield: 0.084 g (90 %)
1H-NMR (CDCl3, 400MHz) δ: 0.84 – 0.85 (overlapping 2 x m, 6H, H-15 and H-
16), 1.09 (m, 2H, H-14), 1.27 (m, 11H, H-8-H-13), 1.61 (quintet, 2H, 7.0 Hz, H-
6), 2.56 (t, 2H, 7.0 Hz, H-5), 5.86 (m, 1H, H-3), 6.04 (m, 1H, H-2), 6.67 (m, 1H,
H-1).
13C-NMR (CDCl3, 100MHz) δ: 11.32 (C-15 or C-16), 19.13 (C15 or C-16), 25.36, 
26.98, 28.13, 29.42, 29.44 and 29.78 (2 signal missing due to overlapping, C-5-
C-12), 34.30 (C-13), 36.53 (C-14),104.25 (C-3), 108.31 (C-2), 115.98 (C-1),
132.11 (C-4)
IR (νmax/cm-1): 3395, 2995, 2951, 2819
HRMS: m/z calculated for C16H29N: 236.2373 [M+H]+. Found: 236.2371
R-(4-D1)-2-Undecyl-1H-pyrrole 145
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Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
Yield: 0.070 g (78 %)
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1H-NMR (CDCl3, 400MHz) δ: 0.82 (t, 3H, 7.5 Hz, H-15), 1.22 (m, 15H, H-7-H-14), 
1.56 (quintet, 2H, H-6, 7.0 Hz), 2.53 (t, 2H, 7.0 Hz, H-5), 5.81 (m, 1H, H-3), 6.03
(m, 1H, H-2), 6.63 (m, 1H, H-1)
13C-NMR (CDCl3, 100MHz) δ: 14.51 (C-15), 22.41, 27.84, 29.38, 29.51, 29.62, 
29.68, 29.72 and 31.84 (1 signal missing due to overlap, C-5-C-7 and C-9-C-
14), 29.43 (3 signals, C-8) 104.87 (C-3), 108.31 (C-2), 115.91 (C-1), 132.92 (C-
4).
IR (νmax/cm-1): 3351, 2914, 2831
m.p.: 44 – 45 °C
HRMS: m/z calculated for C15H26DN: 223.2279 [M+H]+. Found: 223.2280
S-(4-D1)-2-Undecyl-1H-pyrrole 145
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Product was purified by flash column chromatography (silica, 10% ethyl acetate
in hexane) to leave a white solid.
Yield: 0.088 g (95 %)
1H-NMR (CDCl3, 400MHz) δ: 0.81 (t, 3H, 7.5 Hz, H-15), 1.22 (m, 15H, H-7-H-14), 
1.56 (quintet, 2H, H-6, 7.0 Hz), 2.53 (t, 2H, 7.0 Hz, H-5), 5.82 (m, 1H, H-3), 6.03
(m, 1H, H-2), 6.63 (m, 1H, H-1)
13C-NMR (CDCl3, 100MHz) δ: 14.61 (C-15), 22.84, 27.98, 29.37, 29.49, 29.61, 
29.69, 29.72 and 31.87 (1 signal missing due to overlap, C-5-C-7 and C-9-C-
14), 29.44 (3 signals, C-8) 104.87 (C-3), 108.21 (C-2), 115.84 (C-1), 132.96 (C-
4).
IR (νmax/cm-1): 3349, 2916, 2834
HRMS: m/z calculated for C15H26DN: 223.2279 [M+H]+. Found: 223.2280
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S-5-Oxo-tetrahydro-furan-2-carboxylic acid 147108
O
OH
O
HO 1
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A solution of NaNO2 (31.57 g, 457.5 mmol, 1.5 equiv) in water (70 ml) was
added dropwise over approximately 6 hours to a vigorously stirred mixture of L-
glutamic acid (44.87 g, 305.0 mmol, 1.0 equiv) in water (120 ml) and HCl.
(conc., 65 ml) at 0-5 °C. The resulting pale yellow solution was left to stir
overnight at room temperature. Evaporation of solvent under reduced pressure
left a pale yellow oil together with white solid. Ethyl acetate (150 ml) was added
and the insoluble material was removed by vacuum filtration. The organic filtrate
was then dried over magnesium sulphate and evaporated to leave a pale yellow
oil which partially crystallised under vacuum. The resulting sticky solid was
triturated with chloroform twice to leave the desired product as a crude white
solid. Purification by vacuum distillation (b.p. 158 °C, 0.5 mmHg) gave the
desired product as a pure white solid.
Yield: 13.28 g (53 %)
1H-NMR (CDCl3, 400MHz) δ: 2.41 (m, 1H, H-3a), 2.65 (m, 3H, H-4 and H-3b), 
5.03 (m, 1H, H-2), 10.15 (br s, 1H, -COOH)
13C-NMR (DMSO-d6, 100MHz) δ: 25.33 (C-3), 26.67 (C-4), 75.35 (C-2), 171.56 
(C-5), 176.73 (C-1).
IR (νmax/cm-1): 1711, 1778, 2939, 2975, 3034
m.p.: 65 – 68 °C [lit. 71 – 73 °C]108
[α]D
25: +14.9 (c = 1.0, EtOH) [lit. +15.6 (c = 2.0, EtOH)]108
HRMS: m/z calculated for C5H6O4: 153.0158 [M+Na]+. Found: 153.0159
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S-5-Hydroxymethyl-dihydro-furan-2-one 148108
O
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In a 3-neck flask fitted with a reflux condenser borane methyl sulphide (10 M,
11.7 ml, 116.3 mmol, 1.15 equiv) was added dropwise over 1 hour at room
temperature to a stirred solution of S-5-Oxo-tetrahydro-furan-2-carboxylic acid
(13.14g, 101.03 mmol, 1.00 equiv) in THF (70 ml) under argon. The reaction
was then stirred for a further 3 hours before quenching by the cautious addition
of methanol (60 ml). The solvent was then removed by distillation at atmospheric
pressure and the resulting residue was distilled under vacuum to give the
desired product as a colourless oil (134 – 135 °C, 1.0 mmHg).
Yield: 8.13 g (69 %)
1H-NMR (CDCl3, 400MHz) δ: 2.21 (m, 2H, H-3), 2.60 (m, 2H, H-4), 3.02 (br s, 
1H, -OH), 3.65 (m, 1H, H-1a), 3.92 (m, 1H, H-1b), 4.66 (m, 1H, H-2)
13C-NMR (CDCl3, 100MHz) δ: 23.16 (C-3), 28.71 (C-4), 64.08 (C-1), 80.71 (C-2), 
177.89 (C-5).
IR (νmax/cm-1): 3404 (broad), 2937, 3873, 1752.
[α]D
25: +28.3 (c = 1.0, EtOH) [lit. +29.6 (c = 0.4, EtOH)]108
HRMS: m/z calculated for C5H8O3: 117.0546 [M+H]+. Found: 117.0549
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S-Toluene-4-sulfonic acid 5-oxo-tetrahydro-furan-2-ylmethyl ester 14998
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To S-5-Hydroxymethyl-dihydro-furan-2-one (7.87g, 67.77 mmol, 1.0 equiv) in
chloroform (70 ml) at 0 °C was added pyridine (10.91 ml, 135.54 mmol, 2.0
equiv). To the resulting mixture was added p-toluenesulfonyl chloride (19.38 g,
101.66, 1.5 equiv) in small portions. The reaction was stirred for 7 hours (until
complete by TLC), and was then quenched by the dropwise addition of water
(60 ml) and the resulting cloudy solution was stirred for 30 minutes. The reaction
was then diluted with DCM (50 ml), and the organic layer was separated and
washed successively with HCl (aq. 0.5 N, 50 ml), water (50 ml), NaHCO3 (sat.
50 ml) and water (50 ml). The organic layer was then dried over magnesium
sulphate and the solvent evaporated in vacuo. The resulting solid was
recrystallised from ethanol to yield the desired product as a white solid.
Yield: 15.60 (86 %)
1H-NMR (CDCl3, 400MHz) δ: 2.15 (m, 1H, H-3a), 2.36 (m, 1H, H-3b), 2.41 (s, 
3H, H-10), 2.51 (m, 2H, H-2), 4.16 (dd, 1H, 11.0 Hz, 3.5 Hz, H-5a), 4.20 (dd, 1H,
11.0 Hz, 3.5 Hz, H-5b), 4.69 (m, 1H, H-4), 7.38 (d, 2H, 8.0 Hz, H-8), 7.80 (d, 2H,
8.0 Hz, H-9)
13C-NMR (CDCl3, 100MHz) δ: 21.68 (C-10), 23.46 (C-3), 27.92 (C-2), 70.11 (C-
5), 76.52 (C-4), 127.94 (C-7), 130.10 (C-8), 132.17 (C-6), 145.48 (C-9), 176.22
(C-1)
IR (νmax/cm-1): 1419, 1597, 1767, 2961
[α]D
25: +46.5 (c = 1.0, CHCl3) [lit. +46.2 (c = 1.63, CHCl3)]98
m.p.: 82 - 83 °C [lit. 84 – 85 °C]98
HRMS: m/z calculated for C12H14O5S: 271.0635 [M+H]+. Found: 271.0637
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S-3-Oxiranyl-propionic acid methyl ester 150109
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S-Toluene-4-sulfonic acid 5-oxo-tetrahydro-furan-2-ylmethyl ester (13.92 g,
51.50 mmol, 1.0 equiv) was added to a solution prepared by dissolving sodium
(1.20 g, 54.07 mmol, 1.01 equiv) in anhydrous methanol (125 ml). The mixture
was left for 2 hours (until complete by TLC). The solvent was then removed from
the reaction in vacuo and the resulting residue was partitioned between water
(75 ml) and diethyl ether (75 ml). The aqueous layer was then further extracted
with diethyl ether (2 x 50 ml), and the combined organic fractions were then
washed with brine (2 x 40 ml), dried over magnesium sulphate and the solvent
removed in vacuo to leave the desired product as a volatile colourless oil.
Yield: 4.88 g (76 %)
1H-NMR (CDCl3, 400MHz) δ: 1.78 (m, 1H, H-3a), 1.97 (m, 1H, H-3b), 2.47 (t, 2H, 
7.5 Hz, H-4), 2.51 (m, 1H, H-1a), 2.77 (t, 1H, 4.5 Hz, H-1b), 2.98 (m, 1H, H-2),
3.69 (s, 3H, H-6)
13C-NMR (CDCl3, 100MHz) δ: 27.51 (C-3), 30.13 (C-4), 46.83 (C-1), 51.02 (C-2), 
51.51 (C-6), 173.11 (C-5)
IR (νmax/cm-1): 1437, 1732, 2929, 2954, 2995
[α]D
25: -23.3 (c = 1.0, CHCl3) [lit. -18.0 (c = 1.1, CHCl3)]109
HRMS: m/z calculated for C6H10O3: 131.0703 [M+H]+. Found 131.0702
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R-5-Heptyl-dihydro-furan-2-one 15197, 98
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To a slowed stirred slurry of copper(I) cyanide (3.01 g, 33.64 mmol, 1.0 equiv) in
THF (35 ml) at -78 °C was added hexyl lithium (2.3 M in hexanes, 29.25 ml,
67.28 mmol, 2.0 equiv). The heterogeneous mixture was then allowed to
gradually warm until complete dissolution (-10 °C). The resulting mixture was
added dropwise to a solution of S-Toluene-4-sulfonic acid 5-oxo-tetrahydro-
furan-2-ylmethyl ester (4.37 g, 33.64 mmol, 1.0 equiv) in THF (50 ml) at -78 °C
over approximately 45 minutes. The reaction was monitored by TLC. On
completion, the reaction was quenched with 10% NH4OH/sat. NH4Cl (aq., 50ml),
and diluted with diethyl ether (50 ml). The aqueous layer was then extracted with
diethyl ether (2 x 50 ml). The combined organic fractions were washed with
water (50 ml), brine (50 ml), dried over magnesium sulphate and the solvent
removed in vacuo to leave the desired product as a colourless oil, which was
purified by flash column chromatography on silica (40% diethyl ether/petroleum
ether).
Yield: 5.83 g (94 %)
1H-NMR (CDCl3, 400MHz) δ: 0.88 (t, 3H, 7.0 Hz, H-1), 1.29 -1.44 (m, 10H,  
H-2-H-6), 1.58 (m, 1H, H-7a), 1.73 (m, 1H, H-7b), 1.85 (m, 1H, H-9a), 2.32 (dt,
1H, 19.0 Hz, 8.0 Hz, H-9b), 2.53 (t, 2H, 8.0 Hz, H-10), 4.48 (quintet, 1H, 7.0 Hz,
H-8).
13C-NMR (CDCl3, 100MHz) δ: 14.15 (C-1), 22.69, 25.31, 28.09, 28.95, 29.20, 
29.37, and 31.80 (C-2-C-6 and C-9-C-10), 35.67 (C-7), 81.15 (C-8), 177.39 (C-
11).
IR (νmax/cm-1): 1459, 1771, 2855, 2924
[α]D
25: + 47.6 (c = 1.0, CHCl3) [lit. +45.3 (c = 1.5 - 2.5, MeOH)]97
212
HRMS: m/z calculated for C11H20O2: 185.1536 [M+H]+. Found 185.1533
R-4-Hydroxy-undecanoic acid dimethylamide 159
1
2
3
4
5
6
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Ha Hb
To a stirred suspension of dimethylamine hydrochloride (1.17 g, 14.34 mmol, 2.0
equiv) in DCM (30 ml) at 0 °C was added trimethyl aluminium (2.0 M in hexanes,
7.46 ml, 14.92 mmol, 2.08 equiv). The resulting mixture was stirred for
approximately 2 hours to result in a clear colourless solution. This solution was
then added in a dropwise manner to a solution of R-5-Heptyl-dihydro-furan-2-
one (1.32 g, 7.17 mmol, 1.0 equiv) in DCM (30 ml) at room temperature. The
reaction mixture was left overnight at room temperature after which the reaction
was judged to have reach completion by TLC and was quenched by the
cautious dropwise addition of HCl (aq., 1 N, 20ml) at 0 °C. The organic layer
was separated and the aqueous layer further extracted with DCM (3 x 30 ml).
The combined organic fractions were dried over magnesium sulphate and
evaporated in vacuo to leave the desired compound as a yellow oil. The product
was purified by passage through a small plug of silica eluted with diethyl ether to
yield a pale yellow oil.
Yield: 1.32 g (80 %)
1H-NMR (CDCl3, 400MHz) δ: 0.86 (t, 3H, 7.0 Hz, H-1), 1.26 (m, 10H, H-2-H-6), 
1.43 (m, 2H, H-7), 1.72 (m, 1H, H-9a), 1.83 (m, 1H, H-9b), 2.50 (m, 2H, H-10),
2.71 (br s, 1H, -OH), 2.95 (s, 3H, H-12), 3.0 (s, 3H, H-13), 3.60 (m, 1H, H-8)
13C-NMR (CDCl3, 100MHz) δ: 14.50 (C-1), 23.06, 26.17, 29.72, 30.12, 30.53, 
32.25 and 32.32 (C-9, C-10 and C-2-C-6), 35.97 (C13), 37.79 (C12), 38.25 (C-
7), 71.83 (C-8), 174.31 (C-11)
[α]D
25: + 4.0 (c = 1.0, CHCl3)
HRMS: m/z calculated for C13H27NO2: 230.2115 [M+H]+. Found: 230.2117
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S-5-Heptyl-dihydro-furan-2-one 151
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To R-4-Hydroxy-undecanoic acid dimethylamide (0.354 g, 1.54 mmol, 1.0 equiv)
in chloroform (2.0 ml) was added pyridine (0.25 ml, 3.08 mmol, 2.0 equiv) at 0
°C. p-toluenesulfonyl chloride (0.441 g, 2.31 mmol, 1.5 equiv) was then added in
portions to the solution still held at 0 °C. The mixture was then allowed to warm
to room temperature overnight. After quenching with the addition of HCl (aq., 2
N, 10 ml) the chloroform was removed in vacuo and the resulting aqueous
residue was extracted with diethyl ether (3 x 15 ml) to remove the tosylated
amine by-product otherwise inseparable from the desired product. The aqueous
layer was then basified to hydrolyse the intermediate imine to the desired
lactone. After re-acidification with HCl (conc.), the aqueous layer was extracted
with diethyl ether (3 x 15 ml). The combined organic fractions were then dried
over magnesium sulphate and evaporated in vacuo to leave the desired lactone
as a pale yellow oil. The crude oil was purified by flash column chromatography
(silica, 30% diethyl ether/petroleum ether).
Yield: 0.229 g (81 %)
1H-NMR (CDCl3, 400MHz) δ: 0.88 (t, 3H, 7.0 Hz, H-1), 1.29 -1.44 (m, 10H,  
H-2-H-6), 1.58 (m, 1H, H-7a), 1.73 (m, 1H, H-7b), 1.85 (m, 1H, H-9a), 2.32 (dt,
1H, 19.0 Hz, 8.0 Hz, H-9b), 2.53 (t, 2H, 8.0 Hz, H-10), 4.48 (quintet, 1H, 7.0 Hz,
H-8).
13C-NMR (CDCl3, 100MHz) δ: 14.15 (C-1), 22.54, 25.56, 28.12, 28.96, 29.21, 
29.37, and 31.80 (C-2-C-6 and C-9-C-10), 35.68 (C-7), 81.15 (C-8), 177.40 (C-
11).
IR (νmax/cm-1): 1459, 1771, 2855, 2924
[α]D
25: - 47.4 (c = 1.0, CHCl3)
214
HRMS: m/z calculated for C11H20O2: 185.1536 [M+H]+. Found: 185.1532
S-4-Iodo-undecanoic acid methyl ester 164
To a stirred solution of R-5-Heptyl-dihydro-furan-2-one (0.815 g, 4.43 mmol, 1.0
equiv) under argon in DCM (15 ml) that was protected from light was added
iodotrimethylsilane (2.4 ml, 17.72 mmol, 4.0 equiv) dropwise. The resulting pale
yellow solution was left to stir at room temperature until the lactone ring-opening
was complete as judged by 1H-NMR. Upon completion anhydrous methanol
(0.90 ml, 22.15 mmol, 5.0 equiv) was added. The reaction was monitored by
1H-NMR until complete ester formation (as judged by comparison of integral
values of signals corresponding to H-8 and H-12). The reaction was then diluted
with DCM (10 ml) and Na2S2O3 (10 %, 30 ml) added. The aqueous layer was
then extracted with diethyl ether (2 x 20 ml) and all organic fractions were
combined, dried over magnesium sulphate and evaporated in vacuo. The
residual pale yellow oil was purified by flash column chromatography (silica, 1 %
diethyl ether/petroleum ether) to leave the desired compound as a colourless oil.
Yield: 1.38 g (96 %)
1H-NMR (CDCl3, 400MHz) δ: 0.81 (t, 3H, H-1), 1.22 (m, 8H, H-2-H-5), 1.35 (m, 
1H, H-6a), 1.45 (m, 1H, H-6b), 1.65 (m, 1H, H-7a), 1.81 (m, 1H, H-7b), 2.00 (q,
2H, 8.0 Hz, H-9), 2.46 (m, 2H, H-10), 3.61 (s, 3H, H-12), 4.05 (m, 1H, H-8)
13C-NMR (CDCl3, 100MHz) δ: 13.99 (C-1), 22.53, 28.65, 29.01, 29.36 and 31.67 
(C2-C-6), 34.06 (C-10), 35.35 (C-9), 38.18 (C-8), 40.64 (C-7), 51.57 (C-12),
172.95 (C-11)
IR (νmax/cm-1): 2953, 2854, 1755, 1095, 586
[α]D
25: - 3.52 (c = 1.0, CHCl3)
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HRMS: m/z calculated for C12H23IO2: 327.0815 [M+H]+. Found: 327.0818
R-4-Iodo-undecanoic acid methyl ester 164
Method as for S-4-Iodo-undecanoic acid methyl ester above.
Yield: 1.26 g (92 %)
1H-NMR (CDCl3, 400MHz) δ: 0.81 (t, 3H, H-1), 1.22 (m, 8H, H-2-H-5), 1.35 (m, 
1H, H-6a), 1.45 (m, 1H, H-6b), 1.65 (m, 1H, H-7a), 1.81 (m, 1H, H-7b), 2.00 (q,
2H, 8.0 Hz, H-9), 2.46 (m, 2H, H-10), 3.61 (s, 3H, H-12), 4.05 (m, 1H, H-8)
13C-NMR (CDCl3, 100MHz) δ: 13.99 (C-1), 22.53, 28.65, 29.01, 29.36 and 31.67 
(C2-C-6), 34.06 (C-10), 35.35 (C-9), 38.18 (C-8), 40.64 (C-7), 51.57 (C-12),
172.95 (C-11)
IR (νmax/cm-1): 2952, 2858, 1761, 1111, 582
[α]D
25: + 3.50 (c = 1.0, CHCl3)
HRMS: m/z calculated for C12H23IO2: 327.0815 [M+H]+. Found: 327.0812
R-4-D1-Undecanoic acid methyl ester 165
To a solution of S-4-Iodo-undecanoic acid methyl ester (1.38 g, 4.23 mmol, 1.0
equiv) in dimethylsulphoxide (20 ml) was added sodium borodeuteride (0.355 g,
8.46 mmol, 2.0 equiv). The resulting suspension was heated to 85 °C for 4
hours (complete by TLC). The reaction was quenched by the addition of HCl
(aq., 2 N, 20 ml) after which the mixture was diluted with water (30 ml) and
extracted with petroleum ether (3 x 40 ml). The combined organic fractions were
dried over magnesium sulphate and evaporated in vacuo to leave the desired
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compound as a pale pink oil. The product was purified by flash column
chromatography (silica, 2 % diethyl ether/petroleum ether) to leave the desired
compound as a colourless oil.
Yield: 0.733 g (86 %)
1H-NMR (CDCl3, 400MHz) δ: 0.85 (t, 3H, H-1), 1.23 (m, 13H, H-2-H-8), 1.58 (m, 
2H, H-9), 2.27 (t, 2H, 7.5 Hz, H-10), 3.63 (s, 3H, H-12).
13C-NMR (CDCl3, 100MHz) δ: 14.63 (C-1), 25.42 (C-9), 29.30 (3 signals, C-8), 
23.23, 29.72, 29.86, 29.98, 30.10 and 32.44 (C-2-C-7), 34.63 (C-10), 51.92 (C-
12), 174.84 (C-11).
IR (νmax/cm-1): 3012, 2963, 2878, 1743
HRMS: m/z calculated for C12H23DO2: 202.1912 [M+H]+. Found: 202.1916
S-4-D1-Undecanoic acid methyl ester 165
Method as for R-4-D1-Undecanoic acid methyl ester above.
Yield: 0.453 g (93 %)
1H-NMR (CDCl3, 400MHz) δ: 0.85 (t, 3H, H-1), 1.23 (m, 13H, H-2-H-8), 1.58 (m, 
2H, H-9), 2.27 (t, 2H, 7.5 Hz, H-10), 3.63 (s, 3H, H-12).
13C-NMR (CDCl3, 100MHz) δ: 14.61 (C-1), 25.84 (C-9), 29.32 (3 signals, C-8), 
23.41, 29.77, 29.81, 29.94, 30.20 and 32.51 (C-2-C-7), 34.41 (C-10), 51.98 (C-
12), 174.89 (C-11).
IR (νmax/cm-1): 3012, 2963, 2878, 1742
HRMS: m/z calculated for C12H23DO2: 202.1912 [M+H]+. Found: 202.1914
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R-4-D1-Undecanoic acid 152
To a solution of R-4-D1-Undecanoic acid methyl ester (0.668 g, 3.33 mmol) in
THF (50 ml) was added NaOH (aq, 2N, 50 ml) and the resulting immiscible
liquids stirred vigorously under reflux (75 °C) overnight. The aqueous layer was
then separated and acidified (HCl. aq, 10 N). The acidified aqueous layer was
then extracted with diethyl ether (3 x 50 ml), and the combined organic extracts
were washed with brine (40 ml), dried over magnesium sulphate and evaporated
in vacuo leave the desired compound as a white solid.
Yield: 0.558 g (90 %)
1H-NMR (CDCl3, 400MHz) δ: 0.85 (t, 3H, H-1), 1.23 (m, 13H, H-2-H-8), 1.58 (m, 
2H, H-9), 2.37 (t, 2H, 7.5 Hz, H-10).
13C-NMR (CDCl3, 100MHz) δ: 14.08 (C-1), 24.58 (C-9), 28.66 (3 signals, C-8), 
22.68, 29.15, 29.31, 29.42, 29.56 and 31.90 (C-2-C-8), 34.13 (C-10), 180.68 (C-
11)
IR (νmax/cm-1): 3005, 2963, 1705
m.p.: 28 – 31 °C [undecanoic acid lit. 28.5 °C]
HRMS: m/z calculated for C11H21DO2: 188.1755 [M+H]+. Found: 188.1756
S-4-D1-Undecanoic acid 152
Method as for R-4-D1-Undecanoic acid above.
Yield: 0.318 g (75 %)
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1H-NMR (CDCl3, 400MHz) δ: 0.85 (t, 3H, H-1), 1.23 (m, 13H, H-2-H-8), 1.58 (m, 
2H, H-9), 2.37 (t, 2H, 7.5 Hz, H-10).
13C-NMR (CDCl3, 100MHz) δ: 14.12 (C-1), 24.56 (C-9), 28.65 (3 signals, C-8), 
22.63, 29.18, 29.33, 29.48, 29.55 and 31.95 (C-2-C-8), 34.18 (C-10), 180.67 (C-
11)
IR (νmax/cm-1): 2998, 2965, 1707
m.p.: 29 – 31 °C [undecanoic acid lit. 28.5 °C]
HRMS: m/z calculated for C11H21DO2: 188.1755 [M+H]+. Found: 188.1757
General procedure for acid catalysed coupling of bicyclic and monocyclic
compounds
To a suspension of the corresponding bicyclic aldehyde (0.25 mmol, 1.0 equiv)
and corresponding substituted pyrrole (0.30 mmol, 1.2 equiv) in methanol (5 ml)
was added methanolic HCl (2 N, 100 μl). The resulting brightly coloured solution 
was stirred for 3 hours at room temperature. The solvent was then removed in
vacuo and the resulting solid dissolved in ethyl acetate (20 ml), and washed with
saturated aqueous sodium bicarbonate (2 x 25 ml) and brine (30 ml). Resulting
organic layer was dried over magnesium sulphate and the solvent removed in
vacuo to leave a brightly coloured crude solid, which was purified by flash
column chromatography.
Undecylprodiginine
Crude residue was not washed with sodium carbonate prior to purification.
Residue was purified using flash column chromatography over silica gel with
gradient elution of 0-70% diethyl ether/petroleum ether.
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51 mg (52 %)
1H-NMR (CDCl3) δ: 0.80 (t, 3H, 7.0 Hz, H-24), 1.20 (m, 18H, H-15-H-23), 2.10 
(m, 2H, H-14), 3.90 (s, 3H, H-25), 5.75 (d, 1H, 3.5 Hz, H-11), 5.95 (s, 1H, H-6),
6.05 (t, 1H, 3.5 Hz, H-3), 6.40 (d, 1H, 3.5 Hz, H-12), 6.55 (d, 1H, 3.5 Hz, H-4),
6.60 (d, 1H, 4.0 Hz, H-2), 6.75 (s, 1H, H-9)
13C-NMR (CDCl3, 100MHz) δ: 14.28, 22.85, 27.49, 29.34, 29.53, 29.54, 29.74, 
29.78, 29.83, 29.89, 32.09, 58.51, 95.80, 108.71, 110.19, 112.88, 116.14,
121.07, 122.98, 128.48, 128.54, 138.83, 144.62, 160.22, 169.16.
IR (νmax/cm-1): 3267, 3102, 2919, 2849, 1613, 1575, 1561, 1547
m.p.: 86-87 °C
HRMS: m/z calculated for C25H35N3O: 394.2853 [M+H]+. Found: 394.2855
Pyrrolyl-2,4-dimethylprodiginine
Crude residue was not washed with sodium carbonate prior to purification.
Crude residue purified using flash column chromatography over silica gel with
gradient elution of 0-70% ethyl acetate/hexane. Compound appears as two
rotational conformers on 1H-NMR timescale. Peaks unresolved at 298 K.
41 mg (62 %)
Conformer 1: 1H-NMR (CDCl3 at 233 K, 500MHz) δ: 1.50 (s, 3H, H-14), 2.05 (s, 
3H, H-15), 3.90 (s, 3H, H-16), 5.55 (s, 1H, H-12), 6.00 (d, 1H, 3.0 Hz, H-2), 6.10
(s, 1H, H-6), 6.50 (d, 1H, 3.0 Hz, H-4), 6.55 (t, 1H, 3.0 Hz, H-3), 6.80 (s, 1H, H-
9), 11.16 (s, 1H, NH), 12.30 (s, 1H, NH).
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Conformer 2: 1H-NMR (CDCl3 at 233 K, 500MHz) δ: 2.20 (s, 3H, H-14), 2.50 (s,
3H, H-15), 3.95 (s, 3H, H-16), 5.95 (d, 1H, 3.5 Hz, H-2), 6.05 (s, 1H, H-12), 6.30
(d, 1H, 3.5 Hz, H-4), 6.85 (t, 1H, 3.5 Hz, H-3), 6.90 (s, 1H, H-6), 7.15 (s, 1H, H-
9), 12.25 (s, 1H, NH), 12.45 (s, 1H, NH)
IR (νmax/cm-1): 3215, 2936, 2856, 1645, 1598, 1564
HRMS: m/z calculated for C16H17N3O: 268.1444 [M+H]+. Found: 268.1449
Indolyl undecylprodiginine analogue
Crude residue purified using flash column chromatography over silica gel with
gradient elution of 0-20 % diethyl ether/petroleum ether.
16 mg (18 %)
1H-NMR (CDCl3, 400MHz) δ: 0.80 (t, 3H, 7.0 Hz, H-28), 1.20 (m, 16H, H-27-H-
20), 1.60 (m, 2H, H-19), 2.60 (t, 2H, 7.5 Hz, H-18), 3.80 (s, 3H, H-29), 5.75 (s,
1H, H-10), 5.95 (d, 1H, 3.5 Hz, H-15), 6.50 (d, 1H, 3.5 Hz, H-16), 6.85 (s, 1H, H-
8), 6.90 (s, 1H, H-13), 7.15 (t, 1H, 6.5 Hz, H-4), 7.25 (t, 1H, 7.5 Hz, H-5), 7.50
(d, 1H, 7.5 Hz, H-6), 8.05 (d, 1H, 7.5 Hz, H-3)
13C-NMR (CDCl3, 100MHz) δ: 14.12, 28.41, 28.93, 29.34, 29.36, 29.41, 29.54, 
29.60, 29.64, 31.90, 58.27, 83.78, 97.91, 109.47, 111.53, 114.68, 118.75,
121.15, 121.54, 122.95, 125.19, 128.93, 129.70, 136.59, 138.26, 150.34,
159.57, 166.85.
IR (νmax/cm-1): 3250, 3118, 2923, 2852, 1732, 1623, 1571, 1547
m.p.: 58-59 °C
HRMS: m/z calculated for C29H37N3O: 444.3009 [M+H]+. Found: 444.3008
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Indolyl-2,4-dimethylprodiginine
Crude residue purified using flash column chromatography over silica gel with
gradient elution of 0-20% ethyl acetate/hexane.
43 mg (50 %)
1H-NMR (CDCl3, 400MHz) δ: 1.65 (s, 3H, H-18), 2.05 (s, 3H, H-19), 4.00 (s, 3H, 
H-20), 5.60 (s, 1H, H-16), 6.30 (s, 1H, H-10), 6.65 (d, 1H, 6.0 Hz, H-6), 6.80 (s,
1H, H-8), 6.85 (t, 1H, 6.0 Hz, H-4), 6.90 (t, 1H, 6.0 Hz, H-5), 7.00 (s, 1H, H-13),
7.40 (d, 1H, 6.0 Hz, H-3)
IR (νmax/cm-1): 3242, 2945, 1735, 1635, 1575, 1542
HRMS: m/z calculated for C20H19N3O: 318.1601 [M+H]+. Found: 318.1606
Thiophenylundecylprodiginine analogue
Crude residue purified using flash column chromatography over silica gel with
gradient elution of 0-30% diethyl ether/petroleum ether.
54 mg (52 %)
1H-NMR (CDCl3, 400MHz) δ: 0.80 (t, 3H, 7.0 Hz, H-24), 1.20 (m, 16H, H16-H-
23), 1.70 (m, 2H, H-15), 2.70 (t, 2H, 7.0 Hz, H-14), 3.80 (s, 3H, H-25), 5.85 (s,
1H, H-6), 5.95 (d, 1H, 3.5 Hz, H-11), 6.50 (d, 1H, 3.5 Hz, H-12), 6.75 (s, 1H, H-
9), 7.05 (dd, 1H, 4.0, 3.0 Hz, H-3), 7.30 (d, 1H, 4.0 Hz, H-4), 7.40 (d, 1H, 3.0 Hz,
H-2).
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13C-NMR (CDCl3, 100MHz) δ: 14.27, 22.83, 28.55, 28.94, 29.50, 29.59, 29.65, 
29.78, 29.83, 29.87, 32.06, 58.46, 94.81, 109.50, 117.72, 120.37, 127.02,
127.89, 128.05, 130.04, 140.81, 141.15, 143.38, 160.14, 168.41.
IR (νmax/cm-1): 3254, 2917, 2848, 1603, 1542
m.p.: 87-88 °C
HRMS: m/z calculated for C25H34N2OS: 411.2465 [M+H]+. Found: 411.2464
Thiophenyl-2,4-dimethylprodiginine
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Crude residue purified using flash column chromatography over silica gel with
gradient elution of 0-30% diethyl ether/petroleum ether.
37 mg (52 %)
1H-NMR (CDCl3, 400MHz) δ: 2.05 (s, 3H, H-14), 2.30 (s, 3H, H-15), 3.85 (s, 3H, 
H-16), 5.80 (s, 1H, H-12), 5.90 (s, 1H, H-6), 6.80 (s, 1H, H-9), 7.00 (t, 1H, 4.0
Hz, H-3), 7.30 (d, 1H, 4.0 Hz, H-2), 7.40 (d, 1H, 4.0 Hz, H-4).
IR (νmax/cm-1): 3231, 2951, 2865, 1689, 1515
HRMS: m/z calculated for C16H16N2OS: 285.1056 [M+H]+. Found: 285.1056
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Furanyl undecylprodiginine analogue
Crude residue purified using flash column chromatography over silica gel with
gradient elution of 0-30% diethyl ether/petroleum ether.
15 mg (15 %)
1H-NMR (CDCl3, 400MHz) δ: 0.80 (t, 3H, 7.0 Hz, H-24), 1.20 (m, 16H, H-16-H-
23), 1.70 (m, 2H, H-15), 2.65 (t, 2H, 7.0 Hz, H-14), 3.80 (s, 3H, H-25), 5.90 (d,
1H, 3.5 Hz, H-11), 5.95 (d, 1H, 3.5 Hz, H-12), 6.45 (dd, 1H, 4.0, 3.0 Hz, H-3),
6.50 (d, 1H, 4.0 Hz, H-2), 6.80 (s, 1H, H-6), 6.90 (d, 1H, 3.0 Hz, H-4), 7.50 (s,
1H, H-9)
13C-NMR (CDCl3, 100MHz) δ: 14.58, 23.68, 28.25, 28.68, 29.11, 29.31, 29.42, 
29.45, 29.68, 29.88, 32.98, 58.15, 96.84, 110.15, 115.84, 121.21, 126.31,
127.96, 128.35, 132.65, 143.65, 145.84, 146.84, 163.84, 170.32.
IR (νmax/cm-1): 3261, 2951, 2922, 2848, 1612, 1579, 1541
m.p.: 70-71 °C
HRMS: m/z calculated for C25H34N2O2: 395.2693 [M+H]+. Found: 395.2694
Furanyl-2,4-dimethylprodiginine
1
5
N
8
76
9
OMe
16
4
3
2 O
10
HN
13
12
11
15
14
Crude residue purified using flash column chromatography over silica gel with
gradient elution of 0-40% ethyl acetate/hexane.
23 mg (34 %)
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1H-NMR (CDCl3, 400MHz) δ: 2.20 (s, 3H, H-14), 2.35 (s, 3H, H-15), 3.85 (s, 3H, 
H-16), 5.80 (s, 1H, H-12), 5.90 (s, 1H, H-6), 6.45 (t, 1H, 3.0 Hz, H-3), 6.85 (s,
1H, H-9), 6.90 (d, 1H, 3.0 Hz, H-2), 7.45 (d, 1H, 3.0 Hz, H-4)
IR (νmax/cm-1): 3294, 2913, 2865, 1635, 1568, 1512
HRMS: m/z calculated for C16H16N2O2: 269.1285 [M+H]+. Found: 269.1287
Phenyl undecylprodiginine analogue
Crude residue purified using flash column chromatography over silica gel with
gradient elution of 0-20% ethyl acetate/hexane.
79 mg (97 %)
1H-NMR (CDCl3, 400MHz) δ: 0.80 (t, 3H, 6.5 Hz, H-26), 1.20 (m, 16H, H-18-H-
25), 1.65 (m, 2H, H-17), 2.65 (t, 1H, 7.0 Hz, H-16), 3.80 (s, 1H, H-27), 5.90 (d,
1H, 3.5 Hz, H-13), 6.00 (s, 1H, H-8), 6.50 (d, 1H, 3.5 Hz, H-14), 6.80 (s, 1H, H-
11), 7.35 (m, 3H, H-3-H-5), 7.90 (d, 2H, 7.0 Hz, H-2 and H-6).
13C-NMR (CDCl3, 100MHz) δ: 14.26, 22.82, 28.59, 29.04, 29.48, 29.51, 29.64, 
29.65, 29.75, 29.80, 32.04, 58.39, 94.73, 109.63, 118.45, 120.68, 126.87,
128.63, 129.69, 130.11, 135.23, 140.94, 143.67, 165.56,168.53.
IR (νmax/cm-1): 3251, 2960, 2917, 2848, 1613, 1594, 1579, 1542
m.p.: 100-101 °C
HRMS: m/z calculated for C27H36N2O: 405.2900 [M+H]+. Found: 405.2897
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Phenyl-2,4-dimethylprodiginine
Crude residue purified using flash column chromatography over silica gel with
gradient elution of 0-20% diethyl ether/hexane.
44 mg (79 %)
1H-NMR (CDCl3, 400MHz) δ: 2.10 (s, 3H, H-16), 2.30 (s, 3H, H-17), 3.80 (s, 3H, 
H-18), 5.75 (s, 1H, H-14), 6.00 (s, 1H, H-8), 6.85 (s, 1H, H-11), 7.30 (m, 3H, H-
3-H-5), 7.90 (d, 2H, 7.0 Hz, H-2 and H-6).
IR (νmax/cm-1): 3261, 2953, 2945, 2831, 1648, 1589, 1519
HRMS: m/z calculated for C18H18N2O: 279.1492 [M+H]+. Found: 279.1493
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7.2 Summary of selected characteristic resonances from
1H-NMR spectroscopy analyses of streptorubin B
analogues from mutasynthesis experiments
Proton
number
Streptorubin
B 124 126 130
A2 - - - -
A3 6.90 6.91 6.90 6.91
A4 6.34 6.35 6.34 6.35
A5 7.22 7.23 7.22 7.22
B2 - - - -
B3 - - - -
-OCH3 4.02 4.05 4.03 4.03
B4 6.10 6.10 6.10 6.08
B5 - - - -
C2 - - - -
C3 6.52 6.52 6.52 6.51 or6.33
C4 - - - -
C5 - - - -
1′ 
(a) 3.34
(b) 2.54
(a) 3.34
(b) 2.56
(a) 3.34
(b) 2.54
(a) 3.30-3.34
(b) 2.52-2.53
4′ 
(a) 1.11-1.89
(b) -1.54
(a) 1.23-
1.91
(b) -1.54
(a) 1.18-1.87
(b) -1.54
(a) ~1.19-
1.23
(b) -1.54 or
0.26
7′ 3.10 3.13 3.12 3.10 or 3.02 
10′ 1.32-1.42 5.87 0.91-0.96 ~ 1.35 – 1.42 
11′ 0.90-0.97 
(a) 5.00
(b) 5.03 n/a ~ 1.33 – 1.42
12′ n/a n/a n/a 0.91 – 0.95 
1′′ 7.12 7.11 7.13 
7.13 or
7.09
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Proton
number Streptorubin B 134 136a
A2 - - -
A3 6.90 6.90 6.90
A4 6.34 6.34 6.35
A5 7.22 7.22 7.22
B2 - - -
B3 - - -
-OCH3 4.02 4.03 4.03
B4 6.10 6.10 6.10
B5 - - -
C2 - - -
C3 6.52 6.51 6.52 or6.50
C4 - - -
C5 - - -
1′ 
(a) 3.34
(b) 2.54
(a) 3.34
(b) 2.54
(a) 3.34
(b) 2.53
4′ 
(a) 1.11-1.89
(b) -1.54
(a) 1.12 –
1.91
(b) -1.54
(a) 1.11-
1.90
(b) -1.54
7′ 3.10 3.06 
3.26 or
3.21
10′ 1.32-1.42 1.51-1.67 1.31-1.43 
11′ 0.90-0.97 
~ 0.84 –
0.89 0.89-0.91
12′ n/a 
~ 0.84 –
0.89 0.81-0.85
1′′ 7.12 7.12 7.12 
Proton
number
Undecylprodiginine
(DCM)
136b
(DCM)
A5 7.27 7.26
1′′ 7.06 7.06 
C3 7.02 7.03
A3 6.89 6.89
A4 6.39 6.40
C2 6.24 6.24
B4 6.17 6.17
C6′-C8′ n/a 5.36-5.06(mulitplet)
-OCH3 4.03 4.03
1′ 2.92 2.91 
11′ 
0.87
(triplet)
0.83
(multiplet)
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7.3 General procedure for Streptomyces sp. spore stock
creation 110
To mannitol-soy flour agar110 plates was added 100 μl of sterile water, followed 
by 10 μl of spore suspension and the spores were spread across the surface of 
the plate. After incubation for 3 days at 30 °C sterile water (5 ml) was added to
the plate, and an inoculation loop was used to loosen the spores on the surface.
The spores suspended in the water were transferred to a syringe with a glass
wool filter, and filtered into a 15 ml sterile tube to remove mycelial fragments.
The water was then centrifuged for 10 min at 4000 rpm to pellet the spores, the
supernatant was discarded and the spores then re-suspended in the remaining
water. The spore suspension was then diluted with water (300 μl) and 
transferred to a cryotube, to which 50 % glycerol solution (300 μl) was added. 
The resulting spore suspension in 25 % glycerol was stored at -20 °C for future
use.
7.4 Feeding of synthetic MBC analogues for
mutasynthesis and restoration experiments
R5 agar plates110 were overlaid with sterile permeable membranes (12 – 14 kDa
molecular weight cut off). Sterile water (100 μl) was added to the plates, 
followed by the spore suspension (10 μl) and the spores were spread across the 
surface of the plate. After 3 days of incubation at 30 °C, the desired MBC (or
MBC analogue) in DMSO (200 μl, 5 mg/ml) was diluted with water (2 ml) and the 
resulting suspension was added to the plate in small droplets across the
surface.
The plate was incubated at 30 °C for a further 2 days. The membrane was then
peeled off and the mycelia were placed into a 15 ml centrifuge tube.
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Acetonitrile:Methanol (1:1, 10 ml) + 0.1%(v/v) HCl (aq, 2 N) was added followed
by sonication (approximately 5 minutes) to break up the mycelia. The resulting
suspension was then centrifuged at 4000 rpm for 10 min and the organic
supernatants were analysed by LC-MS.
7.5 Feeding of synthetic 2-undecylpyrrole analogues for
large scale mutasynthesis and isolation
25 square 50 ml R5 agar plates110 were overlaid with sterile permeable
membranes (12 - 14 KDa molecular weight cut-off). Sterile water (200 μl) was 
added to the plates, followed by the spore suspension (20 μl) and the spores 
were spread across the surface of the plate. After 3 days of incubation at 30 °C,
the desired 2-undecylpyrrole analogue in methanol (200 μl, 5 mg/ml) was diluted 
with water (2 ml) and the resulting suspension was added to each plate in small
droplets across the surface.
The plates were incubated at 30 °C for a further 2 days. The membranes were
then peeled off and the mycelia combined into four 50 ml centrifuge tubes.
Methanol (20 ml) + 0.1%(v/v) HCl (aq, 2 N) was added followed by sonication
(approximately 5 minutes) to break up the mycelia. The resulting suspension
was then centrifuged at 4000 rpm for 10 min and the organic supernatants were
combined. The mycelia were then further extracted with two further sequences
of methanol (20 ml) + 0.1%(v/v) HCl (aq, 2 N) and centrifugation (4000 rpm for
10 min). The combined bright red organic extracts were then concentrated in
vacuo, and the resulting residue was then partitioned between water (pH 3, 100
ml) and chloroform (100 ml) and filtered under vacuum to remove residual
mycelial fragments. The resulting biphasic mixture was then diluted with water
(pH 3, 100 ml), and the deep red organic layer was separated. The resulting
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aqueous layer was then further extracted with chloroform (2 x 100 ml) and the
resulting organic extracts were combined, dried over magnesium sulphate and
concentrated in vacuo to leave a dark red viscous oil.
7.6 LC-MS analysis
Liquid chromatography – mass spectrometry was used to analyse the extracts
from feeding studies. An Agilent 1100 HPLC instrument connected to a Bruker
HCT+ mass spectrometer was used. Samples were analysed on an Agilent
Ecilpse XDB-C8 column (4.6 mm x 150 mm, 5 μm, column temperature 25 °C) 
using the elution profile in Table 1 below.
Table 1: Elution profile for LC-MS analysis of prodiginines
Time
(mins)
Water (pH 3 with
HCl)
Acetonitrile (or
Methanol)
Flow Rate
(ml/min)
0 50 50 1.0
1 50 50 1.0
4 25 75 1.3
21 20 80 1.4
23 50 50 1.0
7.7 Semi-preparative liquid chromatography purification
of streptorubin B and analogues
The crude mixture isolated from the mycelial extraction procedure was purified
through basic alumina, eluting with hexane/ethyl acetate (0-15 %) as follows.
Initial washing of the column with hexane yielded a black pigmented mixture of
compounds which was discarded. Subsequent washing with 5-15 %
hexane/ethyl acetate yielded one small fraction of a yellow pigment fraction
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which was also discarded followed by a large brightly coloured yellow pigmented
fraction. Elution with 15% ethyl acetate/hexane was then continued until the
pigmentation of the fractions faded. The later yellow pigmented fraction was
evaporated to dryness in vacuo to leave a bright yellowish red semi-crude
mixture of undecylprodiginine (or an analogue) and streptorubin B (or an
analogue) as their free bases. The mixture was then dissolved in chloroform and
washed with water (pH 3 with HCl.). The aqueous layer was then separated and
extracted with two further portions of chloroform. The combined organic fractions
were then dried over magnesium sulphate and evaporated to dryness in vacuo
to leave a bright red semi-crude mixture of undecylprodiginine (or an analogue)
and streptorubin B (or an analogue).
An Agilent 1200 HPLC instrument was used to purify the desired streptorubin B
(or an analogue) from the semi-crude mixture of undecylprodiginine (or an
analogue) and streptorubin B (or an analogue) obtained after purification
through basic alumina. Streptorubin B (or an analogue) was purified first on an
Agilent Zorbax XDB-C18 column (21.2 x 150 mm, 5 μm, column temperature 
25 °C) using the elution profiles detailed below in either Table 2, Table 3 or
Table 4.
Table 2: 1st purification for streptorubin B and for all analogues (with the
exception of C9′-methyl branched analogue and the C3′-oxa analogue). 
Time
(mins)
Water (pH 3 with
HCl)
MeOH (+ 0.1 % 2N
HCl)
Flow Rate
(ml/min)
0.00 30 70 20.0
5.00 25 75 20.0
7.50 20 80 20.0
10.00 10 90 20.0
11.25 10 90 20.0
11.50 30 70 20.0
12.50 30 70 20.0
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Table 3: 1st purification for C9′-methyl branched analogue  
Time
(mins)
Water (pH 3 with
HCl)
MeOH (+0.1 % 2N
HCl)
Flow Rate
(ml/min)
0.00 28 72 20.0
5.00 25 75 20.0
7.50 24 76 20.0
13.00 24 76 20.0
14.00 10 90 20.0
16.00 10 90 20.0
16.25 28 72 20.0
17.00 28 72 20.0
Table 4: 1st purification for C3′-oxa analogue 
Time
(mins)
Water (pH 3 with
HCl)
MeOH (+0.1 % 2N
HCl)
Flow Rate
(ml/min)
0.00 32 68 20.0
5.00 29 71 20.0
7.50 20 80 20.0
10.00 10 90 20.0
11.25 10 90 20.0
11.50 32 68 20.0
12.50 32 68 20.0
The products with retention times as listed below (Table 5) were collected by an
automated fraction collector system triggered by either time or peak gradient.
The combined fractions were then partitioned between chloroform and water (pH
3, with HCl). The aqueous layer was separated and extracted with two further
portions of chloroform. The combined organic extracts were then washed with
water, dried over magnesium sulphate and evaporated in vacuo to leave the
streptorubin B (or an analogue) as a bright red solid.
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Table 5: Retention time of carbocyclic prodiginines during first purification on C18
column
Prodiginine Retention time (mins)
Streptorubin B 6.5 – 7.8
C10 streptorubin B analogue 5.5 – 6.5
C12 streptorubin B analogue 8.2 – 9.3
Alkenyl streptorubin B analogue 4.0 – 5.0
C10 methyl branched streptorubin B analogue 5.7 – 6.2
C9 methyl branched streptorubin B analogue 6.2 – 7.5
C2-C4 ether linked streptorubin B analogue 3.5 – 4.8
The resulting solid was re-dissolved in methanol for subsequent additional
purification on the same Agilent 1200 HPLC system. An Agilent Zorbax SB-
Phenyl column (21.2 x 250 mm, 7 μm, column temperature 25 °C) was used 
with the elution profile detailed below in Table 6.
Table 6: 2nd Purification for streptorubin B and all analogues
Time
(mins)
Water (pH 3 with
HCl)
MeOH (+0.1 % 2N
HCl)
Flow Rate
(ml/min)
0.00 24 76 20.0
10.00 17 83 20.0
11.00 10 90 20.0
13.00 10 90 20.0
13.10 24 76 20.0
16.50 24 76 20.0
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7.8 Stereochemical analyses of streptorubin B and
analogues by CD spectroscopy
A Jasco J-815 CD spectrometer was used to record the circular dichroism
spectra of streptorubin B (or an analogue) and metacycloprodigiosin. Samples
were dissolved in spectroscopic grade methanol (Sigma-Aldrich) and the CD
spectrum from 700 to 200 nm of each solution was measured in a 1 mm path
length cuvette. Instrument settings were as follows: resolution 0.4 nm, band
width 2.0 nm, sensitivity 200 mdeg, response 1 s, speed 200 nm/min. The
concentration of each sample was subsequently determined from the intensities
of the signal at 533 nm in the UV-vis chromatogram (recorded on a Perkin-Elmer
Lambda 35 UV/VIS spectrometer, 1 cm path length) of each compound with the
known extinction coefficient (100 500 M-1 cm-1) after an appropriate dilution.
7.9 Stereochemical analyses of streptorubin B and
analogues by HPLC on a homochiral stationary phase
Liquid chromatography on a homochiral stationary phase was used to analyse
streptorubin B (or an analogue) and metacycloprodigiosin. Samples were
prepared as the corresponding free base before analyses by dissolving in
hexane/isopropanol (95:5) + 0.1 % diethylamine. An Agilent 1100 HPLC
instrument was used. Samples were analysed on a Chiral Technologies Europe
ChiralPak IA column (4.6 mm x 250 mm, column temperature 20 °C) using the
elution profile in Table 7 below.
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Table 7: Elution profile for HPLC analyses of prodiginines on a homochiral
stationary phase.
Time
(mins)
Hexane (+0.1 %
diethylamine)
Isopropanol (+0.1 %
diethylamine)
Flow Rate
(ml/min)
0.00 95 5 1.0
20.00 95 5 1.0
21.00 90 10 1.0
50.00 90 10 1.0
51.00 95 5 1.0
60.00 95 5 1.0
7.10 Stereochemical analyses of lactone intermediates
(R)- and (S)-151 by HPLC on a homochiral stationary
phase
Liquid chromatography on a homochiral stationary phase was used to analyse
the lactone intermediates (R)- and (S)-151. Samples were prepared by
dissolving in hexane/isopropanol. An Agilent 1100 HPLC instrument was used.
Samples were analysed on a Chiral Technologies Europe ChiralPak IA column
(4.6 mm x 250 mm, column temperature 20 °C) using the elution profile in Table
8 below.
Table 8: Elution profile for HPLC analyses of lactones (R)- and (S)-151 on a
homochiral stationary phase.
Time (mins) Hexane Isopropanol Flow Rate (ml/min)
0.00 96 4 1.0
10.00 95 5 1.0
25.00 95 5 1.0
26.00 96 4 1.0
30.00 96 4 1.0
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